<?xml version='1.0' encoding='UTF-8'?>
<chapter id="ch0074">
    <title>57 Bacteroides, Porphyromonas, Prevotella, Fusobacterium, and Other Anaerobic Gram-Negative Rods</title>
    <sect1 id="ch0074s0001">
      <title>57 Bacteroides, Porphyromonas, Prevotella, Fusobacterium, and Other Anaerobic Gram-Negative Rods</title>
      <anchor id="ch0074s0001a0001"/>
      <anchor id="ch0074s0001a0002"/>
      <para role="chapterAuthor"><phrase role="center">GEORG CONRADS, ELISABETH NAGY, AND EIJA KÖNÖNEN</phrase>
      </para>
      <sect2 id="ch0074s0001s0001">
        <title>TAXONOMY AND DESCRIPTION OF THE GROUP</title>
        <anchor id="ch0074s0001s0001a0001"/>
        <anchor id="ch0074s0001s0001a0002"/>
        <para id="ch0074s0001s0001p0001">Most of the obligately anaerobic, Gram-negative, non-spore-forming rods of clinical relevance belong to the phylum<emphasis>Bacteroidetes</emphasis>, order <emphasis>Bacteroidales</emphasis>, including families <emphasis>Bacteroidaceae, Porphyromonadaceae, Prevotellaceae</emphasis>, and <emphasis>Rikenellaceae</emphasis>, and to the phylum <emphasis>Fusobacteria</emphasis>, order <emphasis>Fusobacteriales</emphasis>, including the families <emphasis>Fusobacteriaceae</emphasis> and <emphasis>Leptotrichiaceae.</emphasis> In addition, clinically important taxa representing anaerobic, Gram-negative, non-spore-forming rods exist in some other phyla, such as <emphasis>Firmicutes, Proteobacteria</emphasis>, and <emphasis>Synergistetes.</emphasis> There have been a considerable number of changes in the taxonomy of the taxa that are covered in this chapter; two new genera have been named, and several novel species have been described in the past few years. The changes made since 2017 are restricted to validly published new taxa, which are listed in Table 1. Table 2 gives characteristics of anaerobic Gram-negative genera that have grown from clinical specimens, and these are summarized below.</para>
        <para id="ch0074s0001s0001p0002">Within the family<emphasis>Bacteroidaceae</emphasis>, the genus <emphasis>Bacteroides</emphasis> consists of saccharolytic, bile-resistant, and nonpigmented species, mainly isolated from the gut. The genus is limited to species within the <emphasis>Bacteroides fragilis</emphasis> group (<link linkend="ch0074s0011s0003li0001">1</link>). It includes 101 validly published species, of which more than half have been recovered from humans (for an update see <ulink url="http://www.bacterio.net">www.bacterio.net</ulink>). Of these, especially <emphasis>B. fragilis, B. thetaiotaomicron</emphasis>, and <emphasis>B. ovatus</emphasis> are most relevant in human infections (<link linkend="ch0074s0011s0003li0002">2</link>). Five new species, <emphasis>B. faecalis, B. koreensis, B. kribbi, B. luhongzhouii</emphasis>, and <emphasis>B. zhangwenhongii</emphasis>, were recently isolated from human fecal samples (Table 1) (<link linkend="ch0074s0011s0003li0003">3</link>–<link linkend="ch0074s0011s0003li0005">5</link>).</para>
        <para id="ch0074s0001s0001p0003">The genus<emphasis>Alistipes</emphasis>, which belongs to the family <emphasis>Rikenellaceae</emphasis>, currently includes 10 validly published species: <emphasis>A. communis</emphasis> (new), <emphasis>A. dispar</emphasis> (new), <emphasis>A. finegoldii, A. indistinctus, A. ihumii</emphasis> (validated), <emphasis>A. inops, A. onderdonkii</emphasis> (now divided into two subspecies), <emphasis>A. putredinis, A. shahii</emphasis>, and <emphasis>A. timonensis</emphasis> (<link linkend="ch0074s0011s0003li0006">6</link>–<link linkend="ch0074s0011s0003li0008">8</link>). In general, <emphasis>Alistipes</emphasis> species are straight or slightly curved short rods. Pigmentation, catalase reaction, indole production, and resistance to bile are variable.</para>
        <para id="ch0074s0001s0001p0004">The family<emphasis>Porphyromonadaceae</emphasis> includes seven genera with species detected in humans: <emphasis>Barnesiella, Butyricimonas, Coprobacter, Odoribacter, Parabacteroides, Porphyromonas</emphasis>, and <emphasis>Tannerella.</emphasis> Of these genera, <emphasis>Porphyromonas</emphasis> is clinically most relevant. There are currently 20 validly published <emphasis>Porphyromonas</emphasis> species, many of which are of animal origin. <emphasis>P. asaccharolytica, P. bennonis, P. catoniae, P. endodontalis, P. gingivalis, P. somerae</emphasis>, and <emphasis>P. uenonis</emphasis> are frequently detected in humans (<link linkend="ch0074s0011s0003li0009">9</link>–<link linkend="ch0074s0011s0003li0013">13</link>). More recently described species of human origin are <emphasis>P. bronchialis</emphasis> (a validly published synonym of <emphasis>P. macacae</emphasis>), isolated from intraoperative bronchial fluids of an elderly patient with non-small cell lung cancer (<link linkend="ch0074s0011s0003li0014">14</link>); <emphasis>P. pasteri</emphasis>, isolated from human saliva (<link linkend="ch0074s0011s0003li0015">15</link>); and <emphasis>P. pogonae</emphasis>, isolated from lizards, but also from human specimens taken from acute sinusitis, soft tissue infection, and blood (<link linkend="ch0074s0011s0003li0016">16</link>–<link linkend="ch0074s0011s0003li0018">18</link>). Most species are asaccharolytic and pigmented; however, a growing number of species, including <emphasis>P. bennonis, P. catoniae, P. pasteri, P. pogonae</emphasis>, and <emphasis>P. bronchialis</emphasis>, are nonpigmented. Human <emphasis>Parabacteroides</emphasis> species consist of <emphasis>P. distasonis, P. faecis, P. goldsteinii, P. gordonii, P. johnsonii</emphasis>, and <emphasis>P. merdae</emphasis>, as well as two novel species, <emphasis>P. acidifaciens</emphasis> from human feces (<link linkend="ch0074s0011s0003li0019">19</link>) and <emphasis>P. chongii</emphasis>, isolated from blood of a patient with periodontitis (<link linkend="ch0074s0011s0003li0020">20</link>). <emphasis>Parabacteroides</emphasis> organisms are saccharolytic and resistant to 20% bile. The genus is phylogenetically closely related to the genera <emphasis>Tannerella</emphasis> and <emphasis>Barnesiella</emphasis>, both being anaerobic, nonpigmented, nonmotile, pleomorphic rods. The genus <emphasis>Tannerella</emphasis> currently contains two species, <emphasis>T. forsythia</emphasis> (formerly <emphasis>T. forsythensis</emphasis>) (<link linkend="ch0074s0011s0003li0021">21</link>), which is an important oral pathogen, and the newly described <emphasis>T. serpentiformis</emphasis>, with a snake-like morphology (<link linkend="ch0074s0011s0003li0022">22</link>). The genus <emphasis>Barnesiella</emphasis> still has only one human species, <emphasis>B. intestinihominis</emphasis>, isolated from feces (<link linkend="ch0074s0011s0003li0023">23</link>). The genus <emphasis>Butyricimonas</emphasis> contains the novel species <emphasis>B. faecalis</emphasis> (<link linkend="ch0074s0011s0003li0024">24</link>), <emphasis>B. faecihominis</emphasis>, and <emphasis>B. paravirosa</emphasis> of human fecal origin. <emphasis>B. virosa</emphasis>, originally isolated from rat feces, has been isolated from several cases of bacteremia in humans (<link linkend="ch0074s0011s0003li0025">25</link>, <link linkend="ch0074s0011s0003li0026">26</link>). The genus <emphasis>Coprobacter</emphasis>, with <emphasis>C. fastidiosus</emphasis>, a nonmotile Gram-negative rod isolated from infant feces, and the second discovered species <emphasis>C. secundus</emphasis>, isolated from stool (<link linkend="ch0074s0011s0003li0027">27</link>), is most closely related to <emphasis>Barnesiella</emphasis> (<link linkend="ch0074s0011s0003li0028">28</link>) and has no reported clinical significance to date. The genus <emphasis>Odoribacter</emphasis> includes two human-derived species, <emphasis>O. splanchnicus</emphasis> (formerly <emphasis>Bacteroides</emphasis>) and <emphasis>O. laneus</emphasis> (<link linkend="ch0074s0011s0003li0029">29</link>, <link linkend="ch0074s0011s0003li0030">30</link>). <emphasis>O. splanchnicus</emphasis> is saccharolytic and bile resistant, while <emphasis>O. laneus</emphasis> is asaccharolytic and susceptible to 20% bile.</para>
        <para id="ch0074s0001s0001p0005">The family<emphasis>Prevotellaceae</emphasis> includes saccharolytic or moderately saccharolytic short rods that produce acetic and succinic acids as their major end products of fermentation (<link linkend="ch0074s0011s0003li0031">31</link>). This family has increased by the addition of a tremendous number of novel species and species candidates in recent years. Most novel <emphasis>Prevotella</emphasis> species have been isolated from the oral cavity (<link linkend="ch0074s0011s0003li0032">32</link>–<link linkend="ch0074s0011s0003li0036">36</link>) but also from feces (<link linkend="ch0074s0011s0003li0037">37</link>) and from other sites of the body, where they have been associated with various clinical conditions (<link linkend="ch0074s0011s0003li0038">38</link>–<link linkend="ch0074s0011s0003li0043">43</link>). Six validly published <emphasis>Prevotella</emphasis> species of human origin, <emphasis>P. brunnea, P. hominis, P. lascolaii, P. phocaeensis, P. rara</emphasis>, and <emphasis>P. vespertina</emphasis>, were described recently (<link linkend="ch0074s0011s0003li0044">44</link>–<link linkend="ch0074s0011s0003li0049">49</link>). <emphasis>P. heparinolytica</emphasis> and <emphasis>P. zoogleoformans</emphasis>, mainly isolated from infected cat and dog bite wounds, are only loosely connected to other <emphasis>Prevotella</emphasis> species and, instead, cluster phylogenetically with <emphasis>Bacteroides</emphasis> species. <emphasis>Alloprevotella</emphasis>, a genus phylogenetically close to <emphasis>Prevotella</emphasis>, contains the former <emphasis>Prevotella tannerae</emphasis>, reassigned to <emphasis>A. tannerae</emphasis>, and <emphasis>A. rava</emphasis> (<link linkend="ch0074s0011s0003li0050">50</link>). Another genus distantly related to <emphasis>Prevotella, Paraprevotella</emphasis>, consists of <emphasis>P. clara</emphasis> and <emphasis>P. xylaniphila</emphasis>, isolated from human feces (<link linkend="ch0074s0011s0003li0051">51</link>).</para>
        <anchor id="ch0074s0001s0001a0003"/>
        <beginpage pagenum="1101"/>
        <para id="ch0074s0001s0001p0006">The phylum<emphasis>Bacteroidetes</emphasis> includes a genus <emphasis>Phocaeicola</emphasis>, with 12 validly published species. Two recent milestone publications validated most of the species described (<link linkend="ch0074s0011s0003li0052">52</link>, <link linkend="ch0074s0011s0003li0053">53</link>) and quite a few are of human fecal origin. However, except for <emphasis>P. abscessus</emphasis> (<link linkend="ch0074s0011s0003li0054">54</link>), <emphasis>P. dorei</emphasis> (<link linkend="ch0074s0011s0003li0055">55</link>) (with most information available under the former name <emphasis>Bacteroides dorei</emphasis>), and <emphasis>P.</emphasis> (formerly <emphasis>Bacteroides</emphasis>) <emphasis>massiliensis</emphasis> (<link linkend="ch0074s0011s0003li0056">56</link>), no clinical implications in humans have been described.</para>
        <para id="ch0074s0001s0001p0007">In the family<emphasis>Fusobacteriaceae</emphasis> of the phylum <emphasis>Fusobacteria</emphasis>, the genera of clinical interest are <emphasis>Fusobacterium, Leptotrichia</emphasis>, and <emphasis>Sneathia.</emphasis> These organisms are nonmotile, pleomorphic rods, mainly isolated from the oral cavity and female genital tract. The somewhat fuzzy phylogeny of fusobacteria and great heterogeneity of <emphasis>F. nucleatum</emphasis>, in particular, have been explained by potential horizontal gene transfer that occurred in the close interaction of oral bacteria within dental biofilms (<link linkend="ch0074s0011s0003li0057">57</link>, <link linkend="ch0074s0011s0003li0058">58</link>). The fusobacterial subspecies show sex-specific differences in abundance and are implicated in carcinogenesis (<link linkend="ch0074s0011s0003li0059">59</link>, <link linkend="ch0074s0011s0003li0060">60</link>). The genus <emphasis>Leptotrichia</emphasis> consists of nonmotile, highly saccharolytic, long rods that typically produce lactic acid. The current validly described <emphasis>Leptotrichia</emphasis> species are <emphasis>L. buccalis, L. hofstadii, L. hongkongensis, L. shahii, L. trevisanii</emphasis>, and <emphasis>L. wadei</emphasis>, while <emphasis>L. goodfellowii</emphasis> has been reclassified as <emphasis>Pseudoleptotrichia</emphasis> (new genus) <emphasis>goodfellowii</emphasis> (<link linkend="ch0074s0011s0003li0061">61</link>). “<emphasis>L. amnionii</emphasis>,” originally isolated from amniotic fluid (<link linkend="ch0074s0011s0003li0062">62</link>), was recently validly reclassified as <emphasis>Sneathia vaginalis</emphasis> (<link linkend="ch0074s0011s0003li0063">63</link>), also replacing <emphasis>S. a</emphasis><emphasis>mnii</emphasis> (<link linkend="ch0074s0011s0003li0064">64</link>).</para>
        <para id="ch0074s0001s0001p0008">Among the phylum<emphasis>Synergistetes</emphasis>, there are few cultivable human species, namely <emphasis>Fretibacterium fastidiosum</emphasis> (<link linkend="ch0074s0011s0003li0065">65</link>), <emphasis>Jonquetella anthropi</emphasis> (<link linkend="ch0074s0011s0003li0066">66</link>), <emphasis>Pyramidobacter piscolens</emphasis> (<link linkend="ch0074s0011s0003li0067">67</link>), and <emphasis>Rarimicrobium hominis</emphasis> (<link linkend="ch0074s0011s0003li0068">68</link>, <link linkend="ch0074s0011s0003li0069">69</link>). In addition, two <emphasis>Cloacibacillus</emphasis> species, <emphasis>C. evryensis</emphasis> and <emphasis>C. porcorum</emphasis>, originating from an anaerobic sludge digestor and from a pig cecum, respectively, have been isolated from human specimens (<link linkend="ch0074s0011s0003li0069">69</link>). They are obligately anaerobic, nonmotile, Gram-negative organisms. Fluorescence <emphasis>in situ</emphasis> hybridization analysis has revealed that the oral cavity harbors further unculturable <emphasis>Synergistetes</emphasis>, which are large curved bacilli (<link linkend="ch0074s0011s0003li0070">70</link>), and they are widely distributed in various human ecosystems in both health and disease (<link linkend="ch0074s0011s0003li0070">70</link>, <link linkend="ch0074s0011s0003li0071">71</link>).</para>
        <para id="ch0074s0001s0001p0009">In the Gram-positive phylum<emphasis>Firmicutes</emphasis>, the class <emphasis>Negativicutes</emphasis> harbors organisms with a traditional Gram-negative cell wall structure (<link linkend="ch0074s0011s0003li0072">72</link>), including some clinically important genera such as <emphasis>Dialister, Megamonas, Selenomonas</emphasis>, and <emphasis>Centipeda.</emphasis> The genus <emphasis>Dialister</emphasis> includes six species of human origin: <emphasis>D. invisus</emphasis> (<link linkend="ch0074s0011s0003li0073">73</link>) and <emphasis>D. pneumosintes</emphasis> (formerly <emphasis>Bacteroides pneumosintes</emphasis>) isolated from the oral cavity, <emphasis>D. micraerophilus</emphasis> and <emphasis>D. propionicifaciens</emphasis> (<link linkend="ch0074s0011s0003li0074">74</link>) from clinical specimens, as well as <emphasis>D. succinatiphilus</emphasis> and the recently described <emphasis>D. hominis</emphasis> from feces (<link linkend="ch0074s0011s0003li0023">23</link>, <link linkend="ch0074s0011s0003li0075">75</link>). These anaerobic or microaerobic, Gram-negative coccobacilli are asaccharolytic and largely unreactive in biochemical tests (<link linkend="ch0074s0011s0003li0074">74</link>). The two human species of the genus <emphasis>Megamonas, M. hypermegale</emphasis> and <emphasis>M. funiformis</emphasis> (<link linkend="ch0074s0011s0003li0076">76</link>), are anaerobic, Gram-negative, very large rods. In the genus <emphasis>Selenomonas, S. artemidis, S. dianae, S. flueggei, S. infelix, S. noxia</emphasis>, and <emphasis>S. sputigena</emphasis>, and also the closely related <emphasis>Centipeda periodontii</emphasis>, have been isolated from the human oral cavity (<link linkend="ch0074s0011s0003li0077">77</link>). They are anaerobic, space Gram-negative curved motile rods. Two strictly anaerobic, Gram-negative, nonmotile, long rod-shaped strains from human feces have been characterized and classified as <emphasis>Phascolarctobacterium succinatutens</emphasis> in the family <emphasis>Acidaminococcaceae</emphasis> (<link linkend="ch0074s0011s0003li0078">78</link>). <emphasis>Christensenella minuta</emphasis> and <emphasis>Christensenella intestinihominis</emphasis>, from human feces or mixed anaerobic infections, are anaerobic short rods with a Gram-negative cell wall (<link linkend="ch0074s0011s0003li0079">79</link>–<link linkend="ch0074s0011s0003li0081">81</link>). Phylogenetically, they belong to a novel family, <emphasis>Christensenellaceae</emphasis>, within the phylum <emphasis>F</emphasis><emphasis>irmicutes</emphasis>.</para>
        <anchor id="ch0074s0001s0001a0004"/>
        <beginpage pagenum="1102"/>
        <anchor id="ch0074s0001s0001a0005"/>
        <beginpage pagenum="1103"/>
        <para id="ch0074s0001s0001p0010">Various families in the phylum<emphasis>Proteobacteria</emphasis> include some anaerobic genera and species with clinical importance in humans. The genera <emphasis>Sutterella, Mesosutterella</emphasis> (new genus), and <emphasis>Parasutterella</emphasis> are among the family <emphasis>Sutterellaceae</emphasis> (<link linkend="ch0074s0011s0003li0082">82</link>). They consist of asaccharolytic, bile-resistant, Gram-negative short rods or coccobacilli, of which <emphasis>S. wadsworthensis, S. parvirubra, S. megalosphaeroides</emphasis> (new species [83]), <emphasis>P. excrementihominis, P. secunda</emphasis>, and <emphasis>M. multiformis</emphasis> (new species [83]) have been isolated from human specimens. The family <emphasis>Desulfovibrionaceae</emphasis> contains two genera of clinical interest, <emphasis>Bilophila</emphasis> and <emphasis>Desulfovibrio. Bilophila wadsworthia</emphasis> is an anaerobic, asaccharolytic, bile-resistant, Gram-negative rod and is a significant pathogen in humans (<link linkend="ch0074s0011s0003li0084">84</link>). Of the more than 70 <emphasis>Desulfovibrio</emphasis> species and subspecies, only a few infrequently cause a variety of human infections (<link linkend="ch0074s0011s0003li0085">85</link>). In the family <emphasis>Desulfomicrobiaceae</emphasis>, the genus <emphasis>Desulfomicrobium</emphasis> includes one human species, <emphasis>D. orale</emphasis>, which is associated with periodontal diseases (<link linkend="ch0074s0011s0003li0086">86</link>). In the family <emphasis>Succinivibrionaceae</emphasis>, the genus <emphasis>Anaerobiospirillum</emphasis> includes two species, <emphasis>A. thomasii</emphasis> and <emphasis>A. succiniciproducens</emphasis>, isolated from feces of humans, cats, and dogs (<link linkend="ch0074s0011s0003li0087">87</link>) but the latter species has also been isolated from prosthetic joint infections (<link linkend="ch0074s0011s0003li0088">88</link>), while the genus <emphasis>Succinatimonas</emphasis> has one species, <emphasis>S. hippei</emphasis>, isolated from human feces (<link linkend="ch0074s0011s0003li0089">89</link>). <emphasis>S. hippei</emphasis> is nonmotile and has nonspiral cells without flagella, whereas <emphasis>Anaerobiospirillum, Desulfovibrio</emphasis> (except <emphasis>D. piger</emphasis>), and <emphasis>Desulfomicrobium</emphasis> are motile, spiral-shaped bacteria that reduce sulfate.</para>
        <para id="ch0074s0001s0001p0011">Since 2002, genome projects have produced a tremendous number of complete genome sequences for a variety of Gram-negative anaerobic species, including members of almost all the genera discussed in this chapter. Readers are directed to the NCBI homepage (<ulink url="https://www.ncbi.nlm.nih.gov/genome/browse/">https://www.ncbi.nlm.nih.gov/genome/browse/</ulink>) for detailed information. Interestingly, the genome sequence for <emphasis>F. nucleatum</emphasis> revealed that although this species has a Gram-negative cell wall, including an outer membrane, a significant proportion of genes were related to homologues from Gram-positive species in the phylum <emphasis>Firmicutes</emphasis>, suggesting that <emphasis>Fusobacterium</emphasis> has a Gram-positive evolutionary history (<link linkend="ch0074s0011s0003li0090">90</link>).</para>
        <para id="ch0074s0001s0001p0012">Current methods used for taxonomic studies are mainly based on nucleic acid analyses, in particular, sequencing of the 16S rRNA gene and the comparison of these sequences in order to reveal the phylogenetic relatedness of taxa. Multilocus sequence typing, average-nucleotide-identity analyses, and genome-to-genome distance analyses have been introduced and might supplement or even replace DNA-DNA hybridization to delineate bacteria at the species level. These approaches do not necessarily correlate with phenotypic characteristics, such as cell and colony morphologies, atmospheric growth requirements, and various biochemical test results, which are still widely used in clinical microbiology laboratories. However, appropriate atmospheric requirements should be determined for all isolates, because the true anaerobes can be differentiated from facultatively anaerobic bacteria by their inability to grow in the presence of oxygen and by their susceptibility to metronidazole (<link linkend="ch0074s0011s0003li0091">91</link>). Table 2 presents differential characteristics of clinically relevant genera within the Gram-negative anaerobic rods.</para>
        <para id="ch0074s0001s0001p0013">Since the preparation of the last edition of this<emphasis>Manual</emphasis>, many additional candidate species were isolated from various clinical sites by a culturomics approach. We, the authors and editors of this chapter, decided not to include these candidate species, in most cases based on a single isolate, before their names are approved and/or their clinical significance is validated. However, without any doubt, and as we know from the “great plate count anomaly,” there are many additional new species out there (<link linkend="ch0074s0011s0003li0092">92</link>).</para>
      </sect2>
      <sect2 id="ch0074s0001s0002">
        <title>EPIDEMIOLOGY AND TRANSMISSION</title>
        <anchor id="ch0074s0001s0002a0001"/>
        <anchor id="ch0074s0001s0002a0002"/>
        <para id="ch0074s0001s0002p0001">Gram-negative anaerobic rods inhabit the mucosal surfaces of the oral cavity and gastrointestinal tract of animals and humans. Infants acquire oral and intestinal anaerobic commensals mainly from their mother and become simultaneously colonized by multiple strains of commensal species, e.g.,<emphasis>Prevotella melaninogenica, Fusobacterium nucleatum</emphasis>, or <emphasis>Bacteroides fragilis</emphasis> (<link linkend="ch0074s0011s0003li0093">93</link>–<link linkend="ch0074s0011s0003li0095">95</link>). In fact, some of these organisms, such as <emphasis>Fusobacterium</emphasis> and <emphasis>Prevotella</emphasis>, are ubiquitous members of the mouth from the early months of life and, when teeth erupt, form integral parts of dental biofilms (<link linkend="ch0074s0011s0003li0093">93</link>, <link linkend="ch0074s0011s0003li0096">96</link>). Furthermore, <emphasis>Prevotella</emphasis> has been shown among the dominant genera in other habitats, such as the esophagus, stomach, and lungs (<link linkend="ch0074s0011s0003li0097">97</link>–<link linkend="ch0074s0011s0003li0099">99</link>), which have previously been considered to have a very limited microbial diversity. Interestingly, in non-Westernized populations consuming fresh, unprocessed food, intestinal <emphasis>Prevotella</emphasis> species are common, playing an important role in nutrition and metabolism (<link linkend="ch0074s0011s0003li0100">100</link>). In the gut, <emphasis>Bacteroides</emphasis> becomes part of the microbiota in early infancy (<link linkend="ch0074s0011s0003li0095">95</link>), although as a result of cesarean section, the colonization of the <emphasis>B. fragilis</emphasis> group organisms can be delayed and the levels are greatly reduced (<link linkend="ch0074s0011s0003li0101">101</link>). Moreover, the composition of <emphasis>Bacteroides</emphasis> populations varies depending on the type of milk-feeding (<link linkend="ch0074s0011s0003li0102">102</link>). Two bacterial phyla, <emphasis>Firmicutes</emphasis> and <emphasis>Bacteroidetes</emphasis>, dominate in the gut. Changes in the microbial composition affect the gut barrier function with consequences for host physiology, energy balance (obesity risk), or mucosal immune system. In this context, Gram-negative anaerobes play a key role (<link linkend="ch0074s0011s0003li0002">2</link>, <link linkend="ch0074s0011s0003li0103">103</link>). In the female genital tract, when the vaginal hydrogen peroxide-producing lactobacilli decrease in numbers, some <emphasis>Prevotella</emphasis> species increase and become an important part with other commensal vaginosis-associated microorganisms (<link linkend="ch0074s0011s0003li0104">104</link>, <link linkend="ch0074s0011s0003li0105">105</link>). Notably, the microbiotas at different body sites are still poorly defined due to considerable proportions of not-yet-cultivated bacteria (<link linkend="ch0074s0011s0003li0071">71</link>, <link linkend="ch0074s0011s0003li0106">106</link>–<link linkend="ch0074s0011s0003li0108">108</link>).</para>
        <para id="ch0074s0001s0002p0002">Also, an important point to be mentioned is the considerable variation observed in the microbiotas due to geographical and ethnic differences. This variation clearly influences the recovery rates of disease-associated organisms in different populations (<link linkend="ch0074s0011s0003li0105">105</link>, <link linkend="ch0074s0011s0003li0109">109</link>–<link linkend="ch0074s0011s0003li0111">111</link>).</para>
        <anchor id="ch0074s0001s0002a0003"/>
        <beginpage pagenum="1104"/>
      </sect2>
      <sect2 id="ch0074s0001s0003">
        <title>CLINICAL SIGNIFICANCE</title>
        <anchor id="ch0074s0001s0003a0001"/>
        <anchor id="ch0074s0001s0003a0002"/>
        <para id="ch0074s0001s0003p0001">Anaerobes, originating mainly from the indigenous microbiota, are detected typically in polymicrobial infections associated with mucosal surfaces close to the site where they reside. Most infections are acquired when the integrity of the colonized mucosa or lumen is breached by trauma or underlying disease or during surgery. Biofilm-associated infections, such as periodontitis and bacterial vaginosis, occur when certain indigenous organisms with virulent properties are enriched within subgingival or vaginal biofilms, respectively, thus causing dysbiosis of the local microbiota (<link linkend="ch0074s0011s0003li0105">105</link>). Exceptions to the endogenous acquisition include clenched-fist wounds contaminated by human oral microbiota as well as animal and human bite wounds. Gram-negative anaerobes, such as <emphasis>B. fragilis</emphasis>, are involved in a variety of infections with a considerable morbidity and mortality (<link linkend="ch0074s0011s0003li0002">2</link>). Table 3 summarizes the infectious sites where Gram-negative anaerobic organisms have been frequently isolated from clinical specimens. They can occasionally spread to adjacent tissues and the bloodstream with serious consequences. Localized dentoalveolar infections can result in life-threatening spread of oral anaerobes along tissue spaces of the head and neck down to the mediastinum (<link linkend="ch0074s0011s0003li0112">112</link>). In cases in which Gram-negative anaerobes gain entrance to the bloodstream and trigger a systemic inflammatory response, this may result in sepsis or infective endocarditis with a fatal outcome. The gastrointestinal tract and the oropharynx are the most common sources for anaerobic bacteremia by Gram-negative anaerobes, with gastrointestinal surgery and underlying malignancies being the major predisposing factors (<link linkend="ch0074s0011s0003li0113">113</link>–<link linkend="ch0074s0011s0003li0115">115</link>). Interestingly, the risk of bacteremia in patients with an inflamed gut, e.g., with inflammatory bowel disease, is usually as low as a few percentages (<link linkend="ch0074s0011s0003li0116">116</link>). In contrast, in the oral cavity, inflamed periodontal tissues are a well-known portal of frequent entry for myriad oral anaerobes to the circulation via daily practices of oral hygiene and chewing food (<link linkend="ch0074s0011s0003li0117">117</link>, <link linkend="ch0074s0011s0003li0118">118</link>). A recent next-generation sequencing (NGS) investigation of blood bacterial communities showed that 43 to 52% of bacterial species and 88% of bacterial sequences in blood were of oral origin, and a minor proportion were of skin, gut, or genital tract origin (<link linkend="ch0074s0011s0003li0119">119</link>). This calls attention to the importance of prevention of oral infections, especially in patients at increased risk for infective endocarditis.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0074s0002">
      <title>Bacteroides and Related Genera</title>
      <anchor id="ch0074s0002a0001"/>
      <anchor id="ch0074s0002a0002"/>
      <para id="ch0074s0002p0001">Among the anaerobes in clinical specimens, members of the bile-resistant<emphasis>B. fragilis</emphasis> group are the most commonly encountered and are more virulent and resistant to antimicrobial agents than most other anaerobes. Although other intestinal <emphasis>Bacteroides</emphasis> species outnumber <emphasis>B. fragilis</emphasis> 10- to 100-fold, <emphasis>B. fragilis</emphasis> has proven to be the most frequent <emphasis>Bacteroides</emphasis> found in specimens from blood, ulcers, abscesses, cellulitis, bronchial secretion, bone, intra-abdominal infections, and inflamed appendix (<link linkend="ch0074s0011s0003li0002">2</link>). In the Wadsworth Anaerobe Collection database, consisting of more than 3,000 clinical specimens, <emphasis>B. thetaiotaomicron</emphasis> and <emphasis>B. ovatus</emphasis> were also detected in these specimens, but less frequently. A large U.S. study series that included over 6,500 isolates of the <emphasis>B. fragilis</emphasis> group from clinical specimens, collected yearly between 1997 and 2007, confirmed this: <emphasis>B. fragilis</emphasis> was most common (51%), followed by <emphasis>B. thetaiotaomicron</emphasis> (19%) and <emphasis>B. ovatus</emphasis> (10%) (<link linkend="ch0074s0011s0003li0120">120</link>). Similar percentages were found for these three species in a Belgian hospital survey on anaerobic bacteremias between 2004 and 2013 (<link linkend="ch0074s0011s0003li0121">121</link>). Most isolates came from blood and intra-abdominal infections. In children, <emphasis>B. fragilis</emphasis> is the main anaerobic organism recovered from intra-abdominal infections (<link linkend="ch0074s0011s0003li0002">2</link>, <link linkend="ch0074s0011s0003li0122">122</link>); for instance, it is isolated from nearly all tissue specimens of acute appendicitis (<link linkend="ch0074s0011s0003li0123">123</link>). Around 10 to 20% of the <emphasis>B. fragilis</emphasis> strains are able to produce enterotoxin encoded by the <emphasis>bft1</emphasis> through <emphasis>bft3</emphasis> genes; these strains have been associated with diarrhea in children as well as in adults, and in addition, their proportion seems to be higher than that of nontoxigenic strains among blood culture isolates (<link linkend="ch0074s0011s0003li0124">124</link>). The <emphasis>B. fragilis</emphasis> group organisms (here also including <emphasis>Parabacteroides distasonis</emphasis>) and other <emphasis>Bacteroides</emphasis> species are the most frequently isolated pathogens from bloodstream infections with involvement of anaerobes (<link linkend="ch0074s0011s0003li0002">2</link>, <link linkend="ch0074s0011s0003li0113">113</link>–<link linkend="ch0074s0011s0003li0115">115</link>, 125). In a population-based 9-year retrospective analysis on anaerobic bloodstream infections conducted in the province of Alberta, Canada, the <emphasis>B. fragilis</emphasis> group accounted for 277 (31%) of the 904 cases (<link linkend="ch0074s0011s0003li0115">115</link>). Comorbidities, especially colorectal cancer, formed a common risk factor for anaerobic bacteremia. On the other hand, enterotoxigenic <emphasis>B. fragilis</emphasis> may play a yet-to-be-confirmed role in the etiology of colorectal cancer (<link linkend="ch0074s0011s0003li0126">126</link>–<link linkend="ch0074s0011s0003li0128">128</link>). Bloodstream infections of several other <emphasis>Bacteroides</emphasis> species, such as <emphasis>B. caccae, B. denticani, B. dorei, B. faecis, B. finegoldii</emphasis>, and <emphasis>B. nordii</emphasis>, have been reported (<link linkend="ch0074s0011s0003li0125">125</link>, <link linkend="ch0074s0011s0003li0129">129</link>–<link linkend="ch0074s0011s0003li0131">131</link>). <emphasis>Bacteroides</emphasis> involvement in infective endocarditis, where <emphasis>B. fragilis</emphasis> of gastrointestinal origin is the most frequent finding, tends to be more serious than that of other anaerobes, sometimes with fatal outcome (<link linkend="ch0074s0011s0003li0132">132</link>). The <emphasis>B. fragilis</emphasis> group has been recovered from pericarditis samples (<link linkend="ch0074s0011s0003li0133">133</link>) and, often as a single isolate, from septic arthritis as well as from osteomyelitis samples (<link linkend="ch0074s0011s0003li0134">134</link>). Although spondylodiscitis caused by anaerobes is not common, the involvement of <emphasis>B. fragilis</emphasis> needs to be taken into account in cases with potential bacteremia of intestinal origin or after surgery (<link linkend="ch0074s0011s0003li0135">135</link>, <link linkend="ch0074s0011s0003li0136">136</link>). In peritoneal dialysis patients, anaerobic peritonitis is a rare event; however, <emphasis>B. fragilis</emphasis> and <emphasis>B. thetaiotaomicron</emphasis> have been isolated (<link linkend="ch0074s0011s0003li0137">137</link>). By hematogeneous spread, the <emphasis>B. fragilis</emphasis> group and other <emphasis>Bacteroides</emphasis> organisms can reach the brain, causing abscesses (<link linkend="ch0074s0011s0003li0138">138</link>–<link linkend="ch0074s0011s0003li0140">140</link>). In addition, members of this group are among the predominant isolates from burn wound infections, with potential involvement in sepsis in this context (<link linkend="ch0074s0011s0003li0141">141</link>). <emphasis>Bacteroides</emphasis> species can be involved in part in polymicrobial necrotizing soft tissue infections (<link linkend="ch0074s0011s0003li0002">2</link>), and the <emphasis>B. fragilis</emphasis> group is, after Gram-positive anaerobic cocci, one of the most common anaerobes found in infected moderate to severe diabetic foot wounds (<link linkend="ch0074s0011s0003li0142">142</link>, <link linkend="ch0074s0011s0003li0143">143</link>). In cat and dog bite infections, <emphasis>B. pyogenes</emphasis> and <emphasis>B. tectum</emphasis> can be found (<link linkend="ch0074s0011s0003li0144">144</link>, <link linkend="ch0074s0011s0003li0145">145</link>), but a <emphasis>B. pyogenes</emphasis> liver abscess and subsequent bacteremia with no history of animal bite was recently described (<link linkend="ch0074s0011s0003li0146">146</link>).</para>
      <anchor id="ch0074s0002a0003"/>
      <beginpage pagenum="1105"/>
      <para id="ch0074s0002p0002">Pigmented, bile-resistant<emphasis>Alistipes</emphasis> species, <emphasis>A. finegoldii, A. onderdonkii</emphasis>, and <emphasis>A. shahii</emphasis>, have been strongly connected to appendicitis, both in children and in adults (<link linkend="ch0074s0011s0003li0008">8</link>, <link linkend="ch0074s0011s0003li0123">123</link>). In addition, all three species have been isolated from intra-abdominal fluid or abscesses and <emphasis>A. onderdonkii</emphasis> (recently divided into two subspecies) also from urine (<link linkend="ch0074s0011s0003li0008">8</link>, <link linkend="ch0074s0011s0003li0125">125</link>, <link linkend="ch0074s0011s0003li0147">147</link>). There is one report with two cases on the detection of <emphasis>A. finegoldii</emphasis> in blood (<link linkend="ch0074s0011s0003li0148">148</link>); by phylogenetic reanalysis, one isolate was later identified as <emphasis>A. onderdonkii</emphasis> (<link linkend="ch0074s0011s0003li0147">147</link>). <emphasis>Alistipes</emphasis> may have protective effects against some diseases. Its association with colorectal cancer or depression (<link linkend="ch0074s0011s0003li0149">149</link>) needs verification.</para>
    </sect1>
    <sect1 id="ch0074s0003">
      <title>Porphyromonas and Related Genera</title>
      <anchor id="ch0074s0003a0001"/>
      <anchor id="ch0074s0003a0002"/>
      <para id="ch0074s0003p0001">Pathogenic potential varies between different<emphasis>Porphyromonas</emphasis> species. Of the four oral <emphasis>Porphyromonas</emphasis> species, <emphasis>P. endodontalis</emphasis> and <emphasis>P. gingivalis</emphasis> are known as significant pathogens. The detection rate of <emphasis>P. gingivalis,</emphasis> one of the major periodontal pathogens, increases with age (<link linkend="ch0074s0011s0003li0150">150</link>, <link linkend="ch0074s0011s0003li0151">151</link>). In addition to periodontitis, it has been frequently detected in oral specimens from necrotizing ulcerative gingivitis, infected root canals, peri-implant lesions, and acute apical abscesses (<link linkend="ch0074s0011s0003li0110">110</link>, <link linkend="ch0074s0011s0003li0152">152</link>, <link linkend="ch0074s0011s0003li0153">153</link>). Besides the oral cavity, it has been detected in clinical specimens from various body sites, e.g., intra-abdominal sites (<link linkend="ch0074s0011s0003li0154">154</link>), vaginal samples in women with bacterial vaginosis (<link linkend="ch0074s0011s0003li0155">155</link>), amniotic fluid (<link linkend="ch0074s0011s0003li0156">156</link>), synovial specimens of rheumatoid arthritis, and psoriatic arthritis (<link linkend="ch0074s0011s0003li0157">157</link>) and, together with some other periodontal organisms, in occluded arteries of lower extremities of Buerger’s disease patients (<link linkend="ch0074s0011s0003li0158">158</link>). Recently investigated links between <emphasis>P. gingivalis</emphasis> and age-related macular degeneration (<link linkend="ch0074s0011s0003li0159">159</link>), adverse pregnancy outcomes (<link linkend="ch0074s0011s0003li0160">160</link>), Alzheimer’s disease (<link linkend="ch0074s0011s0003li0161">161</link>, <link linkend="ch0074s0011s0003li0162">162</link>), atherosclerotic disease (<link linkend="ch0074s0011s0003li0163">163</link>), and cancer (<link linkend="ch0074s0011s0003li0164">164</link>) need confirmation. <emphasis>P. endodontalis</emphasis> is one of the dominant organisms in infected root canals and in acute dental abscesses (<link linkend="ch0074s0011s0003li0108">108</link>, <link linkend="ch0074s0011s0003li0152">152</link>, <link linkend="ch0074s0011s0003li0165">165</link>), but may also be involved in chronic periodontitis (<link linkend="ch0074s0011s0003li0166">166</link>). <emphasis>P. uenonis</emphasis>, which is phenotypically similar to <emphasis>P. endodontalis</emphasis> and <emphasis>P. asaccharolytica</emphasis>, has been detected in polymicrobial infections below the waistline: appendicitis, peritonitis, pilonidal abscess, an infected sacral decubitus ulcer, and bacterial vaginosis (<link linkend="ch0074s0011s0003li0009">9</link>, <link linkend="ch0074s0011s0003li0167">167</link>). <emphasis>P. asaccharolytica</emphasis> and <emphasis>P. somerae</emphasis> were among the anaerobic isolates from moderate to severe diabetic foot infections (<link linkend="ch0074s0011s0003li0142">142</link>). At the VA Wadsworth Medical Center laboratory, 58 <emphasis>P. somerae</emphasis> isolates originated from a variety of specimens, including lower extremity skin and soft tissue or bone, abscesses of the inguinal or sacral area, intra-abdominal abscess, transtracheal aspirate, axillary abscess, mastoiditis, blood culture, brain tissue, and infected scalp (presented in order of their frequency) (<link linkend="ch0074s0011s0003li0011">11</link>). <emphasis>P. bennonis</emphasis> has been detected in human wound infections and abscesses, especially in patients with chronic skin and soft tissue lesions in the perirectal, buttock, and groin regions (<link linkend="ch0074s0011s0003li0012">12</link>). Although <emphasis>P. catoniae</emphasis> inhabits the oral cavity without any disease association described to date, it has been isolated from an abdominal abscess (<link linkend="ch0074s0011s0003li0010">10</link>). <emphasis>Porphyromonas</emphasis> species of animal origin, e.g., <emphasis>P. cangingivalis, P. canoris, P. cansulci, P. gulae, P. macacae</emphasis>, and <emphasis>P. pogonae</emphasis>, have been encountered in humans, in most cases after animal bite infections (<link linkend="ch0074s0011s0003li0017">17</link>, <link linkend="ch0074s0011s0003li0018">18</link>, <link linkend="ch0074s0011s0003li0145">145</link>).</para>
      <para id="ch0074s0003p0002"><emphasis>Parabacteroides</emphasis> species are common inhabitants of the human gut, and <emphasis>P. distasonis</emphasis> is one of the anaerobes of clinical importance in specimens from intra-abdominal infections and inflamed appendixes, where <emphasis>P. goldsteinii</emphasis> and <emphasis>P. merdae</emphasis> can also be found (<link linkend="ch0074s0011s0003li0002">2</link>, <link linkend="ch0074s0011s0003li0168">168</link>). A few cases of splenic abscess formation by <emphasis>P. distasonis</emphasis> are described (<link linkend="ch0074s0011s0003li0169">169</link>). In addition, <emphasis>P. distasonis, P. merdae, P. goldsteinii, P. gordonii</emphasis>, and the novel <emphasis>P. chongii</emphasis> have been isolated from human blood (<link linkend="ch0074s0011s0003li0002">2</link>, <link linkend="ch0074s0011s0003li0020">20</link>, <link linkend="ch0074s0011s0003li0125">125</link>, <link linkend="ch0074s0011s0003li0170">170</link>–<link linkend="ch0074s0011s0003li0172">172</link>). Recently, <emphasis>P. goldsteinii</emphasis> was isolated from a case of abdominal infection in a patient with lymphoma (<link linkend="ch0074s0011s0003li0173">173</link>).</para>
      <anchor id="ch0074s0003a0003"/>
      <beginpage pagenum="1106"/>
      <para id="ch0074s0003p0003"><emphasis>Tannerella forsythia</emphasis> is considered one of the major periodontal pathogens (<link linkend="ch0074s0011s0003li0150">150</link>, <link linkend="ch0074s0011s0003li0174">174</link>). In addition, it is one of the predominant organisms in root canal infections (<link linkend="ch0074s0011s0003li0110">110</link>, <link linkend="ch0074s0011s0003li0165">165</link>) and has been found in infected sites around dental implants (<link linkend="ch0074s0011s0003li0153">153</link>). Moreover, <emphasis>T. forsythia</emphasis> can be recovered in substantial amounts from tonsillar crypts of adults (<link linkend="ch0074s0011s0003li0107">107</link>). In laryngectomized patients with voice rehabilitation, <emphasis>T. forsythia</emphasis> proved to be one of the main biofilm-forming anaerobes on voice prostheses that needed replacement (<link linkend="ch0074s0011s0003li0175">175</link>). This oral bacterium has also been recovered from vaginal samples in women with bacterial vaginosis (<link linkend="ch0074s0011s0003li0155">155</link>) as well as from synovial specimens of patients with rheumatoid or psoriatic arthritis (<link linkend="ch0074s0011s0003li0157">157</link>).</para>
    </sect1>
    <sect1 id="ch0074s0004">
      <title>Prevotella and Related Genera</title>
      <anchor id="ch0074s0004a0001"/>
      <anchor id="ch0074s0004a0002"/>
      <para id="ch0074s0004p0001"><emphasis>Prevotella</emphasis> species are among the dominant microorganisms of the oral cavity, where they, despite their commensalism, can be involved in nearly all types of oral infections. Interestingly, <emphasis>P. melaninogenica</emphasis>, which is a common anaerobic organism in saliva (<link linkend="ch0074s0011s0003li0093">93</link>), is also one of the most prevalent anaerobes, together with <emphasis>F. nucleatum, P. intermedia</emphasis>, and <emphasis>P. buccae</emphasis>, in infected human bite lesions (<link linkend="ch0074s0011s0003li0176">176</link>). Although the cariogenic microbiota mainly consists of Gram-positive species, some proteolytic Gram-negative taxa, including <emphasis>P. denticola</emphasis> and <emphasis>P. tannerae</emphasis> (currently <emphasis>Alloprevotella tannerae</emphasis>), can be frequently encountered in advanced carious lesions (<link linkend="ch0074s0011s0003li0177">177</link>). <emphasis>P. intermedia</emphasis> has been strongly linked to periodontitis (<link linkend="ch0074s0011s0003li0109">109</link>, <link linkend="ch0074s0011s0003li0151">151</link>), and <emphasis>P. intermedia</emphasis> and/or the phenotypically identical <emphasis>P. nigrescens</emphasis> has been detected in samples from dentoalveolar abscesses, necrotizing ulcerative gingivitis, pericoronitis, peri-implantitis, pregnancy gingivitis, root canal infections, and—as one of the rare extraoral examples—from costochondritis (<link linkend="ch0074s0011s0003li0110">110</link>, <link linkend="ch0074s0011s0003li0152">152</link>–<link linkend="ch0074s0011s0003li0154">154</link>, 178, 179). Also, <emphasis>P. baroniae</emphasis> proved to be common in root canal infections and acute dental abscess aspirates (<link linkend="ch0074s0011s0003li0110">110</link>, <link linkend="ch0074s0011s0003li0165">165</link>). In noma (cancrum oris), <emphasis>P. intermedia</emphasis> is considered a key organism (<link linkend="ch0074s0011s0003li0180">180</link>, <link linkend="ch0074s0011s0003li0181">181</link>). In spreading odontogenic infections, members of the genus <emphasis>Prevotella</emphasis> seem to play an important role, with <emphasis>P. buccae</emphasis> and <emphasis>P. oris</emphasis> the most prominent organisms in this context (<link linkend="ch0074s0011s0003li0112">112</link>, <link linkend="ch0074s0011s0003li0182">182</link>–<link linkend="ch0074s0011s0003li0184">184</link>). <emphasis>P. melaninogenica</emphasis>/<emphasis>P. histicola</emphasis> were found to be significantly associated with recurrent tonsillitis in adults (<link linkend="ch0074s0011s0003li0107">107</link>). <emphasis>P. pleuritidis</emphasis>, originally isolated from pleural fluid, was recently isolated from lung abscess (<link linkend="ch0074s0011s0003li0043">43</link>, <link linkend="ch0074s0011s0003li0185">185</link>). A new concept of the polymicrobial bacteriology of cystic fibrosis has been presented, and indeed, not only aerobic <emphasis>Pseudomonas aeruginosa</emphasis> or <emphasis>Staphylococcus aureus</emphasis>, but also some anaerobes—especially <emphasis>Prevotella</emphasis>, such as <emphasis>P. melaninogenica, P. denticola, P. oris</emphasis>, and <emphasis>P. salivae</emphasis>—have been detected as among the persistently dominating organisms in the sputum of these patients (<link linkend="ch0074s0011s0003li0186">186</link>). Also, <emphasis>Prevotella</emphasis> taxa were recovered from bronchoalveolar lavage of ventilator-associated pneumonia (<link linkend="ch0074s0011s0003li0187">187</link>). Furthermore, various <emphasis>Prevotella</emphasis> species are found in extraoral infections and abscesses at a wide range of body sites, for instance, <emphasis>P. amnii, P. bivia, P. corporis, P. disiens, P. intermedia, P. lascolaii</emphasis> (new species), <emphasis>P. nigrescens</emphasis>, and <emphasis>P. timonensis</emphasis> in the female genital tract (<link linkend="ch0074s0011s0003li0042">42</link>, <link linkend="ch0074s0011s0003li0105">105</link>, <link linkend="ch0074s0011s0003li0155">155</link>); <emphasis>P. buccalis</emphasis> in urine (<link linkend="ch0074s0011s0003li0188">188</link>); <emphasis>P. bergensis, P. bivia</emphasis>, and <emphasis>P. melaninogenica</emphasis> in infectious lesions of the skin and soft tissues, including diabetic foot lesions (<link linkend="ch0074s0011s0003li0039">39</link>, <link linkend="ch0074s0011s0003li0142">142</link>); <emphasis>P. intermedia</emphasis> and <emphasis>P. nigrescens</emphasis> from intra-abdominal and soft tissue abscesses (<link linkend="ch0074s0011s0003li0154">154</link>); <emphasis>P. intermedia</emphasis> (<emphasis>sensu lato</emphasis>) and <emphasis>P. melaninogenica</emphasis> from peritonsillar and retropharyngeal abscesses; <emphasis>P. timonensis</emphasis> from breast abscesses as well as genital and wound origins (<link linkend="ch0074s0011s0003li0040">40</link>, <link linkend="ch0074s0011s0003li0189">189</link>); <emphasis>P. intermedia</emphasis> in synovial fluid of arthritis patients (<link linkend="ch0074s0011s0003li0157">157</link>); and <emphasis>P. intermedia</emphasis> and <emphasis>P. nigrescens</emphasis> (with some other periodontal bacteria) in occluded arteries of lower extremities of Buerger’s disease patients (<link linkend="ch0074s0011s0003li0158">158</link>). The newly described <emphasis>P. colorans</emphasis> strain was isolated from a wound specimen as part of a polymicrobial infection (<link linkend="ch0074s0011s0003li0190">190</link>). Several <emphasis>Prevotella</emphasis> species, such as <emphasis>P. bivia, P. buccae, P. denticola, P. disiens</emphasis>, and <emphasis>P. nigrescens</emphasis>, have been among anaerobic findings in bloodstream infections (<link linkend="ch0074s0011s0003li0125">125</link>, <link linkend="ch0074s0011s0003li0154">154</link>). Increased <emphasis>P. bivia</emphasis> abundance has been found associated with severe preeclampsia, a pregnancy complication (<link linkend="ch0074s0011s0003li0191">191</link>). The first clinical case of <emphasis>P. copri</emphasis> was reported from blood of an elderly patient with a <emphasis>Prevotella</emphasis>-dominated gut microbiome (<link linkend="ch0074s0011s0003li0192">192</link>). <emphasis>P. heparinolytica</emphasis> is a relatively common anaerobic isolate from animal bite wounds (<link linkend="ch0074s0011s0003li0145">145</link>). With increasing use of sequencing techniques, obligate anaerobic Gram-negative rods are increasingly detected in clinical infections, such as brain or liver abscesses with <emphasis>Prevotella</emphasis> and <emphasis>Fusobacterium</emphasis> species predominating (<link linkend="ch0074s0011s0003li0193">193</link>, <link linkend="ch0074s0011s0003li0194">194</link>). The related genus and species <emphasis>Phocaeicola abscessus</emphasis> was isolated from a human brain abscess sample and was recently discovered in symptomatic primary endodontic infection as well (<link linkend="ch0074s0011s0003li0195">195</link>, <link linkend="ch0074s0011s0003li0196">196</link>).</para>
    </sect1>
    <sect1 id="ch0074s0005">
      <title>Fusobacterium and Related Genera</title>
      <anchor id="ch0074s0005a0001"/>
      <anchor id="ch0074s0005a0002"/>
      <para id="ch0074s0005p0001">Clinically, the most important<emphasis>Fusobacterium</emphasis> species are <emphasis>F. nucleatum</emphasis> and <emphasis>F. necrophorum</emphasis> (<link linkend="ch0074s0011s0003li0197">197</link>–<link linkend="ch0074s0011s0003li0199">199</link>). Over the past few years, there has been an increased interest directed to the role of fusobacteria in human infections, especially recurrent tonsillitis, Lemierre’s syndrome, brain abscesses, and bacteremia (<link linkend="ch0074s0011s0003li0107">107</link>, <link linkend="ch0074s0011s0003li0194">194</link>, <link linkend="ch0074s0011s0003li0200">200</link>–<link linkend="ch0074s0011s0003li0204">204</link>), but also in diseases not usually regarded as typical infections, such as acute appendicitis, inflammatory bowel disease, and colon cancer (<link linkend="ch0074s0011s0003li0205">205</link>–<link linkend="ch0074s0011s0003li0207">207</link>). Moreover, in children, fusobacterial infections of otogenic origin deserve attention due to potential invasive complications (<link linkend="ch0074s0011s0003li0208">208</link>, <link linkend="ch0074s0011s0003li0209">209</link>).</para>
      <para id="ch0074s0005p0002"><emphasis>F. nucleatum</emphasis> is an oral species, which has been divided into several subspecies with variable pathogenic potentials. It is a key organism in maturation of pathogenic biofilms in periodontal pockets and is considered an important pathogen in peri-implantitis, root canal infections, dentoalveolar abscesses, human bite wounds, and spreading odontogenic infections (<link linkend="ch0074s0011s0003li0110">110</link>, <link linkend="ch0074s0011s0003li0153">153</link>, <link linkend="ch0074s0011s0003li0165">165</link>, <link linkend="ch0074s0011s0003li0182">182</link>). <emphasis>F. nucleatum</emphasis> was found as a dominant species in tonsillar crypts (<link linkend="ch0074s0011s0003li0107">107</link>), which may explain its dominance in biofilms on voice prostheses that needed replacement (<link linkend="ch0074s0011s0003li0175">175</link>). It is also an important etiologic agent in extraoral infections and abscesses at a wide range of body sites, being detected from blood, brain, chest, heart, lung, liver, appendix, (prosthetic) joint, long bone, abdomen, gut, genitourinary tract, and fetal membranes (<link linkend="ch0074s0011s0003li0123">123</link>, <link linkend="ch0074s0011s0003li0125">125</link>, <link linkend="ch0074s0011s0003li0133">133</link>, <link linkend="ch0074s0011s0003li0134">134</link>, <link linkend="ch0074s0011s0003li0138">138</link>, <link linkend="ch0074s0011s0003li0176">176</link>, <link linkend="ch0074s0011s0003li0188">188</link>, <link linkend="ch0074s0011s0003li0198">198</link>, <link linkend="ch0074s0011s0003li0200">200</link>, <link linkend="ch0074s0011s0003li0203">203</link>–<link linkend="ch0074s0011s0003li0205">205</link>, <link linkend="ch0074s0011s0003li0207">207</link>, <link linkend="ch0074s0011s0003li0210">210</link>–<link linkend="ch0074s0011s0003li0216">216</link>). Recently, mechanistic evidence for its implication in adverse pregnancy outcomes was described (<link linkend="ch0074s0011s0003li0217">217</link>). People with bacteremia from <emphasis>F. nucleatum</emphasis> often have underlying comorbidities (<link linkend="ch0074s0011s0003li0200">200</link>, <link linkend="ch0074s0011s0003li0203">203</link>, <link linkend="ch0074s0011s0003li0204">204</link>). Health care-related <emphasis>F. nucleatum</emphasis> bacteremia is associated with increased mortality (<link linkend="ch0074s0011s0003li0204">204</link>). In a tertiary care hospital where all episodes of documented brain abscess cases between 1991 and 2000 were reviewed, in 40% of cerebral puncture specimens, only anaerobes were found; of these, <emphasis>F. nucleatum</emphasis> proved to be the most frequently isolated organism, found in one of three patients (<link linkend="ch0074s0011s0003li0138">138</link>). In another study, using molecular methods for bacterial detection in 51 brain abscess pus specimens, <emphasis>F. nucleatum</emphasis> was among the most frequent findings, especially in patients with preceding sinusitis or dental treatment (<link linkend="ch0074s0011s0003li0210">210</link>). In a Norwegian multicenter study over a period of 2 years in five university hospitals, fusobacteria, mainly <emphasis>F. nucleatum</emphasis>, were detected in 19 out of 20 brain abscesses with anaerobic bacteria (<link linkend="ch0074s0011s0003li0194">194</link>). The presence of <emphasis>Fusobacterium</emphasis> adhesin A seems to allow separation of <emphasis>F. nucleatum</emphasis> (together with oral <emphasis>F. periodonticum</emphasis> and <emphasis>F. simiae</emphasis>) from nonoral fusobacterial species (<emphasis>F. gonidiaformans, F. mortiferum, F. russii</emphasis>, and <emphasis>F. ulcerans</emphasis>) (<link linkend="ch0074s0011s0003li0218">218</link>). There is increasing evidence that <emphasis>F. nucleatum</emphasis> is not only a passenger but coinducer of oral (<link linkend="ch0074s0011s0003li0219">219</link>), breast (<link linkend="ch0074s0011s0003li0220">220</link>), and colorectal (<link linkend="ch0074s0011s0003li0059">59</link>, <link linkend="ch0074s0011s0003li0206">206</link>, <link linkend="ch0074s0011s0003li0221">221</link>) cancers. As potential mechanisms, an excessive inflammatory reaction, suppression of apoptosis, promotion of malignant transformation, and chemoresistance by modulation of autophagy were investigated and—at least partially—proven (<link linkend="ch0074s0011s0003li0222">222</link>–<link linkend="ch0074s0011s0003li0224">224</link>).</para>
      <anchor id="ch0074s0005a0003"/>
      <beginpage pagenum="1107"/>
      <para id="ch0074s0005p0003">Of the two<emphasis>F. necrophorum</emphasis> subspecies, <emphasis>F. necrophorum</emphasis> subsp. <emphasis>funduliforme</emphasis> (biovar B) is the dominant isolate in humans, while <emphasis>F. necrophorum</emphasis> subsp. <emphasis>necrophorum</emphasis> is a common pathogen in animals (<link linkend="ch0074s0011s0003li0197">197</link>, <link linkend="ch0074s0011s0003li0199">199</link>). Important virulence factors, explaining the invasiveness of <emphasis>F. necrophorum</emphasis>, are leukotoxin and plasminogen binding (<link linkend="ch0074s0011s0003li0225">225</link>). <emphasis>F. necrophorum</emphasis> is best known for its connection to Lemierre’s syndrome (necrobacillosis), which can be considered an invasive <emphasis>F. necrophorum</emphasis> disease, often with pleuropulmonary involvement, in previously healthy adolescents, young adults, and pediatric populations (<link linkend="ch0074s0011s0003li0197">197</link>, <link linkend="ch0074s0011s0003li0199">199</link>, <link linkend="ch0074s0011s0003li0201">201</link>, <link linkend="ch0074s0011s0003li0202">202</link>, <link linkend="ch0074s0011s0003li0226">226</link>, <link linkend="ch0074s0011s0003li0227">227</link>). It is notable that invasive disease with <emphasis>F. necrophorum</emphasis> may be on the increase (<link linkend="ch0074s0011s0003li0197">197</link>). In Denmark, the overall mortality of Lemierre’s syndrome, originating mainly from oropharyngeal sites, was reported to be 9% in adolescents, and that of disseminated <emphasis>F. necrophorum</emphasis> infections, originating from lower parts of the body, was 26% in elderly patients with predisposing diseases (<link linkend="ch0074s0011s0003li0226">226</link>). In the latter type of cases, underlying cancers should be considered. Interestingly, <emphasis>F. necrophorum</emphasis> can be found in adolescents as the causative agent in approximately 10% of the cases of tonsillitis (persistent sore throat) not caused by group A streptococci (<link linkend="ch0074s0011s0003li0197">197</link>, <link linkend="ch0074s0011s0003li0199">199</link>, <link linkend="ch0074s0011s0003li0228">228</link>). In a Danish retrospective study, including 847 patients with peritonsillar abscesses in the years 2001 to 2006, <emphasis>F. necrophorum</emphasis> was detected in 23% of the pus aspirate or swab specimens, most of them growing as a pure culture (<link linkend="ch0074s0011s0003li0229">229</link>). Another Danish study among 1,930 throat swabs, taken from 15- to 24-year-old patients by general practitioners between 2007 and 2009, reported the detection rate of 22% for <emphasis>F. necrophorum</emphasis> (<link linkend="ch0074s0011s0003li0230">230</link>). A wide variety of infections can be caused by <emphasis>F. necrophorum</emphasis>; in the head and neck: tonsillitis, peritonsillar abscess, deep neck space infection, mediastinitis, otogenic infection, mastoiditis, sinusitis, and odontogenic infection; as intracranial complications: sinus thrombosis, cerebral and epidural abscesses, and meningitis; and as systemic manifestations: bacteremia, septicemia, pleuropulmonary infections, bone and joint infections, soft tissue infections, liver abscess, intra-abdominal sepsis, pelvic peritonitis, endocarditis, and pericarditis (<link linkend="ch0074s0011s0003li0199">199</link>–<link linkend="ch0074s0011s0003li0203">203</link>, <link linkend="ch0074s0011s0003li0208">208</link>, <link linkend="ch0074s0011s0003li0209">209</link>, <link linkend="ch0074s0011s0003li0229">229</link>, <link linkend="ch0074s0011s0003li0231">231</link>–<link linkend="ch0074s0011s0003li0234">234</link>).</para>
      <para id="ch0074s0005p0004">Other<emphasis>Fusobacterium</emphasis> taxa, such as <emphasis>F. gonidiaformans, F. necrogenes, F. ulcerans</emphasis>, and the <emphasis>F. mortiferum</emphasis>-<emphasis>F. varium</emphasis> group, have been only occasionally isolated from human clinical specimens (<link linkend="ch0074s0011s0003li0122">122</link>, <link linkend="ch0074s0011s0003li0142">142</link>, <link linkend="ch0074s0011s0003li0198">198</link>, <link linkend="ch0074s0011s0003li0208">208</link>, <link linkend="ch0074s0011s0003li0235">235</link>–<link linkend="ch0074s0011s0003li0237">237</link>). <emphasis>F. nucleatum</emphasis> and the closely related species of animal origin, <emphasis>F. canifelinum</emphasis> and <emphasis>F. russii</emphasis>, are of importance in cats and dogs as well as in the bite wounds of these pets in humans (<link linkend="ch0074s0011s0003li0145">145</link>, <link linkend="ch0074s0011s0003li0238">238</link>). <emphasis>F. russii</emphasis> was isolated from a deep forefoot ulcer of a patient with close contacts to cats, but apart from some scratches the patient denied any bite injuries (<link linkend="ch0074s0011s0003li0239">239</link>). <emphasis>F. canifelinum</emphasis> sequences were detected also in the human oral cavity (<link linkend="ch0074s0011s0003li0240">240</link>), but this needs confirmation. However, pet owners might not be astonished about this fact.</para>
      <para id="ch0074s0005p0005">Commensal<emphasis>Leptotrichia</emphasis> species are increasingly implicated in anaerobic bacteremias in immunocompromised patients with lesions of the oral or gastrointestinal mucosa but are also occasionally considered etiologic agents of bacteremia and infective endocarditis in immunocompetent individuals (<link linkend="ch0074s0011s0003li0113">113</link>, <link linkend="ch0074s0011s0003li0241">241</link>–<link linkend="ch0074s0011s0003li0246">246</link>). <emphasis>L. buccalis, L. goodfellowii, L. trevisanii</emphasis>, and <emphasis>L. wadei</emphasis> are the main <emphasis>Leptotrichia</emphasis> species in blood specimens. According to a 5-year retrospective analysis on <emphasis>Leptotrichia</emphasis> organisms in a national reference laboratory in Utah where 51 isolates were identified to species level, <emphasis>L. trevisanii</emphasis> comprised 47%, <emphasis>L. goodfellowii, L. wadei</emphasis>, and <emphasis>L. hongkongensis</emphasis> each 9%, and <emphasis>L. buccalis</emphasis> 1.5% of the 68 <emphasis>Leptotrichia</emphasis>-positive cultures (<link linkend="ch0074s0011s0003li0243">243</link>). Interestingly, <emphasis>L. hongkongensis</emphasis> was isolated especially from multiple myeloma patients. In an immunocompetent subject, <emphasis>L. wadei</emphasis> was reported as a causative organism of a severe pneumonia (<link linkend="ch0074s0011s0003li0247">247</link>). In the female genital tract, some infectious cases, including bacterial vaginosis, intrauterine fetal demise, and septic abortion, have been reported in connection with <emphasis>L. trevisanii</emphasis> (<link linkend="ch0074s0011s0003li0248">248</link>) and “<emphasis>L. amnionii</emphasis>,” a candidate species also known as <emphasis>Sneathia amnii</emphasis> and recently reclassified as <emphasis>Sneathia vaginalis</emphasis> (<link linkend="ch0074s0011s0003li0062">62</link>, <link linkend="ch0074s0011s0003li0105">105</link>, <link linkend="ch0074s0011s0003li0167">167</link>, <link linkend="ch0074s0011s0003li0211">211</link>, <link linkend="ch0074s0011s0003li0249">249</link>). In fact, this organism significantly associates with all four Amsel’s criteria (pH, Whiff test, vaginal discharge, clue cells) used in clinical diagnostics of bacterial vaginosis (<link linkend="ch0074s0011s0003li0105">105</link>). Furthermore, a few bacteremia cases in connection to delivery (<link linkend="ch0074s0011s0003li0250">250</link>) and one neonatal meningitis case (<link linkend="ch0074s0011s0003li0251">251</link>) have been reported. However, it has also been isolated from a knee joint specimen of a male patient (<link linkend="ch0074s0011s0003li0252">252</link>), revealing that the organism is not restricted to the female genital tract. Based on the high number of <emphasis>S. vaginalis</emphasis> in urine samples from renal transplant recipients, it may also be considered one of the etiologic agents of urinary tract infections (<link linkend="ch0074s0011s0003li0188">188</link>). One case of septic arthritis with an involvement of other <emphasis>Sneathia</emphasis> species, most closely related to <emphasis>S. sanguinegens</emphasis>, has been reported in an immunocompetent woman (<link linkend="ch0074s0011s0003li0253">253</link>). Although <emphasis>S. sanguinegens</emphasis> was originally isolated from blood (<link linkend="ch0074s0011s0003li0254">254</link>), it has been mainly reported from various infectious conditions of the female genital tract, such as preterm labor, neonatal sepsis, postpartum bacteremia and prosthetic valve infective endocarditis, and pyosalpinx, and in amniotic fluid associated with various clinical syndromes (<link linkend="ch0074s0011s0003li0167">167</link>, <link linkend="ch0074s0011s0003li0211">211</link>, <link linkend="ch0074s0011s0003li0214">214</link>, <link linkend="ch0074s0011s0003li0250">250</link>, <link linkend="ch0074s0011s0003li0254">254</link>, <link linkend="ch0074s0011s0003li0255">255</link>). Using metagenomic 16S rRNA gene identification for <emphasis>Sneathia</emphasis> in mid-vaginal samples from 736 women in an urban outpatient clinic in Virginia, the target organism was detected in 30 to 43% of the samples, depending on the selected abundance treshold (<link linkend="ch0074s0011s0003li0064">64</link>). It was also shown that <emphasis>S. vaginalis</emphasis> (under the former name <emphasis>S. amnii</emphasis>) is able to adhere to the cervical epithelium and, presumably, to invade the uterine cavity. <emphasis>Leptotrichia/Sneathia</emphasis> can be considered clinically relevant intra-amniotic pathogens (<link linkend="ch0074s0011s0003li0211">211</link>, <link linkend="ch0074s0011s0003li0212">212</link>), and, in fact, their role in adverse perinatal outcomes, including preterm labor, was underestimated until recently (<link linkend="ch0074s0011s0003li0256">256</link>).</para>
    </sect1>
    <sect1 id="ch0074s0006">
      <title>Other Anaerobic Gram-Negative Rods</title>
      <anchor id="ch0074s0006a0001"/>
      <anchor id="ch0074s0006a0002"/>
      <para id="ch0074s0006p0001">In the novel phylum<emphasis>Synergistetes</emphasis>, six cultivable species representing five genera, i.e., <emphasis>Fretibacterium fastidiosum, Jonquetella anthropi, Pyramidobacter piscolens</emphasis>, and the recently discovered <emphasis>Rarimicrobium hominis</emphasis> (<link linkend="ch0074s0011s0003li0068">68</link>), as well as <emphasis>Cloacibacillus evryensis</emphasis> and <emphasis>C. porcorum</emphasis> (<link linkend="ch0074s0011s0003li0069">69</link>), have been isolated from human clinical specimens. <emphasis>J. anthropi</emphasis> isolates came from breast abscess, pelvic abscess, sebaceous cyst, wound, and peritoneal fluid specimens (<link linkend="ch0074s0011s0003li0066">66</link>), while <emphasis>F. fastidiosum</emphasis> and <emphasis>P. piscolens</emphasis> were found in periodontitis, dental root canals, and odontogenic abscesses (<link linkend="ch0074s0011s0003li0065">65</link>, <link linkend="ch0074s0011s0003li0067">67</link>, <link linkend="ch0074s0011s0003li0110">110</link>). Clinical <emphasis>R. hominis</emphasis> isolates came from gynecological surgery material, parietal abscess, sacrum, and perianal abscess specimens (<link linkend="ch0074s0011s0003li0068">68</link>), and <emphasis>C. evryensis</emphasis> and <emphasis>C. porcorum</emphasis> isolates from blood (<link linkend="ch0074s0011s0003li0069">69</link>).</para>
      <anchor id="ch0074s0006a0003"/>
      <beginpage pagenum="1108"/>
      <para id="ch0074s0006p0002">Two<emphasis>Dialister</emphasis> species, <emphasis>D. pneumosintes</emphasis> and <emphasis>D. invisus</emphasis>, are inhabitants of the oral cavity, where they have been implicated as pathogens in endodontal and periodontal infections as well as acute dental abscesses and sinusitis (<link linkend="ch0074s0011s0003li0073">73</link>, <link linkend="ch0074s0011s0003li0110">110</link>, <link linkend="ch0074s0011s0003li0257">257</link>–<link linkend="ch0074s0011s0003li0259">259</link>). In addition, they have been recovered from blood, abscesses (brain, neck/mediastinal, hepatic, Bartholin’s), bronchoalveolar lavage of ventilator-associated pneumonia and cystic fibrosis, urine, and human bite wounds (<link linkend="ch0074s0011s0003li0117">117</link>, <link linkend="ch0074s0011s0003li0176">176</link>, <link linkend="ch0074s0011s0003li0186">186</link>–<link linkend="ch0074s0011s0003li0188">188</link>, <link linkend="ch0074s0011s0003li0260">260</link>–<link linkend="ch0074s0011s0003li0264">264</link>). A considerable number of <emphasis>D. pneumosintes</emphasis> isolates originate from various cutaneous/soft tissue infections (<link linkend="ch0074s0011s0003li0260">260</link>). It may be that the patient’s poor dental hygiene is a predisposing factor in certain nonoral cases, e.g., bacteremia and brain abscess (<link linkend="ch0074s0011s0003li0187">187</link>, <link linkend="ch0074s0011s0003li0261">261</link>). <emphasis>D. micraerophilus</emphasis>, which is not a strict anaerobe, <emphasis>D. propionicifaciens</emphasis>, and—recently—<emphasis>D. hominis</emphasis> have been isolated from a variety of clinical specimens, mainly below the waistline (<link linkend="ch0074s0011s0003li0074">74</link>, <link linkend="ch0074s0011s0003li0075">75</link>, <link linkend="ch0074s0011s0003li0105">105</link>, <link linkend="ch0074s0011s0003li0260">260</link>).</para>
      <para id="ch0074s0006p0003"><emphasis>Selenomonas</emphasis> species and <emphasis>Centipeda periodontii</emphasis> (also a member of <emphasis>Selenomonadaceae</emphasis>) are motile organisms recovered from the oral cavity, where they are components of dental biofilms (<link linkend="ch0074s0011s0003li0084">84</link>, <link linkend="ch0074s0011s0003li0265">265</link>, <link linkend="ch0074s0011s0003li0266">266</link>). <emphasis>S. sputigena</emphasis> has been found in specimens from necrotizing ulcerative gingivitis, generalized aggressive periodontitis, and acute dental abscesses (<link linkend="ch0074s0011s0003li0109">109</link>, <link linkend="ch0074s0011s0003li0110">110</link>). <emphasis>S. noxia</emphasis> has been reported in chronic and aggressive periodontitis lesions (<link linkend="ch0074s0011s0003li0109">109</link>). <emphasis>C. periodontii</emphasis> has been recovered from endodontic infections (<link linkend="ch0074s0011s0003li0266">266</link>). Furthermore, there have been a few reports on the involvement of <emphasis>Selenomonas</emphasis> in nonoral infections, including cystic fibrosis and bacteremia (<link linkend="ch0074s0011s0003li0186">186</link>).</para>
      <para id="ch0074s0006p0004">Occasional<emphasis>Phascolarctobacterium</emphasis> findings, identified as <emphasis>P. faecium</emphasis> (an animal-derived, koala associated species), have been reported from anaerobic bacteremia cases in humans (<link linkend="ch0074s0011s0003li0121">121</link>). These isolates may represent <emphasis>P. succinatutens</emphasis>, which was later isolated and characterized from human feces (<link linkend="ch0074s0011s0003li0078">78</link>).</para>
      <para id="ch0074s0006p0005">Recently, the first clinical case with involvement of<emphasis>Christensella minuta</emphasis>, together with <emphasis>Desulfovibrio desulfuricans</emphasis>, was reported in blood of a patient suffering from acute appendicitis (<link linkend="ch0074s0011s0003li0080">80</link>).</para>
      <para id="ch0074s0006p0006"><emphasis>Sutterella wadsworthensis</emphasis>, a microaerobic organism phenotypically but not phylogenetically close to fastidious <emphasis>Campylobacter</emphasis> species, has been isolated from a variety of infections, such as appendicitis, peritonitis, and rectal or perirectal abscesses (<link linkend="ch0074s0011s0003li0267">267</link>). <emphasis>Sutterella</emphasis> was suggested to play a dominant role in gastrointestinal disturbances in children with autism (<link linkend="ch0074s0011s0003li0268">268</link>), but this needs confirmation.</para>
      <para id="ch0074s0006p0007"><emphasis>Bilophila wadsworthia</emphasis> is a significant human pathogen in polymicrobial intra-abdominal infections, especially in appendicitis, at an increasing frequency with deteriorating disease status (<link linkend="ch0074s0011s0003li0084">84</link>). In gangrenous appendices of children, <emphasis>B. wadsworthia</emphasis> is even more common than in those of adults (<link linkend="ch0074s0011s0003li0123">123</link>). Moreover, <emphasis>B. wadsworthia</emphasis> has been isolated from abscesses at various body sites as well as from blood (<link linkend="ch0074s0011s0003li0084">84</link>, <link linkend="ch0074s0011s0003li0269">269</link>).</para>
      <para id="ch0074s0006p0008">Some<emphasis>Anaerobiospirillum</emphasis> and <emphasis>Desulfovibrio</emphasis> organisms reside in the gastrointestinal tract of humans and can also be infrequently encountered in clinical specimens; typical cases are bacteremia and abdominal infections in immunocompromised patients (<link linkend="ch0074s0011s0003li0085">85</link>, <link linkend="ch0074s0011s0003li0270">270</link>–<link linkend="ch0074s0011s0003li0272">272</link>). Of the two <emphasis>Anaerobiospirillum</emphasis> species, <emphasis>A. succiniciproducens</emphasis> has been connected to bacteremia, diarrheal illness, and prosthetic joint infections, whereas <emphasis>A. thomasii</emphasis> is considered a potential cause of diarrhea but not of bacteremia (<link linkend="ch0074s0011s0003li0087">87</link>, <link linkend="ch0074s0011s0003li0088">88</link>, <link linkend="ch0074s0011s0003li0273">273</link>–<link linkend="ch0074s0011s0003li0276">276</link>). In the case of diarrhea and sepsis, the possibility of zoonotic transmission exists (<link linkend="ch0074s0011s0003li0271">271</link>, <link linkend="ch0074s0011s0003li0276">276</link>). The main <emphasis>Desulfovibrio</emphasis> species isolated from human infections include <emphasis>D. desulfuricans</emphasis>, “<emphasis>D. fairfieldensis</emphasis>,” <emphasis>D. piger</emphasis>, and <emphasis>D. vulgaris</emphasis> (<link linkend="ch0074s0011s0003li0085">85</link>, <link linkend="ch0074s0011s0003li0277">277</link>–<link linkend="ch0074s0011s0003li0279">279</link>). <emphasis>D. desulfuricans</emphasis> is common also in the environment, whereas “<emphasis>D. fairfieldensis</emphasis>” and <emphasis>D. piger</emphasis> have been detected only in humans so far. The first human findings of <emphasis>D. intestinalis</emphasis> came from vaginal specimens of four Japanese women (<link linkend="ch0074s0011s0003li0280">280</link>). “<emphasis>D. fairfieldensis</emphasis>,” a taxon never validly described, has been isolated from blood in particular, but also from various intra-abdominal sites, urine, and periodontal pockets (<link linkend="ch0074s0011s0003li0278">278</link>). <emphasis>D. desulfuricans</emphasis> bacteremia cases are mainly connected to abdominal illnesses (<link linkend="ch0074s0011s0003li0281">281</link>–<link linkend="ch0074s0011s0003li0283">283</link>), and a case of liver abscess (in coculture with <emphasis>Escherichia coli</emphasis>) was described recently (<link linkend="ch0074s0011s0003li0284">284</link>). In addition to “<emphasis>D. fairfieldensis</emphasis>,” an oral <emphasis>Desulfomicrobium</emphasis> species, <emphasis>D. orale</emphasis>, has been connected to periodontitis (<link linkend="ch0074s0011s0003li0086">86</link>). On the basis of differences in pyrosequencing results of stools collected from autistic children with gastrointestinal symptoms and their sibling and nonsibling controls, <emphasis>Desulfovibrio</emphasis> was suggested to be linked to regressive autism (<link linkend="ch0074s0011s0003li0285">285</link>), but this needs confirmation. Together with methanogens, sulfate reducers such as <emphasis>Desulfovibrio</emphasis> consume the end product H<subscript>2</subscript>, forming a “hydrogen sink” and enhancing the fermentation and growth of bacteria in anaerobic (infectious) processes, as an interesting concept of pathogenicity (<link linkend="ch0074s0011s0003li0111">111</link>, <link linkend="ch0074s0011s0003li0286">286</link>).</para>
      <sect2 id="ch0074s0006s0001">
        <title>COLLECTION, TRANSPORT, AND STORAGE OF SPECIMENS</title>
        <anchor id="ch0074s0006s0001a0001"/>
        <anchor id="ch0074s0006s0001a0002"/>
        <para id="ch0074s0006s0001p0001">General guidelines for collection, transport, and storage of specimens are discussed in<ulink url="ch0028#ch0028s0001">chapters 13</ulink> and <ulink url="ch0035#ch0035s0001">19</ulink> of this <emphasis>Manual.</emphasis> Specimens suitable for the isolation of anaerobes include blood, tissue biopsies, aspirates (e.g., cerebrospinal fluid, joint fluids, and pus), dental root canal exudates, and subgingival plaque (exclusively from the base level of the periodontal pocket). Appropriate respiratory tract specimens include bronchoscopic protected-brush specimens, centesis samples from the thoracic/pleural cavity, percutaneous transtracheal aspirates, and lung tissue biopsies acquired at surgery or autopsy. Also, wound and ulcer specimens should preferably be taken by tissue biopsy, wound curettage, or aspiration. For example, for diabetic foot ulcers, the lesion is cleaned and carefully debrided, and tissue samples are collected from the base or progressive edge, where bacteria actively multiply (<link linkend="ch0074s0011s0003li0142">142</link>). Infected tissue, obtained by excision or biopsy, is always preferable to pus as a clinical specimen. However, when pus is collected, it is best aspirated into a syringe through a needle and injected into an anaerobic transport vial containing an oxidation-reduction indicator (e.g., products from Anaerobe Systems, Morgan Hill, CA, and Becton Dickinson, Sparks, MD). It is notable that syringes used for aspiration should not be used as transporters because of the potential danger of needle stick injuries or accidental expulsion and because oxygen diffuses through plastic syringes (<link linkend="ch0074s0011s0003li0091">91</link>). Mucosal or cutaneous swabs are not recommended. In cases where bacteremia is suspected, culture of 20 ml of blood (at least two separate samples) is recommended. Anaerobic culture is important, especially in patients with complex underlying diseases and when the source of bacteremia is unknown (<link linkend="ch0074s0011s0003li0114">114</link>). Also, blood collected from patients with abdominal or gynecological processes, peritoneal abscess, dirty wound, decubitus ulcers, osteomyelitis, or spreading oropharyngeal disease should be examined for anaerobes.</para>
        <para id="ch0074s0006s0001p0002">Specimens must be transported to the laboratory under anaerobic conditions (e.g., Anaerobe Systems PRAS Anaerobic Transport Media [ATM] AS-911, [ATMSurgeryPack] AS-914, or [DentalTM] AS-920; Becton Dickinson BBL Port-A-Cul Transport Systems; BBL Vacutainer Anaerobic Specimen Collector [media-free in order to minimize sample dilution]; or AnaeroGRO of Hardy Diagnostics, Santa Maria, CA) without delay for further processing. An optimal transport system is able to maintain the viability of anaerobic organisms without allowing the overgrowth of aerobic bacteria. However, if clinical specimens contain fastidious organisms, the transport to the clinical laboratory should occur within 24 h (<link linkend="ch0074s0011s0003li0287">287</link>). Tissue samples are best transported in specific anaerobic transport vials or in loosely capped containers sealed in gas-impermeable bags in which an anaerobic atmosphere has been generated. For small tissue and biopsy specimens and for subgingival and dental root canal samples, a semisolid anaerobic transport medium (e.g., those of Anaerobe Systems, Becton Dickinson, and Hardy Diagnostics), in which the specimen can be submerged, can be used.</para>
        <anchor id="ch0074s0006s0001a0003"/>
        <beginpage pagenum="1109"/>
        <para id="ch0074s0006s0001p0003">Further guidance for the collection of specimens from different body sites and by various methods, as well as transport systems and anaerobic techniques, can be found in more detail elsewhere (<link linkend="ch0074s0011s0003li0091">91</link>).</para>
        <para id="ch0074s0006s0001p0004">For long-term storage, 2- to 3-day-old cultures can be transferred into vials containing sterilized 20% skim milk and kept frozen at –70°C. Another freezing method is to mix four parts of a 48-h broth culture, such as cooked-meat medium without glucose, with sterile glycerol (final concentration, 10 to 25%), and pipette into a sterile vial.</para>
      </sect2>
      <sect2 id="ch0074s0006s0002">
        <title>DIRECT EXAMINATION</title>
        <anchor id="ch0074s0006s0002a0001"/>
        <anchor id="ch0074s0006s0002a0002"/>
        <para id="ch0074s0006s0002p0001">The gross appearance, fluorescence under long-wave UV light, and odor of the specimen can give the laboratory valuable clues to the presence of anaerobes. A fetid or putrid odor due to volatile short-chain fatty acids and amines is always associated with the presence of anaerobes in the sample. Black necrotic tissue and/or red fluorescence of the sample may be indicative of the presence of pigmented Gram-negative rods (<link linkend="ch0074s0011s0003li0091">91</link>).</para>
        <para id="ch0074s0006s0002p0002">The Gram stain is quick, simple, and likely to yield significant information, and one should be prepared from all specimens accepted for anaerobic culture. Many Gram-negative anaerobic rods have unique cell morphology, e.g., different species within the genus<emphasis>Fusobacterium.</emphasis> For instance, a Gram-stained smear with highly pleomorphic Gram-negative rods in a positive blood culture bottle from a septic patient following a sore throat may indicate invasive <emphasis>F. necrophorum</emphasis> infection (<link linkend="ch0074s0011s0003li0197">197</link>). The morphotypes and relative quantities of the bacteria and host inflammatory cells present in the preparation should be reported. Gram stain using the Nugent criteria for interpretation of vaginal discharge is still considered the best method for diagnosis of bacterial vaginosis (<link linkend="ch0074s0011s0003li0104">104</link>). However, nucleic acid amplification test measurements of the abundance of normal and dysbiotic microbiota, relative to total bacteria in vaginal fluid, may provide a more accurate diagnosis (<link linkend="ch0074s0011s0003li0288">288</link>).</para>
      </sect2>
    </sect1>
    <sect1 id="ch0074s0007">
      <title>Molecular Detection</title>
      <anchor id="ch0074s0007a0001"/>
      <anchor id="ch0074s0007a0002"/>
      <para id="ch0074s0007p0001">Molecular methods are nowadays commonly used for direct detection of bacteria from clinical specimens or for confirmation of identity. Almost complete or partial (the V3 through V6 regions are the most informative) sequencing of the 16S rRNA gene is successfully used for identifying fastidious organisms and potential pathogens in typical polymicrobial lesions such as periodontitis, endodontic infections, and spreading odontogenic infections (<link linkend="ch0074s0011s0003li0070">70</link>, <link linkend="ch0074s0011s0003li0108">108</link>, <link linkend="ch0074s0011s0003li0166">166</link>, <link linkend="ch0074s0011s0003li0182">182</link>), but also in infections where the involvement of anaerobic bacteria has not been traditionally taken into account, e.g., cystic fibrosis (<link linkend="ch0074s0011s0003li0186">186</link>). It is notable that a culture-based approach can underestimate the presence of etiologic but fastidious or uncultivable organisms in clinical specimens. For example, <emphasis>Prevotella</emphasis> species are highly prevalent in the lungs of cystic fibrosis patients (<link linkend="ch0074s0011s0003li0186">186</link>, <link linkend="ch0074s0011s0003li0289">289</link>), but routine culture of sputum does not include anaerobes and potential anaerobic pathogens are not reported. Furthermore, in women who experienced preterm labor and whose amniotic fluid tested positive by culture or PCR, seven species, including <emphasis>Sneathia sanguinegens</emphasis> and <emphasis>S. vaginalis</emphasis> (formerly <emphasis>S. amnii</emphasis> or “<emphasis>Leptotrichia amnionii</emphasis>”), were detected by PCR only (<link linkend="ch0074s0011s0003li0211">211</link>). A molecular-based and FDA-approved test using vaginal swabs collected by clinicians or patients was found to accurately diagnose most common bacterial, fungal, and protozoan causes of vaginitis (<link linkend="ch0074s0011s0003li0290">290</link>). In addition, in a study of urinary tract specimens from renal transplant recipients (<link linkend="ch0074s0011s0003li0188">188</link>), the 16S rRNA PCR method detected a wide range of bacteria, including Gram-negative anaerobes such as <emphasis>B. vulgatus, D. invisus, F. nucleatum, S. vaginalis</emphasis> (“<emphasis>L. amnionii</emphasis>”), <emphasis>P. buccalis</emphasis>, and <emphasis>P. ruminicola</emphasis>, in culture-negative samples. A study that subjected pus specimens from 51 brain abscesses to 16S rRNA gene amplification, cloning, and sequencing revealed 19 cases of polymicrobial infections with 76 different species, including 22 uncultured taxa, among them 10 <emphasis>Bacteroides</emphasis> phylotypes (<link linkend="ch0074s0011s0003li0210">210</link>). A study applying massive parallel sequencing on samples from 52 brain abscesses, categorized as either spontaneous intracerebral, spontaneous subdural, or postoperative, demonstrated <emphasis>Fusobacterium</emphasis> and <emphasis>Prevotella</emphasis> among the top 10 species detectable (<link linkend="ch0074s0011s0003li0194">194</link>). An increasing number of metagenomics deep-sequencing studies have demonstrated that the species diversity in such polymicrobial infections is much richer than previously assumed. With decreasing prices and new methods, e.g., bar code labeling and V6 tagging, next-generation sequencing will expand the power to investigate health- and disease-associated mixed anaerobic microbial communities or outbreak history (<link linkend="ch0074s0011s0003li0291">291</link>–<link linkend="ch0074s0011s0003li0293">293</link>). Challenges associated with molecular techniques include exclusion of any contamination (sampling, transport, processing stages), differences in the lysis efficiency depending on the bacterial cell wall composition, human competitor DNA in clinical samples, primer discrimination because of mismatches or limited accessibility of template site, persistence of DNA of dead cells, inability of the antimicrobial susceptibility testing, and interpretation of complex results and clinical consequences (<link linkend="ch0074s0011s0003li0294">294</link>–<link linkend="ch0074s0011s0003li0296">296</link>).</para>
      <sect2 id="ch0074s0007s0001">
        <title>ISOLATION PROCEDURES</title>
        <anchor id="ch0074s0007s0001a0001"/>
        <anchor id="ch0074s0007s0001a0002"/>
        <para id="ch0074s0007s0001p0001">Except for blood and joint fluid cultures, the use of liquid medium as the only anaerobic culture technique is not acceptable (<link linkend="ch0074s0011s0003li0091">91</link>). The use of solid nonselective medium together with selective medium increases the yield and saves time in terms of recognition and isolation of colonies. The selective media are chosen based on the expected microbiota at the collection site, or in the case of bite wounds, on the oral microbiota of the biter (human or animal). Freshly prepared or prereduced and anaerobically sterilized medium should be used (<link linkend="ch0074s0011s0003li0091">91</link>). Different basal media differ in their abilities to support the growth of anaerobes; brucella base and Fastidious Anaerobe Agar (Lab M, Bury, United Kingdom) may be the best basal medium for isolation of Gram-negative anaerobic rods. In particular, Fastidious Anaerobe Agar enhances the growth of fusobacteria (<link linkend="ch0074s0011s0003li0197">197</link>). In academic centers performing large-scale anaerobic bacteriology, it would be ideal to use two different basal media to maximize isolation efficiency.</para>
        <anchor id="ch0074s0007s0001a0003"/>
        <beginpage pagenum="1110"/>
        <para id="ch0074s0007s0001p0002">Culture methods in general are discussed in<ulink url="ch0035#ch0035s0001">chapter 19</ulink> <emphasis>Manual.</emphasis> The minimum medium setup for isolating Gram-negative anaerobic rods includes (i) a nonselective, enriched, brucella base sheep blood agar plate supplemented with vitamin K<subscript>1</subscript> and hemin (BA); (ii) a kanamycin-vancomycin laked sheep blood agar plate for the selection of <emphasis>Bacteroides</emphasis> and <emphasis>Prevotella</emphasis> species; and (iii) a <emphasis>Bacteroides</emphasis> bile-esculin (BBE) agar plate for specimens from areas below the diaphragm for the selection and presumptive identification of the <emphasis>B. fragilis</emphasis> group and <emphasis>Bilophila</emphasis> species. BBE and kanamycin-vancomycin laked sheep blood are also available as biplates. A phenylethyl alcohol sheep blood agar plate used to prevent overgrowth by aerobic Gram-negative rods and swarming of some clostridia is indicated for purulent specimens and in the case of mixed infections. Use of a metronidazole disk (5 μg) on nonselective agar is useful for the detection of Gram-negative obligate anaerobes; however, it may mask the presence of infrequently encountered metronidazole-resistant organisms.</para>
        <para id="ch0074s0007s0001p0003">After inoculation, the anaerobic plates are immediately incubated at 36 to 37°C in an anaerobic environment, such as an anaerobic bag, jar, or chamber. Alternatively, setup and incubation may all be done in an anaerobic chamber. Plates should not be exposed to air during the first 48 h, to avoid loss of the more oxygen-sensitive species. The availability of an anaerobic chamber enables the examination of the culture whenever necessary. An incubation period of 48 h will reveal the presence of rapidly growing strains, such as<emphasis>Bacteroides</emphasis> or <emphasis>Clostridium</emphasis>, but reincubation for 5 to 7 days for primary plates is recommended, since some species, such as <emphasis>Bilophila, Desulfovibrio</emphasis>, and <emphasis>Porphyromonas</emphasis>, may not be detected with shorter incubation times and require at least 4 to 5 days for growth (<link linkend="ch0074s0011s0003li0084">84</link>, <link linkend="ch0074s0011s0003li0085">85</link>, <link linkend="ch0074s0011s0003li0091">91</link>). For successful culture and susceptibility testing of anaerobes, a strictly anaerobic atmosphere needs to be maintained inside the chamber, jar, or bag. Chambers may fail to keep a proper gaseous condition in an especially busy laboratory and, therefore, repeated quality controls should be performed; e.g., with a simple method of growing an aerotolerant <emphasis>Clostridium perfringens</emphasis> strain with a metronidazole (5 μg) disk, an inhibition zone of &gt;27 mm indicates acceptable anaerobiosis (<link linkend="ch0074s0011s0003li0297">297</link>).</para>
        <para id="ch0074s0007s0001p0004">Increased awareness of the importance of anaerobic organisms as a cause of systemic infections may contribute to the increase of their isolation and detection in blood samples in clinical microbiology laboratories. For instance, to reliably detect anaerobic organisms, the BACTEC Lytic/10 Anaerobic/F culture medium (Becton Dickinson) has been shown to be a rapid and reliable method, improving the detection of low levels of anaerobic bacteria, such as<emphasis>Prevotella</emphasis> and <emphasis>Fusobacterium</emphasis>, in the sample (<link linkend="ch0074s0011s0003li0117">117</link>). In a separate study, it was shown that blood culture sets comprising one aerobic bottle and one anaerobic bottle have higher pathogen yields than two sets of aerobic bottles (<link linkend="ch0074s0011s0003li0298">298</link>). There is broad variation in anaerobic blood culture practices among hospitals, even in industrialized countries (<link linkend="ch0074s0011s0003li0172">172</link>, <link linkend="ch0074s0011s0003li0299">299</link>). <ulink url="ch0020#ch0020s0001">Chapter 5</ulink> of this <emphasis>Manual</emphasis> gives more information about blood culture systems.</para>
      </sect2>
      <sect2 id="ch0074s0007s0002">
        <title>IDENTIFICATION</title>
        <anchor id="ch0074s0007s0002a0001"/>
        <anchor id="ch0074s0007s0002a0002"/>
        <para id="ch0074s0007s0002p0001">After anaerobic incubation, the relative quantities of distinct colony types are recorded. Plates should be examined with a dissecting microscope to facilitate detection. Even after incubation for 7 days, certain species, such as<emphasis>Desulfovibrio</emphasis> and <emphasis>Dialister</emphasis>, grow as transparent colonies that are pinpoint in size and are easily overlooked in mixed cultures (<link linkend="ch0074s0011s0003li0074">74</link>, <link linkend="ch0074s0011s0003li0085">85</link>, <link linkend="ch0074s0011s0003li0277">277</link>, <link linkend="ch0074s0011s0003li0278">278</link>). <anchor id="ch0074s0007s0002a0003"/><link linkend="ch0074s0007s0002a0004">Figure 1</link> gives an example of a mixed anaerobic culture, in this particular case a sample from a pelvic abscess of a patient using an IUD for &gt;10 years. The isolates should then be subcultured onto BA and, at this point, a rabbit laked blood agar plate (available from Kohjin-Bio Ltd., Japan) for the rapid demonstration of pigment production; an egg yolk agar plate for the demonstration of lipase, lecithinase, and proteolytic activities may also be inoculated. The primary plates are reincubated along with the purity and test plates.</para>
        <figure id="ch0074s0007s0002f0001"><title><phrase role="figureLabel"><anchor id="ch0074s0007s0002a0004"/><link linkend="ch0074s0007s0002a0003">FIGURE 1</link></phrase> Typical cultivable microbiota associated with a pelvic abscess. The anaerobic Gram-negative species were identified as <emphasis>Prevotella corporis</emphasis> (brownish colonies), <emphasis>Porphyromonas asaccharolytica</emphasis> (black colonies), and <emphasis>Sneathia vaginalis</emphasis> (flat small colonies). Other species involved in this mixed infection are <emphasis>Gardnerella vaginalis</emphasis> (flat colonies) and <emphasis>Atopobium vaginae</emphasis> (pinpoint colonies). Incubation for 72 h in an anaerobic atmosphere on BA.</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0074f04.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
      </sect2>
    </sect1>
    <sect1 id="ch0074s0008">
      <title>Presumptive Identification</title>
      <anchor id="ch0074s0008a0001"/>
      <anchor id="ch0074s0008a0002"/>
      <para id="ch0074s0008p0001">Colony morphology of an isolate in pure culture can be useful for presumptive identification. For example,<emphasis>F. nucleatum</emphasis> can appear on the plate as speckled, iridescent, or bread crumb-like colonies, while <emphasis>B. wadsworthia</emphasis> has typical black-centered colonies on BBE (<link linkend="ch0074s0011s0003li0091">91</link>). Colony morphology, together with the capability of erythrocyte agglutination, is among the features that can be used to separate the two <emphasis>F. necrophorum</emphasis> subspecies using phenotypic tests (<link linkend="ch0074s0011s0003li0300">300</link>). The agglutination procedure, using human and chicken erythrocytes, is performed by a glass slide method, where agglutination is observed by mixing a drop of bacterial suspension and a drop of erythrocyte suspension on a microscope slide. <emphasis>F. necrophorum</emphasis> subsp. <emphasis>funduliforme</emphasis> (agglutination-negative) colonies are pulvinate (very convex or cushion-shaped), creamy, and glistening with entire margins, whereas <emphasis>F. necrophorum</emphasis> subsp. <emphasis>necrophorum</emphasis> (agglutination-positive) colonies are convex or umbonate, waxy, and dull with erose margins. Also, observation of hemolysis may be of diagnostic value; for instance, both <emphasis>F. necrophorum</emphasis> subspecies exhibit beta-hemolysis when grown on horse blood agar (<link linkend="ch0074s0011s0003li0300">300</link>). Hemolytic properties on human blood may aid in separation of different <emphasis>Leptotrichia</emphasis> species (<link linkend="ch0074s0011s0003li0301">301</link>). Production of pigment is another visible characteristic valuable in presumptive identification; the pigmented Gram-negative anaerobic rods are composed of saccharolytic and asaccharolytic species of the genera <emphasis>Prevotella</emphasis> and <emphasis>Porphyromonas</emphasis> and pigment-producing <emphasis>Alistipes</emphasis> species. In this context, it is notable that the statement “after 4 days incubation on laked rabbit blood agar, colonies appear black” in the original description of <emphasis>A. onderdonkii</emphasis> and <emphasis>A. shahii</emphasis> (<link linkend="ch0074s0011s0003li0009">9</link>) is incorrect. Instead, the grade of pigmentation is light or moderately brown on rabbit laked blood agar and, under long-wavelength (365 nm) UV light, colonies appear black. Appearance of pigment requires fresh medium and expanded incubation (<link linkend="ch0074s0011s0003li0147">147</link>). As a novel observation, a diffusible brown pigment on BBE can be useful in presumptive identification of <emphasis>Alistipes</emphasis> species (<link linkend="ch0074s0011s0003li0147">147</link>). The pigmented <emphasis>Prevotella</emphasis> and <emphasis>Porphyromonas</emphasis> species vary greatly in the degree and rapidity of pigment production (2 to 21 days), which ranges from buff to tan to black (<anchor id="ch0074s0008a0003"/><link linkend="ch0074s0008a0006">Fig. 2</link>), depending primarily on the type of blood and the composition of the base medium used in the agar (<link linkend="ch0074s0011s0003li0091">91</link>). Fluorescence under long-wavelength UV light can be helpful in presumptive identification; pigmented <emphasis>Prevotella</emphasis> and <emphasis>Porphyromonas</emphasis> colonies typically fluoresce red (<emphasis>Porphyromonas gingivalis</emphasis> is among the nonfluorescent species of human origin), <emphasis>F. nucleatum</emphasis> and <emphasis>F. necrophorum</emphasis> fluoresce yellow-green, and <emphasis>Desulfovibrio</emphasis> and <emphasis>Bilophila</emphasis> species, when tested with a drop of 2 N NaOH on a swab of cell paste, fluoresce red due to the presence of desulfoviridin pigment (<link linkend="ch0074s0011s0003li0091">91</link>, <link linkend="ch0074s0011s0003li0279">279</link>, <link linkend="ch0074s0011s0003li0300">300</link>). <anchor id="ch0074s0008a0004"/><link linkend="ch0074s0008a0008">Figure 3</link> gives an example of how fluorescence helps to distinguish colonies and differentiate some anaerobes.</para>
      <anchor id="ch0074s0008a0005"/>
      <beginpage pagenum="1111"/>
      <figure id="ch0074s0008f0001"><title><phrase role="figureLabel"><anchor id="ch0074s0008a0006"/><link linkend="ch0074s0008a0003">FIGURE 2</link></phrase> Pigmentation varies among phylogenetically close species. Top row: the <emphasis>Prevotella intermedia</emphasis> group organisms, (A) <emphasis>P. aurantiaca</emphasis>, (B) <emphasis>P. intermedia</emphasis>, (C) <emphasis>P. nigrescens</emphasis>, and (D) <emphasis>P. pallens.</emphasis> Bottom row: the <emphasis>Prevotella melaninogenica</emphasis> group organisms, (E) <emphasis>P. denticola</emphasis>, (F) <emphasis>P. jejuni</emphasis>, (G) <emphasis>P. loescheii</emphasis>, and (H) <emphasis>P. melaninogenica</emphasis> (courtesy of Mervi Gürsoy).</title>
        
        <mediaobject>
          <imageobject>
            <imagedata fileref="Ch0074f05.jpg" width="100%" scalefit="1"/>
          </imageobject>
        </mediaobject>
      </figure>
      <para id="ch0074s0008p0002">Microscopic determination of the morphology of Gram-stained bacterial cells can aid presumptive identification of the organisms present. Among fusiforms,<emphasis>F. nucleatum</emphasis> usually exhibits long, spindle-shaped cells with tapered ends, while <emphasis>F. necrophorum</emphasis> and <emphasis>F. mortiferum</emphasis> have highly pleomorphic cells, with or without swollen areas and large round bodies (<link linkend="ch0074s0011s0003li0006">6</link>, <link linkend="ch0074s0011s0003li0197">197</link>, <link linkend="ch0074s0011s0003li0300">300</link>). <emphasis>Leptotrichia</emphasis> cells, which often stain Gram positive in fresh cultures, have been usually considered as long rods; however, this description fits only with <emphasis>L. buccalis, L. hofstadii, L. shahii</emphasis>, and <emphasis>L. trevisanii</emphasis> (<link linkend="ch0074s0011s0003li0301">301</link>, <link linkend="ch0074s0011s0003li0302">302</link>). <emphasis>Dialister</emphasis> species are small coccobacilli, making their distinction from Gram-negative cocci difficult (<link linkend="ch0074s0011s0003li0074">74</link>). <emphasis>Desulfovibrio piger</emphasis> typically stains bipolar (<link linkend="ch0074s0011s0003li0279">279</link>). Wet slide preparation for microscopic examination reveals the motility of Gram-negative anaerobes: <emphasis>Selenomonas</emphasis> displays a characteristic tumbling motility, often moving side-to-side across the field; <emphasis>Fretibacterium fastidiosum</emphasis> is an important member of the highly motile fraction of the periodontitis-associated microbiota. <emphasis>Anaerobiospirillum</emphasis> cells are spiral with corkscrew-like motility. <emphasis>Desulfovibrio</emphasis> species, except for <emphasis>D. piger</emphasis>, appear as curved rods with rapid, progressive motility (<link linkend="ch0074s0011s0003li0085">85</link>, <link linkend="ch0074s0011s0003li0087">87</link>, <link linkend="ch0074s0011s0003li0303">303</link>).</para>
      <para id="ch0074s0008p0003">Inhibition of growth by bile or antibiotics is useful in identification of anaerobes. The<emphasis>B. fragilis</emphasis> group, in particular, and most <emphasis>Bacteroides</emphasis> species are typically bile resistant (<link linkend="ch0074s0011s0003li0002">2</link>, <link linkend="ch0074s0011s0003li0091">91</link>). Pigment-producing <emphasis>Alistipes</emphasis> can be readily distinguished from pigmented <emphasis>Porphyromonas</emphasis> and <emphasis>Prevotella</emphasis> species by the resistance to 20% bile (<link linkend="ch0074s0011s0003li0008">8</link>, <link linkend="ch0074s0011s0003li0304">304</link>). Among fusobacteria, <emphasis>F. mortiferum, F. varium</emphasis>, and some strains of <emphasis>F. necrophorum</emphasis> grow in the presence of bile, whereas <emphasis>F. nucleatum</emphasis> does not. The profile of susceptibility to special-potency antimicrobial disks (a zone size of ≥10 mm is considered susceptible), containing vancomycin (5 μg), kanamycin (1,000 μg), and colistin (10 μg), is useful in presumptive identification of many Gram-negative anaerobic taxa (Table 2). Gram-negative anaerobic rods are typically resistant to vancomycin, with pigmented <emphasis>Porphyromonas</emphasis> species, <emphasis>Butyricimonas</emphasis>, and <emphasis>Sneathia vaginalis</emphasis> (formerly <emphasis>S. amnii</emphasis>) the only exceptions (<link linkend="ch0074s0011s0003li0009">9</link>, <link linkend="ch0074s0011s0003li0011">11</link>, <link linkend="ch0074s0011s0003li0012">12</link>, <link linkend="ch0074s0011s0003li0064">64</link>, <link linkend="ch0074s0011s0003li0091">91</link>). Susceptibility to both kanamycin and colistin is characteristic of <emphasis>Fusobacterium</emphasis> and <emphasis>Leptotrichia</emphasis>/<emphasis>Sneathia</emphasis> species, <emphasis>Sutterella wadsworthensis</emphasis>, and <emphasis>Tannerella forsythia</emphasis> (<link linkend="ch0074s0011s0003li0074">74</link>). Among motile Gram-negative organisms, <emphasis>Anaerobiospirillum</emphasis> is usually susceptible to colistin, unlike most <emphasis>Desulfovibrio</emphasis> and <emphasis>Selenomonas</emphasis> isolates.</para>
      <anchor id="ch0074s0008a0007"/>
      <beginpage pagenum="1112"/>
      <figure id="ch0074s0008f0002"><title><phrase role="figureLabel"><anchor id="ch0074s0008a0008"/><link linkend="ch0074s0008a0004">FIGURE 3</link></phrase> (A) Differentiation of colonies by fluorescence exemplified by a saliva sample (100 μl, 10<superscript>–4</superscript> diluted) plated on Columbia blood agar and incubated under anaerobic atmosphere: <emphasis>Prevotella melaninogenica</emphasis> (colonies with reddish fluorescence), <emphasis>Prevotella nigrescens</emphasis> (red fluorescence in the center of the dark-pigmented colony), and <emphasis>Fusobacterium nucleatum</emphasis> (large colonies with greenish fluorescence). (B) Same sample under natural light. Images courtesy of Laura Wendt.</title>
        
        <mediaobject>
          <imageobject>
            <imagedata fileref="Ch0074f03.jpg" width="100%" scalefit="1"/>
          </imageobject>
        </mediaobject>
      </figure>
      <para id="ch0074s0008p0004">In addition to the characteristics listed above, there are some simple tests that are within the scope of most clinical laboratories. For example, a bile-resistant organism with typical darkening of the center of colonies on BBE can be easily recognized as<emphasis>Bilophila wadsworthia</emphasis> by its strong catalase reaction with 10 to 15% H<subscript>2</subscript>O<subscript>2</subscript> (<link linkend="ch0074s0011s0003li0084">84</link>), and by combining positive indole and lipase reactions, a <emphasis>Fusobacterium</emphasis>-like organism can be tentatively identified as <emphasis>F. necrophorum</emphasis> (<link linkend="ch0074s0011s0003li0197">197</link>). An indole- and lipase-positive short rod that forms black-pigmented colonies and fluoresces red can be identified as <emphasis>P. intermedia</emphasis>/<emphasis>P. nigrescens</emphasis>, while <emphasis>P. pallens</emphasis> resembles these indole-positive species but has lighter pigment and is lipase negative (<link linkend="ch0074s0011s0003li0091">91</link>). <emphasis>Bilophila</emphasis> and <emphasis>Sutterella</emphasis> typically reduce nitrate. A characteristic smell may guide the identification; a foul smell produced by butyric acid and other metabolic products is typical for <emphasis>Fusobacterium</emphasis> species, while a strong sulfur smell is typical for the presence of <emphasis>Desulfovibrio</emphasis> species (<link linkend="ch0074s0011s0003li0085">85</link>, <link linkend="ch0074s0011s0003li0279">279</link>).</para>
    </sect1>
    <sect1 id="ch0074s0009">
      <title>Biochemical Testing</title>
      <anchor id="ch0074s0009a0001"/>
      <anchor id="ch0074s0009a0002"/>
      <para id="ch0074s0009p0001">With a steadily increasing number of new species, biochemical testing and differentiation may soon lose its accuracy. In culture-based biochemical testing, the main techniques for classification of anaerobic organisms and distinction of individual species include sugar fermentation reactions, using prereduced, anaerobically sterilized (PRAS) carbohydrates or commercial test kits, and the determination of enzyme profiles with individual diagnostic tablets or preformed enzyme kits. In addition, the determination of major volatile fatty acid end products of glucose metabolism, as detected by gas-liquid chromatography (GLC), is a useful adjunct to biochemical and physiological tests (<link linkend="ch0074s0011s0003li0091">91</link>), but together with analysis of the long-chain fatty acids found in bacterial cell walls it is beyond the scope of most clinical laboratories.</para>
      <para id="ch0074s0009p0002">Commercially available test kits, such as the API 20A, API ZYM, and Rapid ID 32 A (bioMérieux, Marcy-l’Etoile, France), RapID ANA II (Remel, Lenexa, KS), BBL crystal identification (Becton Dickinson), and AN MicroPlate (Biolog Inc., Hayward, CA) systems, are used for testing preformed enzyme and carbohydrate fermentation profiles in clinical microbiology laboratories (<link linkend="ch0074s0011s0003li0305">305</link>). Diagnostic tablets (e.g., from Rosco, Taastrup, Denmark, and Key Scientific, Stamford, TX) are also useful for determining individual enzyme reactions of anaerobic isolates. A heavy inoculum from 2- to 3-day-old cultures should be used for testing to obtain optimal reactions. When using different test systems, variation of test results is expected due to differences in the substrate specificities. These rapid, easy-to-use systems are best suited for fast-growing and biochemically reactive anaerobes, such as the <emphasis>B. fragilis</emphasis> group organisms, but even then it may not be possible to reliably identify the isolate to the species level. The VITEK 2 ANC card (bioMérieux) is an automated system for rapid identification of anaerobic (and coryneform, combined as ANC) bacteria from clinical specimens (<link linkend="ch0074s0011s0003li0306">306</link>, <link linkend="ch0074s0011s0003li0307">307</link>). According to the results of a clinical trial performed in three large tertiary-care centers (<link linkend="ch0074s0011s0003li0307">307</link>), the VITEK 2 ANC card allows the rapid and acceptable identification of the most common clinically important anaerobic bacteria within 6 h. Improvement is required for the identification of, e.g., members of the genera <emphasis>Fusobacterium</emphasis> and <emphasis>Prevotella</emphasis> (<link linkend="ch0074s0011s0003li0307">307</link>, <link linkend="ch0074s0011s0003li0308">308</link>). Currently (April 2022), the system’s database for anaerobes includes only 82 organisms. The skillful and accurate reading of the Gram stain preparation considerably improves the percentage of correct identifications (<link linkend="ch0074s0011s0003li0306">306</link>, <link linkend="ch0074s0011s0003li0307">307</link>).</para>
      <para id="ch0074s0009p0003">The most commonly encountered bile-resistant organisms in clinical specimens belong to the<emphasis>B. fragilis</emphasis> group organisms. They grow as gray, circular, convex, and entire colonies on BA and, in addition, grow well on BBE, where they (except for <emphasis>B. vulgatus</emphasis>) blacken the agar by hydrolyzing esculin. Based on their resistance to special-potency antibiotic disks (vancomycin, kanamycin, and colistin) and a few rapid tests, such as the catalase, indole, esculin, and α-fucosidase tests, they can be initially reported as the <emphasis>B. fragilis</emphasis> group or organisms most closely related to this group (<link linkend="ch0074s0011s0003li0091">91</link>). Testing with β-glucosidase can differentiate <emphasis>B. dorei</emphasis> from <emphasis>B. vulgatus</emphasis>, and a negative catalase reaction can identify <emphasis>B. xylanisolvens</emphasis> (<link linkend="ch0074s0011s0003li0309">309</link>). The genus <emphasis>Parabacteroides</emphasis> includes the former <emphasis>B. distasonis</emphasis> and <emphasis>B. merdae</emphasis> (<link linkend="ch0074s0011s0003li0310">310</link>), and <emphasis>B. splanchnicus</emphasis> has been moved to the genus <emphasis>Odoribacter</emphasis> (<link linkend="ch0074s0011s0003li0029">29</link>). In addition, clinically relevant species include <emphasis>P. goldsteinii</emphasis> and <emphasis>P. gordonii</emphasis> (Table 4) (<link linkend="ch0074s0011s0003li0056">56</link>, <link linkend="ch0074s0011s0003li0168">168</link>, <link linkend="ch0074s0011s0003li0170">170</link>, <link linkend="ch0074s0011s0003li0311">311</link>). All <emphasis>Parabacteroides</emphasis> species are negative for indole and α-fucosidase, except for the newly described <emphasis>P. chongii</emphasis>, thus distinguishing them from the <emphasis>B. fragilis</emphasis> group organisms. <emphasis>P. goldsteinii</emphasis> is phylogenetically and phenotypically very similar to <emphasis>P. merdae</emphasis>; however, <emphasis>P. goldsteinii</emphasis> is positive for α-glucosidase and β-glucosidase (Rosco), whereas <emphasis>P. merdae</emphasis> is not (<link linkend="ch0074s0011s0003li0168">168</link>). Furthermore, its positive β-glucuronidase reaction separates it from <emphasis>P. distasonis.</emphasis> Unlike other <emphasis>Parabacteroides</emphasis> species, <emphasis>P. gordonii</emphasis> does not hydrolyze esculin and does not ferment trehalose (<link linkend="ch0074s0011s0003li0170">170</link>). Most of the <emphasis>B. fragilis</emphasis> group and related organisms are highly fermentative. Table 4 presents the key characteristics for distinguishing the <emphasis>B. fragilis</emphasis> group organisms, including <emphasis>Parabacteroides</emphasis> and <emphasis>Odoribacter</emphasis> species.</para>
      <para id="ch0074s0009p0004">In general, most<emphasis>Alistipes</emphasis> species can be separated from <emphasis>Bacteroides</emphasis> by their pigment production; however, fresh rabbit laked blood agar and prolonged incubation are then required (<link linkend="ch0074s0011s0003li0008">8</link>, <link linkend="ch0074s0011s0003li0147">147</link>). Nonpigmented exceptions are the type species of the genus, <emphasis>A. putredinis</emphasis>, and the recently validated <emphasis>A. ihumii. A. putredinis</emphasis> is bile sensitive and asaccharolytic (<link linkend="ch0074s0011s0003li0006">6</link>). <emphasis>A. finegoldii, A. onderdonkii</emphasis>, and <emphasis>A. shahii</emphasis> strains grow well on solid media, where colonies appear beta-hemolytic, but not well in liquid media with or without supplements (<link linkend="ch0074s0011s0003li0008">8</link>, <link linkend="ch0074s0011s0003li0147">147</link>). They are variably saccharolytic due to their poor growth in liquid media and are bile resistant and catalase negative. More characteristics about <emphasis>Alistipes</emphasis> species are summarized in Table 5 (<link linkend="ch0074s0011s0003li0008">8</link>). <emphasis>Tannerella forsythia</emphasis> is a fastidious oral pathogen, and human strains require exogenous <emphasis>N</emphasis>-acetylmuramic acid for growth in pure cultures (<link linkend="ch0074s0011s0003li0021">21</link>, <link linkend="ch0074s0011s0003li0174">174</link>). Key characteristics of <emphasis>T. forsythia</emphasis> are its sensitivity to bile and positive trypsin and esculin reactions. Notably, animal strains from bite wound infections are positive for catalase and indole (<link linkend="ch0074s0011s0003li0312">312</link>). The new <emphasis>Tannerella</emphasis> species, <emphasis>T. serpentiformis</emphasis>, shares many biochemical reactions but is negative for esterase and <emphasis>N</emphasis>-acetyl-β-glucosaminidase (<link linkend="ch0074s0011s0003li0022">22</link>).</para>
      <para id="ch0074s0009p0005"><emphasis>Porphyromonas</emphasis> species, except for <emphasis>P. catoniae, P. pasteri</emphasis>, and <emphasis>P. pogonae</emphasis>, produce pigment. The identification of the closely related and phenotypically similar <emphasis>P. asaccharolytica, P. endodontalis</emphasis>, and <emphasis>P. uenonis</emphasis> is difficult due to their slow pigment production and inactivity in biochemical testing. Testing with prereduced, anaerobically sterilized carbohydrates is not helpful in distinguishing these species, but glyoxylic acid and glycerol in the AN Microplate system (Biolog Inc.) enable their separation: <emphasis>P. asaccharolytica</emphasis> is positive for glyoxylic acid and <emphasis>P. uenonis</emphasis> is positive for glycerol (<link linkend="ch0074s0011s0003li0009">9</link>). In addition, the differences in the degrees of pigmentation may be helpful, with <emphasis>P. uenonis</emphasis> having the most pigmentation and <emphasis>P. bennonis</emphasis> showing the least (<link linkend="ch0074s0011s0003li0009">9</link>). A positive trypsin reaction is typical for <emphasis>P. gingivalis</emphasis> (<link linkend="ch0074s0011s0003li0091">91</link>) and <emphasis>P. pogonae.</emphasis> Unlike most <emphasis>Porphyromonas</emphasis> species, <emphasis>P. bennonis, P. pasteri, P. somerae</emphasis>, and <emphasis>P. catoniae</emphasis> are indole negative, and—except for <emphasis>P. bennonis</emphasis>—also weakly saccharolytic (<link linkend="ch0074s0011s0003li0010">10</link>–<link linkend="ch0074s0011s0003li0012">12</link>, <link linkend="ch0074s0011s0003li0015">15</link>), which may lead to their misidentification as <emphasis>Prevotella</emphasis> species in clinical laboratories (<link linkend="ch0074s0011s0003li0010">10</link>, <link linkend="ch0074s0011s0003li0011">11</link>). <emphasis>P. bennonis</emphasis> is a slow-growing organism with very slight pigmentation after extended incubation of at least 10 days and has a variable susceptibility to vancomycin (<link linkend="ch0074s0011s0003li0012">12</link>). Unlike other <emphasis>Porphyromonas</emphasis> species, it produces major amounts of acetic and succinic acids in GLC, and some strains are catalase positive. Most <emphasis>Porphyromonas</emphasis> species of animal origin have been differentiated from the human strains by a positive catalase reaction (<link linkend="ch0074s0011s0003li0091">91</link>). For <emphasis>P. pogonae</emphasis>, both animal and human isolates are described as catalase positive (<link linkend="ch0074s0011s0003li0016">16</link>). Table 6 presents the key reactions for distinguishing <emphasis>Porphyromonas</emphasis> species.</para>
      <anchor id="ch0074s0009a0003"/>
      <beginpage pagenum="1113"/>
      <anchor id="ch0074s0009a0004"/>
      <beginpage pagenum="1114"/>
      <para id="ch0074s0009p0006">A small number of<emphasis>Prevotella</emphasis> species produce indole (Table 7) (<link linkend="ch0074s0011s0003li0034">34</link>, <link linkend="ch0074s0011s0003li0036">36</link>, <link linkend="ch0074s0011s0003li0091">91</link>). Although most prominent <emphasis>Prevotella</emphasis> species are pigment producing, only half of them show a brownish color within the first few days, and most <emphasis>Prevotella</emphasis> species are nonpigmented. For example, <emphasis>P. colorans</emphasis> is weakly pigmented up to 5 days of incubation, but the color intensifies when further incubated (<link linkend="ch0074s0011s0003li0190">190</link>). <emphasis>P. fusca, P. scopos</emphasis>, and some strains of <emphasis>P. histicola</emphasis> have a bull’s-eye appearance due to pigmentation of the colony center (<link linkend="ch0074s0011s0003li0032">32</link>, <link linkend="ch0074s0011s0003li0033">33</link>). Noteworthy is that pigment production, as well its degree, on blood agar may take up to 14 days and vary from tan to brown to black depending on the species (for examples see <link linkend="ch0074s0008a0006">Fig. 2</link>). Colonies of <emphasis>P. jejuni</emphasis> are surrounded by a varying degree of hemolysis (<link linkend="ch0074s0011s0003li0041">41</link>). Detection of lipase on egg yolk agar may be useful: <emphasis>P. intermedia, P. nigrescens</emphasis>, and many <emphasis>P. loescheii</emphasis> strains are positive (<link linkend="ch0074s0011s0003li0313">313</link>). Besides the production of pigment and indole, <emphasis>Prevotella</emphasis> organisms are characterized by their capability of fermenting a variety of sugars. <emphasis>Prevotella</emphasis> species produce acetic and succinic acids as their major metabolic end products of glucose fermentation in GLC; however, <emphasis>P. marshii</emphasis>, unusually, also produces propionic acid (<link linkend="ch0074s0011s0003li0314">314</link>). Notably, the separation of the majority of <emphasis>Prevotella</emphasis> species is not possible by phenotypic methods. Due to the high and still increasing number of <emphasis>Prevotella</emphasis> species described based on 16S rRNA gene or genome sequencing, their precise identification by biochemical tests reaches impracticality. However, Table 7 lists reactions that are valuable in the identification of <emphasis>Prevotella</emphasis> and related genera.</para>
      <para id="ch0074s0009p0007">Fusobacteria can be presumptively identified by a limited number of simple laboratory tests, including cell morphology with Gram stain, growth in 20% bile, and indole production, but their definitive identification to the species level may require additional biochemical testing (Table 8). Using GLC for volatile fatty acid determination, detection of propionate produced from lactate and/or threonine has been used to separate different<emphasis>Fusobacterium</emphasis> species (<link linkend="ch0074s0011s0003li0091">91</link>). <emphasis>F. nucleatum</emphasis>, appearing as white-yellowish (chartreuse, pronounced under UV light), speckled, or bread crumb-like colonies, is known for its wide heterogeneity. It includes four (to five) subspecies, <emphasis>F. nucleatum</emphasis> subsp. <emphasis>animalis, F. nucleatum</emphasis> subsp. <emphasis>vincentii</emphasis> (<emphasis>fusiforme</emphasis>), <emphasis>F. nucleatum</emphasis> subsp. <emphasis>nucleatum</emphasis>, and <emphasis>F. nucleatum</emphasis> subsp. <emphasis>polymorphum</emphasis>, but phenotypic tests are not able to identify the organism to the subspecies level. Also, <emphasis>F. periodonticum</emphasis> is indistinguishable from <emphasis>F. nucleatum</emphasis> by phenotypic methods. In the case of the increasingly clinically important <emphasis>F. necrophorum</emphasis>, there are two subspecies, <emphasis>F. necrophorum</emphasis> subsp. <emphasis>funduliforme</emphasis>, isolated mainly from human infections, and <emphasis>F. necrophorum</emphasis> subsp. <emphasis>necrophorum</emphasis>, usually from animal infections (<link linkend="ch0074s0011s0003li0197">197</link>, <link linkend="ch0074s0011s0003li0199">199</link>, <link linkend="ch0074s0011s0003li0300">300</link>). Both subspecies are indole and lipase positive, but colony morphology and a few phenotypic tests, including erythrocyte agglutination, are able to distinguish them (<link linkend="ch0074s0011s0003li0300">300</link>). A selective agar for <emphasis>F. necrophorum</emphasis>, containing nalidixin and vancomycin as well as defibrinated horse blood without heat treatment, which allows the direct detection of beta-hemolysis, was found nearly as reliable as real-time PCR in detecting the organism at medium and high concentrations in throat swab samples after 2-day incubation (<link linkend="ch0074s0011s0003li0315">315</link>). An interesting possibility—with economic justification—is culturing throat swabs from adolescents for <emphasis>F. necrophorum</emphasis>, followed by antimicrobial treatment when indicated, to reduce preventable invasive complications (<link linkend="ch0074s0011s0003li0230">230</link>). An indole-negative pleomorphic organism that grows on BBE may be presumptively identified as <emphasis>F. mortiferum</emphasis> (<link linkend="ch0074s0011s0003li0091">91</link>). <emphasis>F. ulcerans</emphasis> closely resembles indole-negative <emphasis>F. varium</emphasis> strains but reduces nitrate. All fusobacteria produce major amounts of butyric acid as their metabolic end product (Table 2), and, in addition, <emphasis>F. naviforme, F. russii</emphasis>, and <emphasis>F. varium</emphasis> produce lactic acid, as detected in GLC (<link linkend="ch0074s0011s0003li0091">91</link>).</para>
      <anchor id="ch0074s0009a0005"/>
      <beginpage pagenum="1115"/>
      <para id="ch0074s0009p0008">Although<emphasis>Leptotrichia</emphasis> and the more fastidious <emphasis>Sneathia</emphasis> species are anaerobic on first isolation, in subcultures some strains can grow aerobically in the presence of CO<subscript>2</subscript> (<link linkend="ch0074s0011s0003li0241">241</link>, <link linkend="ch0074s0011s0003li0246">246</link>). These organisms have been known as large fusiforms; however, their cell morphology varies among the species: <emphasis>L. buccalis, L. hofstadii, L. shahii</emphasis>, and <emphasis>L. trevisanii</emphasis> are long rods whereas <emphasis>L. wadei</emphasis> and <emphasis>L. goodfellowii</emphasis> (recently reclassified as <emphasis>Pseudoleptotrichia goodfellowii</emphasis> [61]) are relatively short rods, while <emphasis>S. vaginalis</emphasis> (formerly <emphasis>S. amnii</emphasis> or “<emphasis>L. amnionii</emphasis>”) has been seen as pleomorphic coccobacilli and fusiforms and <emphasis>S. sanguinegens</emphasis> as pleomorphic rods with some filaments (<link linkend="ch0074s0011s0003li0062">62</link>, <link linkend="ch0074s0011s0003li0254">254</link>, <link linkend="ch0074s0011s0003li0301">301</link>, <link linkend="ch0074s0011s0003li0302">302</link>). Interestingly, the cells of <emphasis>S. vaginalis</emphasis> (formerly <emphasis>S. amnii</emphasis>) were described as variable-size rods up to over 10 μm; however, tandem electron microscopy revealed that the long rods were actually formed of chains of bacilli with rounded ends (<link linkend="ch0074s0011s0003li0064">64</link>). Fresh cells may stain Gram positive (<link linkend="ch0074s0011s0003li0241">241</link>, <link linkend="ch0074s0011s0003li0246">246</link>). Lactate production as the major end product of glucose fermentation is characteristic for <emphasis>Leptotrichia</emphasis> and <emphasis>Sneathia</emphasis> (Table 2). <emphasis>Sneathia</emphasis> species are extremely fastidious, and thus not much is generally known about their biochemical characteristics (<link linkend="ch0074s0011s0003li0062">62</link>, <link linkend="ch0074s0011s0003li0064">64</link>, <link linkend="ch0074s0011s0003li0250">250</link>, <link linkend="ch0074s0011s0003li0254">254</link>). The genome sequence analysis of <emphasis>S. vaginalis</emphasis> (formerly <emphasis>S. amnii</emphasis>) revealed a small genome size that might explain its fastidious nature and its vancomycin susceptibility (<link linkend="ch0074s0011s0003li0064">64</link>). Positive reactions by Rapid ID 32 A (bioMérieux) have been reported for β-glucuronidase, alkaline phosphatase, arginine arylaminidase activity, and raffinose fermentation (<link linkend="ch0074s0011s0003li0250">250</link>, <link linkend="ch0074s0011s0003li0254">254</link>). Table 9 presents some characteristics helpful in the biochemical identification of <emphasis>Leptotrichia, Pseudoleptotrichia</emphasis>, and <emphasis>Sneathia</emphasis> organisms.</para>
      <anchor id="ch0074s0009a0006"/>
      <beginpage pagenum="1116"/>
      <para id="ch0074s0009p0009">Within the phylum<emphasis>Synergistetes, Fretibacterium fastidiosum</emphasis> (<link linkend="ch0074s0011s0003li0065">65</link>), <emphasis>Jonquetella anthropi</emphasis> (<link linkend="ch0074s0011s0003li0066">66</link>), <emphasis>Pyramidobacter piscolens</emphasis> (<link linkend="ch0074s0011s0003li0067">67</link>), and the newly described <emphasis>Rarimicrobium hominis</emphasis> (<link linkend="ch0074s0011s0003li0068">68</link>, <link linkend="ch0074s0011s0003li0069">69</link>) are the human-derived species that have been cultured so far. They are extremely fastidious in nature, requiring incubation of 7 to 21 days, and thus are difficult to characterize. These <emphasis>Synergistetes</emphasis> organisms are asaccharolytic rods, with acetic acid (and <emphasis>R. hominis</emphasis> with acetic and propionic acids) as their major metabolic end products of glucose fermentation. <emphasis>F. fastidiosum</emphasis> forms very small, highly convex colonies on blood agar, but the colony morphology can vary (<link linkend="ch0074s0011s0003li0065">65</link>). A coculture with other oral bacteria or a filtered cell sonicate of <emphasis>F. nucleatum</emphasis> subsp. <emphasis>nucleatum</emphasis> is needed for optimal growth. <emphasis>F. fastidiosum</emphasis> is motile, unlike <emphasis>J. anthropi</emphasis> and <emphasis>P. piscolens. J. anthropi</emphasis> is susceptible to bile and forms pinpoint colonies on blood agar, while the colonies of <emphasis>P. piscolens</emphasis> are somewhat bigger and highly convex to pyramidal and its culture has a specific fishy odor (<link linkend="ch0074s0011s0003li0066">66</link>, <link linkend="ch0074s0011s0003li0067">67</link>). <emphasis>R. hominis</emphasis> has irregular rod-shaped cells and appears as punctiform colonies even after prolonged incubation, and the seafood odor is also typical (<link linkend="ch0074s0011s0003li0068">68</link>). All species are unreactive to most biochemical tests. In the Rapid ID 32 A system (bioMérieux), <emphasis>F. fastidiosum</emphasis> and <emphasis>J. anthropi</emphasis> are positive for both glycine arylamidase and leucyl glycine arylamidase, while <emphasis>P. piscolens</emphasis> is highly positive for glycine arylamidase (<link linkend="ch0074s0011s0003li0065">65</link>–<link linkend="ch0074s0011s0003li0067">67</link>). Although the <emphasis>Cloacibacillus</emphasis> species <emphasis>C. evryensis</emphasis> and <emphasis>C. porcorum</emphasis> were recently isolated from human bacteremia cases (<link linkend="ch0074s0011s0003li0069">69</link>), they are still largely uncharacterized, and conventional methods used in clinical microbiological laboratories are not able to identify these strictly anaerobic Gram-negative rods. The three human isolates were resistant to vancomycin and colistin but susceptible to kanamycin (<link linkend="ch0074s0011s0003li0068">68</link>, <link linkend="ch0074s0011s0003li0069">69</link>).</para>
      <anchor id="ch0074s0009a0007"/>
      <beginpage pagenum="1117"/>
      <para id="ch0074s0009p0010"><emphasis>Dialister</emphasis> species are coccobacilli that form tiny colonies on blood agar. They are asaccharolytic and grow poorly in liquid media; lack of reactivity in conventional biochemical tests hampers their identification. They are often confused with <emphasis>Veillonella</emphasis> because of their tiny cell size. There are a few enzymes in the Rapid ID 32 A system (bioMérieux) that may be useful in distinguishing three <emphasis>Dialister</emphasis> species: <emphasis>D. pneumosintes</emphasis> is positive for glycine arylamidase; <emphasis>D. micraerophilus</emphasis> for alanine, phenylalanine, serine, and tyrosine arylamidases and arginine dihydrolase; and <emphasis>D. succinatiphilus</emphasis> for alkaline phosphatase (<link linkend="ch0074s0011s0003li0023">23</link>, <link linkend="ch0074s0011s0003li0074">74</link>). However, <emphasis>D. invisus</emphasis> and <emphasis>D. propionicifaciens</emphasis> are negative for all tests in this kit. The latter species produces propionate, which can be detected by GLC (<link linkend="ch0074s0011s0003li0074">74</link>). Molecular methods, such as 16S rRNA gene sequencing, are often needed for the accurate detection of <emphasis>Dialister</emphasis> species in clinical specimens (<link linkend="ch0074s0011s0003li0074">74</link>, <link linkend="ch0074s0011s0003li0261">261</link>).</para>
      <para id="ch0074s0009p0011"><emphasis>Bilophila wadsworthia</emphasis> isolates are asaccharolytic, bile resistant, and strongly positive for catalase, and most strains are urease positive (<link linkend="ch0074s0011s0003li0084">84</link>). This species also produces hydrogen sulfide, and its growth is stimulated by bile (oxgall) and pyruvate. This pattern, together with its typical colony characteristics on BBE, may result in its reliable identification.</para>
      <para id="ch0074s0009p0012">Two human<emphasis>Sutterella</emphasis> species, <emphasis>S. wadsworthensis</emphasis> and <emphasis>S. parvirubra</emphasis>, and two human <emphasis>Parasutterella</emphasis> species, <emphasis>P. excrementihominis</emphasis> and <emphasis>P. secunda</emphasis>, are asaccharolytic and very unreactive organisms, of which only <emphasis>S. wadsworthensis</emphasis> has been isolated from infections so far. <emphasis>P. excrementihominis, P. secunda</emphasis>, and <emphasis>S. parvirubra</emphasis> are strictly anaerobic, have coccoid cells, and are negative for nitrate reduction (<link linkend="ch0074s0011s0003li0076">76</link>, <link linkend="ch0074s0011s0003li0082">82</link>, <link linkend="ch0074s0011s0003li0316">316</link>), while <emphasis>S. wadsworthensis</emphasis> is a straight rod that is able to grow in microaerobic conditions and to reduce nitrate.</para>
      <para id="ch0074s0009p0013">Of the motile Gram-negative anaerobic genera isolated from human specimens,<emphasis>Selenomonas</emphasis> and <emphasis>Anaerobiospirillum</emphasis> are saccharolytic, while <emphasis>Desulfovibrio</emphasis> and <emphasis>Phocaeicola</emphasis> are asaccharolytic. Flagellae of <emphasis>Selenomonas</emphasis> are arranged on the concave side of the cell, while those of the related genus <emphasis>Centipeda</emphasis> are around the cell (<link linkend="ch0074s0011s0003li0077">77</link>). <emphasis>Anaerobiospirillum</emphasis> species have a corkscrew shape and a jerky motility. <emphasis>A. succiniciproducens</emphasis> is susceptible to colistin, and it ferments glucose, maltose, lactose, and sucrose. <emphasis>A. thomasii</emphasis> can be differentiated from <emphasis>A. succiniciproducens</emphasis> by carbohydrate fermentations and by α-glucosidase and β-galactosidase activities, the former being negative and the latter positive for both reactions (<link linkend="ch0074s0011s0003li0087">87</link>). <emphasis>Desulfovibrio</emphasis> species are curved rods with a rapid, progressive motility (except the nonmotile <emphasis>D. piger</emphasis>) and are resistant to colistin and to 20% bile (except for the bile-sensitive <emphasis>D. desulfuricans</emphasis>) (<link linkend="ch0074s0011s0003li0279">279</link>). A rather simple test scheme, including catalase, indole, nitrate, and urease, is able to separate the four <emphasis>Desulfovibrio</emphasis> species isolated from human clinical specimens (<link linkend="ch0074s0011s0003li0279">279</link>). Unlike the others, <emphasis>Desulfovibrio</emphasis> species are positive for desulfoviridin, which can be detected by adding 2 N NaOH to cell paste on a swab and observing for red fluorescence under UV light (<link linkend="ch0074s0011s0003li0085">85</link>, <link linkend="ch0074s0011s0003li0279">279</link>). <emphasis>Desulfomicrobium orale</emphasis> is a straight rod and is negative for desulfoviridin but, typically, both <emphasis>D. orale</emphasis> and <emphasis>Desulfovibrio</emphasis> species reduce sulfate to H<subscript>2</subscript>S by consuming hydrogen, a major end product of fermentation (<link linkend="ch0074s0011s0003li0086">86</link>). <emphasis>Phocaeicola abscessus</emphasis> is a slow-growing coccobacillus with lophotrichous flagella arrangement (<link linkend="ch0074s0011s0003li0054">54</link>).</para>
      <para id="ch0074s0009p0014">Table 10 presents an identification scheme for motile Gram-negative anaerobic genera.</para>
    </sect1>
    <sect1 id="ch0074s0010">
      <title>Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry</title>
      <anchor id="ch0074s0010a0001"/>
      <anchor id="ch0074s0010a0002"/>
      <para id="ch0074s0010p0001">Bacterial identification by matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) has proven to be a promising method for the identification of anaerobic bacteria, including Gram-negative organisms (<link linkend="ch0074s0011s0003li0313">313</link>, <link linkend="ch0074s0011s0003li0317">317</link>–<link linkend="ch0074s0011s0003li0321">321</link>). Conserved proteins on a taxon level, such as ribosomal proteins, are used as identification targets. These characteristic peptides and small proteins (ranging mainly in <emphasis>m/z</emphasis> from 3 to 15 kDa) can be measured after laser desorption and ionization of whole cells, cell lysates, or crude bacterial extracts. Accurate identification depends on the unknown organism being present in the database. At present, two systems are available for the routine identification of aerobic and anaerobic bacteria: the IVD MALDI Biotyper (smart) system (Bruker Daltonik GmbH, Bremen, Germany), with the yearly updated MALDI Biotyper (MBT) software and compass library (<emphasis>in vitro</emphasis> diagnostic [IVD]; other versions address research [RUO] and industrial microbiology [GP]) and the VITEK MS IVD (bioMérieux), with a frequently updated IVD and a separate RUO (SARAMIS) database. More anaerobic species are included in the Biotyper (Bruker Daltonik) system database (latest version V6 with 9,234 total Main Spectral Profiles [MSPs]). The percentage of correct identifications of Gram-negative anaerobes at the species or genus level, compared to the phenotypic identification or 16S rRNA gene sequencing, depends on the active development of the databases of the different systems in the field of anaerobic bacteria (<link linkend="ch0074s0011s0003li0318">318</link>–<link linkend="ch0074s0011s0003li0321">321</link>). Different sample preparation methods may also influence the correct identification; however, no significant differences have been observed in the success of species identification among the tested strains of <emphasis>Bacteroides</emphasis> and <emphasis>Fusobacterium</emphasis> species, whether the direct smear or a full chemical extraction was used (<link linkend="ch0074s0011s0003li0322">322</link>). In a study on 123 clinical <emphasis>Prevotella</emphasis> isolates, 60% were identified with direct spotting and 14% after a repeated procedure, whereas 26% needed ethanol-formic acid extraction until identified (<link linkend="ch0074s0011s0003li0313">313</link>). <emphasis>Bacteroides</emphasis> strains resulted in species-level identification, whereas <emphasis>Fusobacterium</emphasis> strains were usually identified at the genus level, but problems encountered within the <emphasis>Fusobacterium</emphasis> genus may be resolved by adding well-characterized strains to the databases. During a 4-year study period in Spain, investigating 4,094 anaerobic strains (190 species and 50 genera) isolated from clinical samples, only 2.1% of the isolates could not be reliably identified by the Bruker system database (V6) and required sequencing for a final identification (<link linkend="ch0074s0011s0003li0323">323</link>). Even phylogenetically closely related species within the genera <emphasis>Bacteroides</emphasis> and <emphasis>Prevotella</emphasis>, such as <emphasis>B. salyersiae</emphasis> and <emphasis>B. nordii</emphasis> (<link linkend="ch0074s0011s0003li0318">318</link>) or <emphasis>P. intermedia</emphasis> and <emphasis>P. nigrescens</emphasis> (<link linkend="ch0074s0011s0003li0319">319</link>, <link linkend="ch0074s0011s0003li0320">320</link>), can be correctly identified by MALDI-TOF MS. However, novel species may be misidentified as their phylogenetic relatives, e.g., <emphasis>P. aurantiaca</emphasis> as <emphasis>P. intermedia</emphasis> and <emphasis>P. jejuni</emphasis> as <emphasis>P. melaninogenica</emphasis> (<link linkend="ch0074s0011s0003li0313">313</link>). Similar to some other aerobic and anaerobic species, peak shifts can be found and used for typing of the divisions I and II of <emphasis>B. fragilis</emphasis> (<link linkend="ch0074s0011s0003li0324">324</link>, <link linkend="ch0074s0011s0003li0325">325</link>). As only isolates in division II harbor the <emphasis>cfiA</emphasis> gene that is responsible for the production of the carbapenemase, typing of <emphasis>B. fragilis</emphasis> by MALDI-TOF MS may have a direct influence for the selection of antibiotic treatment (<link linkend="ch0074s0011s0003li0326">326</link>). Some recent progress in the field of MS-directed identification of anaerobes and carbapenemases is summarized elsewhere (<link linkend="ch0074s0011s0003li0327">327</link>–<link linkend="ch0074s0011s0003li0331">331</link>).</para>
      <anchor id="ch0074s0010a0003"/>
      <beginpage pagenum="1118"/>
    </sect1>
    <sect1 id="ch0074s0011">
      <title>Genetic Identification Methods</title>
      <anchor id="ch0074s0011a0001"/>
      <anchor id="ch0074s0011a0002"/>
      <para id="ch0074s0011p0001">Another method, which can reliably detect as-yet-unnamed taxa as well as identify known species, is 16S rRNA gene sequence analysis (<link linkend="ch0074s0011s0003li0332">332</link>). For clinical purposes, a 500-bp sequence from the 5′ end of the gene is able to identify most, but not all, members of this group to the species level. Even more information per amplicon length can be derived by using V6-specific primers (<link linkend="ch0074s0011s0003li0292">292</link>). These methods are being increasingly used for identification of anaerobic bacteria, because (partial) sequencing of the gene is faster and more accurate than biochemical testing and, notably, independent of the growth characteristics (<link linkend="ch0074s0011s0003li0125">125</link>, <link linkend="ch0074s0011s0003li0333">333</link>). Sequencing of the <emphasis>rpoB</emphasis> gene has also proven its potential for bacterial identification (<link linkend="ch0074s0011s0003li0334">334</link>). For instance, <emphasis>rpoB</emphasis> gene analysis has been successfully used for distinguishing two closely related <emphasis>Fusobacterium</emphasis> species, <emphasis>F. nucleatum</emphasis> and <emphasis>F. periodonticum</emphasis>, and for oral isolates versus isolates from intestinal biopsies (<link linkend="ch0074s0011s0003li0335">335</link>).</para>
      <para id="ch0074s0011p0002">Sequencing, as a routine method, may not be feasible for many clinical laboratories. The development of algorithms to screen for those isolates that can be adequately identified by conventional methods and to refer difficult-to-identify isolates for 16S rRNA gene sequencing has been proposed (<link linkend="ch0074s0011s0003li0125">125</link>, <link linkend="ch0074s0011s0003li0332">332</link>). Also, commercial 16S rRNA gene sequence-based identification kits, containing reagents for DNA extraction and amplification, are available. However, they require instruments including a thermal cycler, an automated gene sequencer, and software for interpretation, and the data needed to assess their value in identifying Gram-negative anaerobes are not available. Although sequencing of the 16S rRNA gene is a useful method for identification of fastidious anaerobic organisms, providing a much faster turnaround time than conventional methods, molecular analysis should complement but not replace culturing in the clinical setting. As a new and promising approach, next-generation sequencing (NGS) of metabolic pathway genes can identify essential nutrients and help to optimize culture for otherwise overlooked species (<link linkend="ch0074s0011s0003li0336">336</link>). In the field of routine clinical diagnostics, the application of NGS is currently limited to typing for epidemiological purposes, even though the implementation of NGS for microbial community analysis may yield clinically important information. This lack of NGS implementation is due to many different factors, including issues relating to standardization, reproducibility, and clinical importance of results (<link linkend="ch0074s0011s0003li0337">337</link>). The future challenge for clinical laboratories will be the translation of vast amounts of accrued NGS microbial data into convenient algorithm testing schemes so that clinically relevant information can be reported to physicians in a format that is understood and actionable (<link linkend="ch0074s0011s0003li0338">338</link>). 16S rRNA-targeted sequencing in conjunction with culture could be useful for identifying bacteria in normally sterile body fluids, especially when patients have been pretreated with antibiotics and when anaerobic infection is suspected (<link linkend="ch0074s0011s0003li0339">339</link>).</para>
      <para id="ch0074s0011p0003">Genetic signatures, applied as DNA probes in colony-blot hybridization assays, are useful for enriching and isolating new species from mixed cultures. On the other hand, phenotypic characteristics, obtained by culture and biochemical testing, assist in correlating the sequence-based data, which can be sometimes difficult to interpret, for example, due to incomplete sequences stored in the reference database. More importantly, culture is necessary for antibiotic susceptibility testing of isolates from clinical specimens. Thus, genetic and culture-based methods are complementary in all instances.</para>
      <sect2 id="ch0074s0011s0001">
        <title>ANTIMICROBIAL SUSCEPTIBILITIES</title>
        <anchor id="ch0074s0011s0001a0001"/>
        <anchor id="ch0074s0011s0001a0002"/>
        <para id="ch0074s0011s0001p0001">Antimicrobial resistance among Gram-negative anaerobes continues to rise (<link linkend="ch0074s0011s0003li0340">340</link>–<link linkend="ch0074s0011s0003li0344">344</link>). This means that important anaerobic pathogens are not <emphasis>per se</emphasis> susceptible to piperacillin-tazobactam, carbapenems, or metronidazole but have to be identified and tested for susceptibility. Although susceptibility to antimicrobials can vary considerably among species within the same genus, most clinical laboratories neither perform the accurate species-level identification of the isolated organism nor test the susceptibilities of anaerobic isolates (<link linkend="ch0074s0011s0003li0305">305</link>).</para>
        <anchor id="ch0074s0011s0001a0003"/>
        <beginpage pagenum="1119"/>
        <para id="ch0074s0011s0001p0002">Table 11, based on current literature, summarizes antimicrobial resistance rates worldwide of the clinically most relevant Gram-negative anaerobic taxa. This summary is based on four conditions, as follows. (i)<emphasis>Bacteroides</emphasis> species are among the most antibiotic-resistant anaerobes and are addressed with priority here. The <emphasis>Bacteroides fragilis</emphasis> group members (<emphasis>Bacteroides</emphasis> other than <emphasis>B. fragilis</emphasis>) are more likely to be resistant to certain antibiotics (e.g., β-lactam/β-lactamase inhibitor combinations) than <emphasis>B. fragilis. B. fragilis</emphasis> susceptibility data are reported separately, as it is the most important (and type) species of the genus <emphasis>Bacteroides</emphasis>, and to enable comparison of data over decades. <emphasis>Parabacteroides</emphasis> data are presented separately. (ii) <emphasis>Prevotella</emphasis> and <emphasis>Fusobacterium</emphasis> data are included, but data of many other genera are excluded as too limited. (iii) Studies not explicitly reporting percentage of resistance, or at least percentage of nonsusceptibility, were not included here, with the exception of eravacycline studies, acknowledging its important contribution to the future antimicrobial agent armamentarium (<link linkend="ch0074s0011s0003li0345">345</link>, <link linkend="ch0074s0011s0003li0346">346</link>). Studies providing only MIC data leave too much room for interpretation. In the case of eravacycline, however, we carefully interpreted the MIC data despite lacking CLSI/FDA or EUCAST guidelines. (iv) We had to make a compromise between reporting most recent data (isolation year of strains presented here is usually 2010 or later) and coverage of the global situation. A few older data from less frequently monitored regions of the world or from underrepresented antibiotics were thus kept from the last edition of the <emphasis>Manual of Clinical Microbiol</emphasis><emphasis>ogy</emphasis> (<link linkend="ch0074s0011s0003li0347">347</link>).</para>
        <para id="ch0074s0011s0001p0003">According to surveys conducted in North America, Europe (Belgium, Denmark, Germany, Greece, Hungary, Poland, Turkey, Slovenia, Spain), and many other countries (Argentina, Hong Kong, China, India, South Korea, Kuwait, Pakistan, Taiwan),<emphasis>B. fragilis</emphasis>, the <emphasis>B. fragilis</emphasis> group, and <emphasis>Parabacteroides</emphasis> species are among the most resistant anaerobes to various antimicrobial agents (<link linkend="ch0074s0011s0003li0340">340</link>–<link linkend="ch0074s0011s0003li0343">343</link>, <link linkend="ch0074s0011s0003li0347">347</link>–<link linkend="ch0074s0011s0003li0352">352</link>). One of the largest studies by Forbes et al. (<link linkend="ch0074s0011s0003li0343">343</link>), addressing 485 <emphasis>B. fragilis</emphasis>, 473 non-<emphasis>B.fragilis Bacteroides</emphasis>, 60 <emphasis>Parabacteroides</emphasis>, 244 <emphasis>Prevotella</emphasis>, and 101 <emphasis>Fusobacterum</emphasis> strains, is used as a core reference for the completely updated Table 11. In a recent study that included 421 extraintestinal <emphasis>B. fragilis</emphasis> isolates in Kuwait, the authors reported almost 50% of strains enterotoxigenic (fragilysin, <emphasis>bft</emphasis> positive) and resistance rates against amoxicillin-clavulanic acid of 32%, clindamycin of 62% (reaching 67.6% in <emphasis>bft</emphasis>-positive strains), cefoxitin of 26%, imipenem of 11%, meropenem of 17%, metronidazole of 4%, and tigecycline of as high as 14% (<link linkend="ch0074s0011s0003li0340">340</link>). In a 2020 study from Japan, 50 <emphasis>B. fragilis</emphasis> blood isolates were tested; the resistance rates were ampicillin-sulbactam 30%, piperacillin-tazobactam 6%, clindamycin 32%, cefmetazole 16%, imipenem 4%, meropenem or doripenem 10%, metronidazole 0%, and tigecycline 14% (<link linkend="ch0074s0011s0003li0352">352</link>). In a 2020 European-wide study by Sóki et al., in total 202 <emphasis>Bacteroides</emphasis>/<emphasis>Parabacteroides</emphasis> strains (of which 11.9% were <emphasis>B. fragilis</emphasis>) were isolated from fecal specimens of healthy donors (<emphasis>n</emphasis> = 42, from five European countries) who did not have an enteric disease and had not received any antibiotics for at least 3 months prior to testing (<link linkend="ch0074s0011s0003li0350">350</link>). The percentage values of isolates resistant to ampicillin, amoxicillin/clavulanate, cefoxitin, imipenem, clindamycin, moxifloxacin, metronidazole, tetracycline, tigecycline, and chloramphenicol were 96.6%, 4.5%, 14.9%, 2.0%, 47.3%, 11.4%, 0%, 66.2%, 1.5%, and 0%, respectively. For comparison, in a study from Denmark (359 consecutive fecal <emphasis>B. fragilis</emphasis> group isolates from patients receiving broad-spectrum antibiotics), the authors found higher resistances to carbapenems (5% in case of meropenem) and to β-lactam/β-lactamase inhibitor combinations (11% in case of piperacillin-tazobactam), respectively. Furthermore, three metronidazole-resistant <emphasis>Bacteroides</emphasis> spp. (<emphasis>B. fragilis, B. ovatus/xylanisolvens</emphasis>, and <emphasis>P. distasonis</emphasis>) were isolated (<link linkend="ch0074s0011s0003li0353">353</link>). Among all 267 (2016–2019) isolates tested in a 2020 study from Greece, the lowest rates of resistance (&lt;5%) were detected to carbapenems, metronidazole, chloramphenicol, and tigecycline (<link linkend="ch0074s0011s0003li0342">342</link>). Resistance to piperacillin-tazobactam was observed in 5.4%, 24.6%, and 3.3% of <emphasis>B. fragilis, B. fragilis</emphasis> group, and <emphasis>Fusobacterium</emphasis> spp. isolates, respectively. Cefoxitin resistance was low for <emphasis>Prevotella</emphasis> spp. (3.2%) and <emphasis>Fusobacterium</emphasis> spp. (3.3%). Results for <emphasis>Bacteroides</emphasis> and <emphasis>Parabacteroides</emphasis> species from Poland again confirm that the problem of resistance is mainly related to strains belonging to non-<emphasis>B. fragilis Bacteroides</emphasis> (<link linkend="ch0074s0011s0003li0341">341</link>). In the analyzed periods (2007–2012 compared to 2013–2017), the authors found an increase of clindamycin- (35.21% vs. 53.33%), amoxicillin/clavulanic acid- (2.83% vs. 8.15%), and imipenem- (1.41% vs. 3.7%) resistant <emphasis>Bacteroides</emphasis> strains and observed a constant high (approximately 50%) clindamycin resistance among <emphasis>P. distasonis</emphasis> strains. Testing 508 clinical isolates of 19 <emphasis>Prevotella</emphasis> species from different parts of Europe, Kuwait, and Turkey according to EUCAST and CLSI/FDA guidelines, Ulger et al. (<link linkend="ch0074s0011s0003li0351">351</link>) found that <emphasis>Prevotella</emphasis> species were susceptible to piperacillin/tazobactam, imipenem, meropenem, tigecycline, and metronidazole. Furthermore, ampicillin/sulbactam and cefoxitin also showed good activity, whereas ampicillin, clindamycin, tetracycline, and moxifloxacin were less active with 51.2%, 33.7%, 36.8%, and 18.3% of isolates, respectively, nonsusceptible. A total of 49 (9.6%) isolates were resistant to three or more antimicrobials. <emphasis>Prevotella bivia</emphasis> was the most prevalent species (<emphasis>n</emphasis> = 118) and accounted for most of the multidrug-resistant isolates (<link linkend="ch0074s0011s0003li0015">15</link>).</para>
        <anchor id="ch0074s0011s0001a0004"/>
        <beginpage pagenum="1120"/>
        <para id="ch0074s0011s0001p0004">There are many new studies describing resistance genes and various mechanisms of resistance among Gram-negative anaerobic pathogens. The diversity of such genes in<emphasis>Bacteroides</emphasis> and <emphasis>Parabacteroides</emphasis> strains was recently described in depth by Rong et al. (<link linkend="ch0074s0011s0003li0354">354</link>). A total of 71 phenotypically resistant <emphasis>Bacteroides</emphasis> spp. from human clinical specimens were screened for the most relevant antibiotic resistance genes. For background, the <emphasis>cfiA</emphasis> gene in <emphasis>B. fragilis</emphasis> encodes a powerful Ambler class B metallo-β-lactamase that can hydrolyze nearly all β-lactam antibiotics and was indeed the most frequently found β-lactam antibiotic resistance gene in this study, which is in contrast to other studies where <emphasis>cepA</emphasis> had a higher prevalence. Many resistance mechanisms against clindamycin and the group of MLSKO (macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone) antibiotics have been found, with important rRNA methylase genes such as <emphasis>ermB</emphasis>, but especially <emphasis>ermF</emphasis> and <emphasis>ermG</emphasis>, among <emphasis>Bacteroides</emphasis> spp. Moxifloxacin resistance is associated with the presence of genes coding for efflux pumps such as <emphasis>bexA</emphasis>, a member of the multidrug and toxic compound extrusion class (MATE) genes, although it is assumed that point mutations in the <emphasis>gyrA</emphasis> gene play the most important role. Due to its intensive use, increasing resistance to tetracycline and acquisition of <emphasis>tet</emphasis> genes (with <emphasis>tetQ</emphasis> dominating) has been observed. Regarding metronidazole resistance, 11 isoforms of the <emphasis>nim</emphasis> genes encoding a nitroreductase are known (<emphasis>nimA</emphasis> through <emphasis>K</emphasis>), with <emphasis>nimA</emphasis> being the most prevalent gene in <emphasis>Bacteroides.</emphasis> In overall summary of this German study, <emphasis>tetQ</emphasis> was the most frequently detected gene, followed by <emphasis>cfiA, ermF, cfxA, ermG, cepA, nim</emphasis>, and <emphasis>bexA</emphasis> (<link linkend="ch0074s0011s0003li0354">354</link>). This study reveals that we still do not know all the mechanisms relevant for expression of phenotypic resistance. Some other recently published articles addressing resistance mechanisms and genes are recommended for further reading (<link linkend="ch0074s0011s0003li0352">352</link>, <link linkend="ch0074s0011s0003li0355">355</link>–<link linkend="ch0074s0011s0003li0358">358</link>).</para>
        <para id="ch0074s0011s0001p0005">A publication by the ESCMID Study Group on Anaerobic Infection (ESGAI) is on the way, evaluating cases where the empiric therapy failed due to resistance of anaerobic pathogens and only a second-line treatment allowed the patients to be cured. Other cases of clinical failures could be linked to the lack of timely detection of resistance (including heteroresistance) (<link linkend="ch0074s0011s0003li0359">359</link>, <link linkend="ch0074s0011s0003li0360">360</link>) of anaerobes, despite the fact that simple agar diffusion methods (disc diffusion or Etest methodology) are suitable in most cases to detect vitally important resistances (<link linkend="ch0074s0011s0003li0361">361</link>).</para>
      </sect2>
      <sect2 id="ch0074s0011s0002">
        <title>EVALUATION, INTERPRETATION, AND REPORTING OF RESULTS</title>
        <anchor id="ch0074s0011s0002a0001"/>
        <anchor id="ch0074s0011s0002a0002"/>
        <para id="ch0074s0011s0002p0001">Knowledge about the resident microbiota and awareness of the role of anaerobic bacteria in disease permit the clinician to anticipate the likely infecting species at different body sites. Training for anaerobic techniques, in general, and introduction of advanced methods for the detection and precise identification of anaerobic organisms are urgently needed in clinical microbiology laboratories. The major issues are (i) increasing frequencies of anaerobic bacteremia and septicemia (<link linkend="ch0074s0011s0003li0114">114</link>, <link linkend="ch0074s0011s0003li0115">115</link>, <link linkend="ch0074s0011s0003li0121">121</link>), (ii) increasing numbers of patients with fusobacterial infections (<link linkend="ch0074s0011s0003li0209">209</link>, <link linkend="ch0074s0011s0003li0213">213</link>), as well as (iii) increasing resistance rates of anaerobes to various antimicrobials (<link linkend="ch0074s0011s0003li0341">341</link>, <link linkend="ch0074s0011s0003li0342">342</link>, <link linkend="ch0074s0011s0003li0344">344</link>, <link linkend="ch0074s0011s0003li0349">349</link>, <link linkend="ch0074s0011s0003li0350">350</link>, <link linkend="ch0074s0011s0003li0352">352</link>, <link linkend="ch0074s0011s0003li0355">355</link>, <link linkend="ch0074s0011s0003li0356">356</link>). In cases of inaccurate microbiology and inappropriate choices of antimicrobial agents in treating an anaerobic infection, mortality rates and other treatment failures increase significantly (<link linkend="ch0074s0011s0003li0115">115</link>, <link linkend="ch0074s0011s0003li0200">200</link>, <link linkend="ch0074s0011s0003li0204">204</link>, <link linkend="ch0074s0011s0003li0361">361</link>). Collection of clinical specimens should avoid the mucosal microbiota, and proper transport media and times should be used for keeping the anaerobes alive. Factors such as foul-smelling discharge, proximity of infection to mucosal surfaces, abscess formation, and necrotic tissue indicate the presence of anaerobes in the specimen. A definitive identification of an anaerobic isolate, at least to the genus level, should be obtained for all isolates from normally sterile body sites, including blood, spinal fluid, and organs or body cavities; when the patient is gravely ill and not responding to treatment; and when prolonged treatment is necessary. It would be desirable for reference laboratories to periodically provide information on local susceptibility patterns of anaerobic species within the clinically important taxa. However, not only appropriate antimicrobial therapy but also proper surgery, such as the drainage of abscesses and excision of necrotic tissue, is important in resolving anaerobic infections. It is notable that chronic infectious lesions, in particular, include consortia of bacteria organized in biofilms. This leads to reduced diffusion of antimicrobials and increased MICs.</para>
        <para id="ch0074s0011s0002p0002">The most important, and often difficult, task in the reporting of results of the isolation of Gram-negative anaerobes is determination of whether the organism is involved in the infectious process or is merely a bystander originating from the patient’s commensal microbiota. All isolations from normally sterile sites should be regarded as significant. A secondary challenge is that these organisms are often found in polymicrobial infections, with a number of different species present and often as a biofilm. Obtaining pure cultures for susceptibility testing can therefore be time-consuming and the resulting susceptibility profiles may be conflicting, making the recommendation of appropriate antimicrobial therapy difficult. Fortunately, such infections typically respond well to empirical treatment, as partial disruption of the bacterial consortium responsible is sufficient to allow the body’s defenses to deal with the infection. However, with continuous emergence of antimicrobial resistance, the value of empirically selected therapy may soon be lost.</para>
        <anchor id="ch0074s0011s0002a0003"/>
        <beginpage pagenum="1121"/>
      </sect2>
      <sect2 id="ch0074s0011s0003">
        <title>REFERENCES</title>
        <anchor id="ch0074s0011s0003a0001"/>
        <anchor id="ch0074s0011s0003a0002"/>
        <itemizedlist mark="none" role="biblioEntryList">
          <listitem id="ch0074s0011s0003li0001" role="bibliographyEntry">
            <para>1.<emphasis role="strong">Shah HN, Collins MD.</emphasis> 1989. Proposal to restrict the genus <citetitle><emphasis>Bacteriodes</emphasis></citetitle> (Castellani and Chalmers) to <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle> and closely related species. <citetitle><emphasis>Int J Syst Bacteriol</emphasis></citetitle> <emphasis role="strong">39:</emphasis>85–87.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0002" role="bibliographyEntry">
            <para>2.<emphasis role="strong">Wexler HM.</emphasis> 2007. <citetitle><emphasis>Bacteroides</emphasis></citetitle>: the good, the bad, and the nitty-gritty. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">20:</emphasis>593–621.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0003" role="bibliographyEntry">
            <para>3.<emphasis role="strong">Shin Y, Park SJ, Paek J, Kim JS, Rhee MS, Kim H, Kook JK, Chang YH.</emphasis> 2017. <citetitle><emphasis>Bacteroides koreensis</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Bacteroides kribbi</emphasis></citetitle> sp. nov., two new members of the genus <citetitle><emphasis>Bacteroides. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">67:</emphasis>4352–4357.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0004" role="bibliographyEntry">
            <para>4.<emphasis role="strong">Yu SY, Kim JS, Oh BS, Park SH, Kang SW, Park JE, Choi SH, Han KI, Lee KC, Eom MK, Suh MK, Lee DH, Yoon H, Kim BY, Yang SJ, Lee JS, Lee JH.</emphasis> 2019. <citetitle><emphasis>Bacteroides faecalis</emphasis></citetitle> sp. nov., isolated from human faeces. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">69:</emphasis>3824–3829.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0005" role="bibliographyEntry">
            <para>5.<emphasis role="strong">Ge Y, Zhang G, Yang J, Lai XH, Jin D, Lu S, Pu J, Huang Y, Luo X, Zheng H, Zhang X, Xu J.</emphasis> 2021. <citetitle><emphasis>Bacteroides luhongzhouii</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Bacteroides zhangwenhongii</emphasis></citetitle> sp. nov., isolated from human faeces. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">71:</emphasis>doi.1099/ijsm.0.004772.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0006" role="bibliographyEntry">
            <para>6.<emphasis role="strong">Rautio M, Eerola E, Väisänen-Tunkelrott ML, Molitoris D, Lawson P, Collins MD, Jousimies-Somer H.</emphasis> 2003. Reclassification of <citetitle><emphasis>Bacteroides putredinis</emphasis></citetitle> (Weinberg et al., 1937) in a new genus <citetitle><emphasis>Alistipes</emphasis></citetitle> gen. nov., as <citetitle><emphasis>Alistipes putredinis</emphasis></citetitle> comb. nov., and description of <citetitle><emphasis>Alistipes finegoldii</emphasis></citetitle> sp. nov., from human sources. <citetitle><emphasis>Syst Appl Microbiol</emphasis></citetitle> <emphasis role="strong">26:</emphasis>182–188.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0007" role="bibliographyEntry">
            <para>7.<emphasis role="strong">Sakamoto M, Ikeyama N, Ogata Y, Suda W, Iino T, Hattori M, Ohkuma M.</emphasis> 2020. <citetitle><emphasis>Alistipes communis</emphasis></citetitle> sp. nov., <citetitle><emphasis>Alistipes dispar</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Alistipes onderdonkii</emphasis></citetitle> subsp. <citetitle><emphasis>vulgaris</emphasis></citetitle> subsp. nov., isolated from human faeces, and creation of <citetitle><emphasis>Alistipes onderdonkii</emphasis></citetitle> subsp. <citetitle><emphasis>onderdonkii</emphasis></citetitle> subsp. nov. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">70:</emphasis>473–480.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0008" role="bibliographyEntry">
            <para>8.<emphasis role="strong">Song Y, Könönen E, Rautio M, Liu C, Bryk A, Eerola E, Finegold SM.</emphasis> 2006. <citetitle><emphasis>Alistipes onderdonkii</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Alistipes shahii</emphasis></citetitle> sp. nov., of human origin. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">56:</emphasis>1985–1990.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0009" role="bibliographyEntry">
            <para>9.<emphasis role="strong">Finegold SM, Väisänen ML, Rautio M, Eerola E, Summanen P, Molitoris D, Song Y, Liu C, Jousimies-Somer H.</emphasis> 2004. <citetitle><emphasis>Porphyromonas uenonis</emphasis></citetitle> sp. nov., a pathogen for humans distinct from <citetitle><emphasis>P. asaccharolytica</emphasis></citetitle> and <citetitle><emphasis>P. endodontalis. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">42:</emphasis>5298–5301.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0010" role="bibliographyEntry">
            <para>10.<emphasis role="strong">Könönen EVM, Finegold SM, Heine R, Jousimies-Somer H.</emphasis> 1996. Cellular fatty acid analysis and enzyme profiles of <citetitle><emphasis>Porphyromonas catoniae</emphasis></citetitle>—a frequent colonizer of the oral cavity in children. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">2:</emphasis>329–335.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0011" role="bibliographyEntry">
            <para>11.<emphasis role="strong">Summanen PH, Durmaz B, Väisänen ML, Liu C, Molitoris D, Eerola E, Helander IM, Finegold SM.</emphasis> 2005. <citetitle><emphasis>Porphyromonas somerae</emphasis></citetitle> sp. nov., a pathogen isolated from humans and distinct from <citetitle><emphasis>porphyromonas levii. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>4455–4459.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0012" role="bibliographyEntry">
            <para>12.<emphasis role="strong">Summanen PH, Lawson PA, Finegold SM.</emphasis> 2009. <citetitle><emphasis>Porphyromonas bennonis</emphasis></citetitle> sp. nov., isolated from human clinical specimens. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">59:</emphasis>1727–1732.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0013" role="bibliographyEntry">
            <para>13.<emphasis role="strong">Shah HN, Collins MD.</emphasis> 1988. Proposal for reclassification of <citetitle><emphasis>Bacteroides asaccharolyticus, Bacteroides gingivalis,</emphasis></citetitle> and <citetitle><emphasis>Bacteroides endodontalis</emphasis></citetitle> in a new genus, <citetitle><emphasis>Porphyromonas. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">38:</emphasis>128–131.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0014" role="bibliographyEntry">
            <para>14.<emphasis role="strong">Sato T, Tomida J, Naka T, Fujiwara N, Hasegawa A, Hoshikawa Y, Matsuyama J, Ishida N, Kondo T, Tanaka K, Takahashi N, Kawamura Y.</emphasis> 2015. <citetitle><emphasis>Porphyromonas bronchialis</emphasis></citetitle> sp. nov. isolated from intraoperative bronchial fluids of a patient with non-small cell lung cancer. <citetitle><emphasis>Tohoku J Exp Med</emphasis></citetitle> <emphasis role="strong">237:</emphasis>31–37.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0015" role="bibliographyEntry">
            <para>15.<emphasis role="strong">Sakamoto M, Li D, Shibata Y, Takeshita T, Yamashita Y, Ohkuma M.</emphasis> 2015. <citetitle><emphasis>Porphyromonas pasteri</emphasis></citetitle> sp. nov., isolated from human saliva. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">65:</emphasis>2511–2515.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0016" role="bibliographyEntry">
            <para>16.<emphasis role="strong">Kawamura Y, Kuwabara S, Kania SA, Kato H, Hamagishi M, Fujiwara N, Sato T, Tomida J, Tanaka K, Bemis DA.</emphasis> 2015. <citetitle><emphasis>Porphyromonas pogonae</emphasis></citetitle> sp. nov., an anaerobic but low concentration oxygen adapted coccobacillus isolated from lizards (<citetitle><emphasis>Pogona vitticeps</emphasis></citetitle>) or human clinical specimens, and emended description of the genus <citetitle><emphasis>Porphyromonas</emphasis></citetitle> Shah and Collins 1988. <citetitle><emphasis>Syst Appl Microbiol</emphasis></citetitle> <emphasis role="strong">38:</emphasis>104–109.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0017" role="bibliographyEntry">
            <para>17.<emphasis role="strong">Kim B, Pai H, Hwang KT, Lee Y.</emphasis> 2016. <citetitle><emphasis>Porphyromonas pogonae</emphasis></citetitle> identification from a soft tissue infection: the first human case. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">42:</emphasis>37–39.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0018" role="bibliographyEntry">
            <para>18.<emphasis role="strong">Schröttner P, Heidrich K, Rudolph WW, Stölzel F, Jacobs E, Gunzer F.</emphasis> 2017. First report on sepsis caused by <citetitle><emphasis>Porphyromonas pogonae. Anaerobe</emphasis></citetitle> <emphasis role="strong">44:</emphasis>96–98.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0019" role="bibliographyEntry">
            <para>19.<emphasis role="strong">Wang YJ, Xu XJ, Zhou N, Sun Y, Liu C, Liu SJ, You X.</emphasis> 2019. <citetitle><emphasis>Parabacteroides acidifaciens</emphasis></citetitle> sp. nov., isolated from human faeces. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">69:</emphasis>761–766.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0020" role="bibliographyEntry">
            <para>20.<emphasis role="strong">Kim H, Im WT, Kim M, Kim D, Seo YH, Yong D, Jeong SH, Lee K.</emphasis> 2018. <citetitle><emphasis>Parabacteroides chongii</emphasis></citetitle> sp. nov., isolated from blood of a patient with peritonitis. <citetitle><emphasis>J Microbiol</emphasis></citetitle> <emphasis role="strong">56:</emphasis>722–726.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0021" role="bibliographyEntry">
            <para>21.<emphasis role="strong">Sakamoto M, Suzuki M, Umeda M, Ishikawa I, Benno Y.</emphasis> 2002. Reclassification of <citetitle><emphasis>Bacteroides forsythus</emphasis></citetitle> (Tanner et al. 1986) as <citetitle><emphasis>Tannerella forsythensis</emphasis></citetitle> corrig., gen. nov., comb. nov. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>841–849.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0022" role="bibliographyEntry">
            <para>22.<emphasis role="strong">Ansbro K, Wade WG, Stafford GP.</emphasis> 2020. <citetitle><emphasis>Tannerella serpentiformis</emphasis></citetitle> sp. nov., isolated from the human mouth. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">70:</emphasis>3749–3754.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0023" role="bibliographyEntry">
            <para>23.<emphasis role="strong">Morotomi M, Nagai F, Sakon H, Tanaka R.</emphasis> 2008. <citetitle><emphasis>Dialister succinatiphilus</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Barnesiella intestinihominis</emphasis></citetitle> sp. nov., isolated from human faeces. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">58:</emphasis>2716–2720.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0024" role="bibliographyEntry">
            <para>24.<emphasis role="strong">Le Roy T, Van der Smissen P, Paquot A, Delzenne N, Muccioli GG, Collet JF, Cani PD.</emphasis> 2019. <citetitle><emphasis>Butyricimonas faecalis</emphasis></citetitle> sp. nov., isolated from human faeces and emended description of the genus <citetitle><emphasis>Butyricimonas. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">69:</emphasis>833–838.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0025" role="bibliographyEntry">
            <para>25.<emphasis role="strong">Enemchukwu CU, Ben-Faras H, Gialanella P, Szymczak WA, Nosanchuk JD, Madaline TF.</emphasis> 2016. <citetitle><emphasis>Butyricimonas virosa</emphasis></citetitle> bacteraemia and bowel disease: case report and review. <citetitle><emphasis>New Microbes New Infect</emphasis></citetitle> <emphasis role="strong">13:</emphasis>34–36.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0026" role="bibliographyEntry">
            <para>26.<emphasis role="strong">García-Agudo L, Nilsen E.</emphasis> 2018. <citetitle><emphasis>Butyricimonas virosa</emphasis></citetitle>: a rare cause of bacteremia. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">54:</emphasis>121–123.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0027" role="bibliographyEntry">
            <para>27.<emphasis role="strong">Shkoporov AN, Chaplin AV, Khokhlova EV, Shcherbakova VA, Motuzova OV, Bozhenko VK, Kafarskaia LI, Efimov BA.</emphasis> 2015. <citetitle><emphasis>Alistipes inops</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Coprobacter secundus</emphasis></citetitle> sp. nov., isolated from human faeces. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">65:</emphasis>4580–4588.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0028" role="bibliographyEntry">
            <para>28.<emphasis role="strong">Shkoporov AN, Kokhlova EV, Chaplin AV, Kafarskaia LI, Nikolin AA, Polyakov VY, Shcherbakova VA, Chernaia ZA, Efimov BA.</emphasis> 2013. <citetitle><emphasis>Coprobacter fastidiosus</emphasis></citetitle> gen. nov., sp. nov., a novel member of the family <citetitle><emphasis>Porphyromonadaceae</emphasis></citetitle> isolated from infant feces. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">63</emphasis>(Pt 11)<emphasis role="strong">:</emphasis>4181–4188.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0029" role="bibliographyEntry">
            <para>29.<emphasis role="strong">Hardham JM, King KW, Dreier K, Wong J, Strietzel C, Eversole RR, Sfintescu C, Evans RT.</emphasis> 2008. Transfer of <citetitle><emphasis>Bacteroides splanchnicus</emphasis></citetitle> to <citetitle><emphasis>Odoribacter</emphasis></citetitle> gen. nov. as <citetitle><emphasis>Odoribacter splanchnicus</emphasis></citetitle> comb. nov., and description of <citetitle><emphasis>Odoribacter denticanis</emphasis></citetitle> sp. nov., isolated from the crevicular spaces of canine periodontitis patients. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">58:</emphasis>103–109.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0030" role="bibliographyEntry">
            <para>30.<emphasis role="strong">Nagai F, Morotomi M, Watanabe Y, Sakon H, Tanaka R.</emphasis> 2010. <citetitle><emphasis>Alistipes indistinctus</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Odoribacter laneus</emphasis></citetitle> sp. nov., common members of the human intestinal microbiota isolated from faeces. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">60:</emphasis>1296–1302.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0031" role="bibliographyEntry">
            <para>31.<emphasis role="strong">Shah HN, Collins DM.</emphasis> 1990. <citetitle><emphasis>Prevotella</emphasis></citetitle>, a new genus to include <citetitle><emphasis>Bacteroides melaninogenicus</emphasis></citetitle> and related species formerly classified in the genus <citetitle><emphasis>Bacteroides. Int J Syst Bacteriol</emphasis></citetitle> <emphasis role="strong">40:</emphasis>205–208.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0032" role="bibliographyEntry">
            <para>32.<emphasis role="strong">Downes J, Wade WG.</emphasis> 2011. <citetitle><emphasis>Prevotella fusca</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Prevotella scopos</emphasis></citetitle> sp. nov., isolated from the human oral cavity. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">61:</emphasis>854–858.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0033" role="bibliographyEntry">
            <para>33.<emphasis role="strong">Downes J, Hooper SJ, Wilson MJ, Wade WG.</emphasis> 2008. <citetitle><emphasis>Prevotella histicola</emphasis></citetitle> sp. nov., isolated from the human oral cavity. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">58:</emphasis>1788–1791.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0034" role="bibliographyEntry">
            <para>34.<emphasis role="strong">Downes J, Liu M, Könönen E, Wade WG.</emphasis> 2009. <citetitle><emphasis>Prevotella micans</emphasis></citetitle> sp. nov., isolated from the human oral cavity. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">59:</emphasis>771–774.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0035" role="bibliographyEntry">
            <anchor id="ch0074s0011s0003a0003"/>
            <para>35.<emphasis role="strong">Downes J, Tanner ACR, Dewhirst FE, Wade WG.</emphasis> 2010. <citetitle><emphasis>Prevotella saccharolytica</emphasis></citetitle> sp. nov., isolated from the human oral cavity. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">60:</emphasis>2458–2461.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0036" role="bibliographyEntry">
            <para>36.<emphasis role="strong">Sakamoto M, Suzuki N, Okamoto M.</emphasis> 2010. <citetitle><emphasis>Prevotella aurantiaca</emphasis></citetitle> sp. nov., isolated from the human oral cavity. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">60:</emphasis>500–503.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0037" role="bibliographyEntry">
            <para>37.<emphasis role="strong">Hayashi H, Shibata K, Sakamoto M, Tomita S, Benno Y.</emphasis> 2007. <citetitle><emphasis>Prevotella copri</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Prevotella stercorea</emphasis></citetitle> sp. nov., isolated from human faeces. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">57:</emphasis>941–946.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0038" role="bibliographyEntry">
            <para>38.<emphasis role="strong">Alauzet C, Mory F, Carlier JP, Marchandin H, Jumas-Bilak E, Lozniewski A.</emphasis> 2007. <citetitle><emphasis>Prevotella nanceiensis</emphasis></citetitle> sp. nov., isolated from human clinical samples. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">57:</emphasis>2216–2220.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0039" role="bibliographyEntry">
            <para>39.<emphasis role="strong">Downes J, Sutcliffe IC, Hofstad T, Wade WG.</emphasis> 2006. <citetitle><emphasis>Prevotella bergensis</emphasis></citetitle> sp. nov., isolated from human infections. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">56:</emphasis>609–612.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0040" role="bibliographyEntry">
            <para>40.<emphasis role="strong">Glazunova OO, Launay T, Raoult D, Roux V.</emphasis> 2007. <citetitle><emphasis>Prevotella timonensis</emphasis></citetitle> sp. nov., isolated from a human breast abscess. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">57:</emphasis>883–886.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0041" role="bibliographyEntry">
            <para>41.<emphasis role="strong">Hedberg ME, Israelsson A, Moore ERB, Svensson-Stadler L, Nyunt Wai S, Pietz G, Sandström O, Hernell O, Hammarström ML, Hammarström S.</emphasis> 2013. <citetitle><emphasis>Prevotella jejuni</emphasis></citetitle> sp. nov., isolated from the small intestine of a child with celiac disease. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">63</emphasis>(Pt 11)<emphasis role="strong">:</emphasis>4218–4223.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0042" role="bibliographyEntry">
            <para>42.<emphasis role="strong">Lawson PA, Moore E, Falsen E.</emphasis> 2008. <citetitle><emphasis>Prevotella amnii</emphasis></citetitle> sp. nov., isolated from human amniotic fluid. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">58:</emphasis>89–92.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0043" role="bibliographyEntry">
            <para>43.<emphasis role="strong">Sakamoto M, Ohkusu K, Masaki T, Kako H, Ezaki T, Benno Y.</emphasis> 2007. <citetitle><emphasis>Prevotella pleuritidis</emphasis></citetitle> sp. nov., isolated from pleural fluid. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">57:</emphasis>1725–1728.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0044" role="bibliographyEntry">
            <para>44.<emphasis role="strong">Buhl M, Dunlap C, Marschal M.</emphasis> 2019. <citetitle><emphasis>Prevotella brunnea</emphasis></citetitle> sp. nov., isolated from a wound of a patient. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">69:</emphasis>3933–3938.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0045" role="bibliographyEntry">
            <para>45.<emphasis role="strong">Buhl M, Marschal M.</emphasis> 2020. <citetitle><emphasis>Prevotella vespertina</emphasis></citetitle> sp. nov., isolated from an abscess of a hospital patient. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">70:</emphasis>4576–4582.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0046" role="bibliographyEntry">
            <para>46.<emphasis role="strong">Efimov BA, Chaplin AV, Shcherbakova VA, Suzina NE, Podoprigora IV, Shkoporov AN.</emphasis> 2018. <citetitle><emphasis>Prevotella rara</emphasis></citetitle> sp. nov., isolated from human faeces. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">68:</emphasis>3818–3825.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0047" role="bibliographyEntry">
            <para>47.<emphasis role="strong">Liou JS, Huang CH, Ikeyama N, Lee AY, Chen IC, Blom J, Chen CC, Chen CH, Lin YC, Hsieh SY, Huang L, Ohkuma M, Watanabe K, Sakamoto M.</emphasis> 2020. <citetitle><emphasis>Prevotella hominis</emphasis></citetitle> sp. nov., isolated from human faeces. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">70:</emphasis>4767–4773.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0048" role="bibliographyEntry">
            <para>48.<emphasis role="strong">Afouda P, Ndongo S, Khelaifia S, Labas N, Cadoret F, Di Pinto F, Delerce J, Raoult D, Million M.</emphasis> 2016. Noncontiguous finished genome sequence and description of <citetitle><emphasis>Prevotella phocaeensis</emphasis></citetitle> sp. nov., a new anaerobic species isolated from human gut infected by <citetitle><emphasis>Clostridium difficile. New Microbes New Infect</emphasis></citetitle> <emphasis role="strong">15:</emphasis>117–127.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0049" role="bibliographyEntry">
            <para>49.<emphasis role="strong">Diop K, Diop A, Levasseur A, Mediannikov O, Robert C, Armstrong N, Couderc C, Bretelle F, Raoult D, Fournier PE, Fenollar F.</emphasis> 2018. Microbial culturomics broadens human vaginal flora diversity: genome sequence and description of <citetitle><emphasis>Prevotella lascolaii</emphasis></citetitle> sp. nov. isolated from a patient with bacterial vaginosis. <citetitle><emphasis>OMICS</emphasis></citetitle> <emphasis role="strong">22:</emphasis>210–222.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0050" role="bibliographyEntry">
            <para>50.<emphasis role="strong">Downes J, Dewhirst FE, Tanner ACR, Wade WG.</emphasis> 2013. Description of <citetitle><emphasis>Alloprevotella rava</emphasis></citetitle> gen. nov., sp. nov., isolated from the human oral cavity, and reclassification of <citetitle><emphasis>Prevotella tannerae</emphasis></citetitle> Moore et al. 1994 as <citetitle><emphasis>Alloprevotella tannerae</emphasis></citetitle> gen. nov., comb. nov. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">63:</emphasis>1214–1218.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0051" role="bibliographyEntry">
            <para>51.<emphasis role="strong">Morotomi M, Nagai F, Sakon H, Tanaka R.</emphasis> 2009. <citetitle><emphasis>Paraprevotella clara</emphasis></citetitle> gen. nov., sp. nov. and <citetitle><emphasis>Paraprevotella xylaniphila</emphasis></citetitle> sp. nov., members of the family ‘<citetitle><emphasis>Prevotellaceae</emphasis></citetitle>’ isolated from human faeces. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">59:</emphasis>1895–1900.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0052" role="bibliographyEntry">
            <para>52.<emphasis role="strong">García-López M, Meier-Kolthoff JP, Tindall BJ, Gronow S, Woyke T, Kyrpides NC, Hahnke RL, Göker M.</emphasis> 2019. Analysis of 1,000 type-strain genomes improves taxonomic classification of Bacteroidetes. <citetitle><emphasis>Front Microbiol</emphasis></citetitle> <emphasis role="strong">10:</emphasis>2083.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0053" role="bibliographyEntry">
            <para>53.<emphasis role="strong">Mukherjee S, Seshadri R, Varghese NJ, Eloe-Fadrosh EA, Meier-Kolthoff JP, Göker M, Coates RC, Hadjithomas M, Pavlopoulos GA, Paez-Espino D, Yoshikuni Y, Visel A, Whitman WB, Garrity GM, Eisen JA, Hugenholtz P, Pati A, Ivanova NN, Woyke T, Klenk HP, Kyrpides NC.</emphasis> 2017. 1,003 reference genomes of bacterial and archaeal isolates expand coverage of the tree of life. <citetitle><emphasis>Nat Biotechnol</emphasis></citetitle> <emphasis role="strong">35:</emphasis>676–683.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0054" role="bibliographyEntry">
            <para>54.<emphasis role="strong">Al Masalma M, Raoult D, Roux V.</emphasis> 2009. <citetitle><emphasis>Phocaeicola abscessus</emphasis></citetitle> gen. nov., sp. nov., an anaerobic bacterium isolated from a human brain abscess sample. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">59:</emphasis>2232–2237.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0055" role="bibliographyEntry">
            <para>55.<emphasis role="strong">Baaity Z, Jamal W, Rotimi VO, Burián K, Leitsch D, Somogyvári F, Nagy E, Sóki J.</emphasis> 2021. Molecular characterization of metronidazole resistant <citetitle><emphasis>Bacteroides</emphasis></citetitle> strains from Kuwait. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">69:</emphasis>102357.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0056" role="bibliographyEntry">
            <para>56.<emphasis role="strong">Fenner L, Roux V, Mallet MN, Raoult D.</emphasis> 2005. <citetitle><emphasis>Bacteroides massiliensis</emphasis></citetitle> sp. nov., isolated from blood culture of a newborn. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">55:</emphasis>1335–1337.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0057" role="bibliographyEntry">
            <para>57.<emphasis role="strong">Conrads G, Claros MC, Citron DM, Tyrrell KL, Merriam V, Goldstein EJC.</emphasis> 2002. 16S-23S rDNA internal transcribed spacer sequences for analysis of the phylogenetic relationships among species of the genus <citetitle><emphasis>Fusobacterium. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>493–499.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0058" role="bibliographyEntry">
            <para>58.<emphasis role="strong">Mira A, Pushker R, Legault BA, Moreira D, Rodríguez-Valera F.</emphasis> 2004. Evolutionary relationships of <citetitle><emphasis>Fusobacterium nucleatum</emphasis></citetitle> based on phylogenetic analysis and comparative genomics. <citetitle><emphasis>BMC Evol Biol</emphasis></citetitle> <emphasis role="strong">4:</emphasis>50.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0059" role="bibliographyEntry">
            <para>59.<emphasis role="strong">Brennan CA, Garrett WS.</emphasis> 2019. <citetitle><emphasis>Fusobacterium nucleatum</emphasis></citetitle>—symbiont, opportunist and oncobacterium. <citetitle><emphasis>Nat Rev Microbiol</emphasis></citetitle> <emphasis role="strong">17:</emphasis>156–166.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0060" role="bibliographyEntry">
            <para>60.<emphasis role="strong">Henne K, Schilling H, Stoneking M, Conrads G, Horz HP.</emphasis> 2018. Sex-specific differences in the occurrence of <citetitle><emphasis>Fusobacterium nucleatum</emphasis></citetitle> subspecies and <citetitle><emphasis>Fusobacterium periodonticum</emphasis></citetitle> in the oral cavity. <citetitle><emphasis>Oncotarget</emphasis></citetitle> <emphasis role="strong">9:</emphasis>20631–20639.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0061" role="bibliographyEntry">
            <para>61.<emphasis role="strong">Eisenberg T, Glaeser SP, Blom J, Kämpfer P.</emphasis> 2020. Proposal to reclassify <citetitle><emphasis>Leptotrichia goodfellowii</emphasis></citetitle> into a novel genus as <citetitle><emphasis>Pseudoleptotrichia goodfellowii</emphasis></citetitle> gen. nov., comb. nov. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">70:</emphasis>2084–2088.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0062" role="bibliographyEntry">
            <para>62.<emphasis role="strong">Shukla SK, Meier PR, Mitchell PD, Frank DN, Reed KD.</emphasis> 2002. <citetitle><emphasis>Leptotrichia amnionii</emphasis></citetitle> sp. nov., a novel bacterium isolated from the amniotic fluid of a woman after intrauterine fetal demise. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">40:</emphasis>3346–3349.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0063" role="bibliographyEntry">
            <para>63.<emphasis role="strong">Eisenberg T, Gronow S, Falgenhauer J, Imirzalioglu C, Mühldorfer K, Rau J, Blom J, Fawzy A, Glaeser SP, Kämpfer P.</emphasis> 2019. <citetitle><emphasis>Sneathia vaginalis</emphasis></citetitle> sp. nov. (<citetitle><emphasis>Fusobacteriales</emphasis></citetitle>, <citetitle><emphasis>Leptotrichiaceae</emphasis></citetitle>) as a replacement of the species ‘<citetitle><emphasis>Sneathia amnii</emphasis></citetitle>’ Harwich et al. 2012 and ‘<citetitle><emphasis>Leptotrichia amnionii</emphasis></citetitle>’ Shukla et al. 2002, and emended description of <citetitle><emphasis>Sneathia</emphasis></citetitle> Collins et al. 2001. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">71</emphasis>(3). doi: 10.1099/ijsem.0.004663.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0064" role="bibliographyEntry">
            <para>64.<emphasis role="strong">Harwich MD Jr, Serrano MG, Fettweis JM, Alves JM, Reimers MA, Buck GA, Jefferson KK, Vaginal Microbiome Consortium (additional members).</emphasis> 2012. Genomic sequence analysis and characterization of <citetitle><emphasis>Sneathia amnii</emphasis></citetitle> sp. nov. <citetitle><emphasis>BMC Genomics</emphasis></citetitle> <emphasis role="strong">13</emphasis>(Suppl 8)<emphasis role="strong">:</emphasis>S4.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0065" role="bibliographyEntry">
            <para>65.<emphasis role="strong">Vartoukian SR, Downes J, Palmer RM, Wade WG.</emphasis> 2013. <citetitle><emphasis>Fretibacterium fastidiosum</emphasis></citetitle> gen. nov., sp. nov., isolated from the human oral cavity. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">63:</emphasis>458–463.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0066" role="bibliographyEntry">
            <para>66.<emphasis role="strong">Jumas-Bilak E, Carlier JP, Jean-Pierre H, Citron D, Bernard K, Damay A, Gay B, Teyssier C, Campos J, Marchandin H.</emphasis> 2007. <citetitle><emphasis>Jonquetella anthropi</emphasis></citetitle> gen. nov., sp. nov., the first member of the candidate phylum ‘<citetitle><emphasis>Synergistetes</emphasis></citetitle>’ isolated from man. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">57:</emphasis>2743–2748.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0067" role="bibliographyEntry">
            <para>67.<emphasis role="strong">Downes J, Vartoukian SR, Dewhirst FE, Izard J, Chen T, Yu WH, Sutcliffe IC, Wade WG.</emphasis> 2009. <citetitle><emphasis>Pyramidobacter piscolens</emphasis></citetitle> gen. nov., sp. nov., a member of the phylum ‘<citetitle><emphasis>Synergistetes</emphasis></citetitle>’ isolated from the human oral cavity. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">59:</emphasis>972–980.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0068" role="bibliographyEntry">
            <para>68.<emphasis role="strong">Jumas-Bilak E, Bouvet P, Allen-Vercoe E, Aujoulat F, Lawson PA, Jean-Pierre H, Marchandin H.</emphasis> 2015. <citetitle><emphasis>Rarimicrobium hominis</emphasis></citetitle> gen. nov., sp. nov., representing the fifth genus in the phylum <citetitle><emphasis>Synergistetes</emphasis></citetitle> that includes human clinical isolates. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">65:</emphasis>3965–3970.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0069" role="bibliographyEntry">
            <para>69.<emphasis role="strong">Domingo MC, Yansouni C, Gaudreau C, Lamothe F, Lévesque S, Tremblay C, Garceau R.</emphasis> 2015. <citetitle><emphasis>Cloacibacillus</emphasis></citetitle> sp., a potential human pathogen associated with bacteremia in Quebec and New Brunswick. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">53:</emphasis>3380–3383.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0070" role="bibliographyEntry">
            <anchor id="ch0074s0011s0003a0004"/>
            <para>70.<emphasis role="strong">Vartoukian SR, Palmer RM, Wade WG.</emphasis> 2009. Diversity and morphology of members of the phylum “<citetitle><emphasis>Synergistetes</emphasis></citetitle>” in periodontal health and disease. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">75:</emphasis>3777–3786.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0071" role="bibliographyEntry">
            <para>71.<emphasis role="strong">Marchandin H, Damay A, Roudière L, Teyssier C, Zorgniotti I, Dechaud H, Jean-Pierre H, Jumas-Bilak E.</emphasis> 2010. Phylogeny, diversity and host specialization in the phylum <citetitle><emphasis>Synergistetes</emphasis></citetitle> with emphasis on strains and clones of human origin. <citetitle><emphasis>Res Microbiol</emphasis></citetitle> <emphasis role="strong">161:</emphasis>91–100.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0072" role="bibliographyEntry">
            <para>72.<emphasis role="strong">Marchandin H, Teyssier C, Campos J, Jean-Pierre H, Roger F, Gay B, Carlier JP, Jumas-Bilak E.</emphasis> 2010. <citetitle><emphasis>Negativicoccus succinicivorans</emphasis></citetitle> gen. nov., sp. nov., isolated from human clinical samples, emended description of the family <citetitle><emphasis>Veillonellaceae</emphasis></citetitle> and description of <citetitle><emphasis>Negativicutes</emphasis></citetitle> classis nov., <citetitle><emphasis>Selenomonadales</emphasis></citetitle> ord. nov. and <citetitle><emphasis>Acidaminococcaceae</emphasis></citetitle> fam. nov. in the bacterial phylum <citetitle><emphasis>Firmicutes. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">60:</emphasis>1271–1279.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0073" role="bibliographyEntry">
            <para>73.<emphasis role="strong">Downes J, Munson M, Wade WG.</emphasis> 2003. <citetitle><emphasis>Dialister invisus</emphasis></citetitle> sp. nov., isolated from the human oral cavity. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">53:</emphasis>1937–1940.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0074" role="bibliographyEntry">
            <para>74.<emphasis role="strong">Jumas-Bilak E, Jean-Pierre H, Carlier JP, Teyssier C, Bernard K, Gay B, Campos J, Morio F, Marchandin H.</emphasis> 2005. <citetitle><emphasis>Dialister micraerophilus</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Dialister propionicifaciens</emphasis></citetitle> sp. nov., isolated from human clinical samples. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">55:</emphasis>2471–2478.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0075" role="bibliographyEntry">
            <para>75.<emphasis role="strong">Sakamoto M, Ikeyama N, Toyoda A, Murakami T, Mori H, Iino T, Ohkuma M.</emphasis> 2020. <citetitle><emphasis>Dialister hominis</emphasis></citetitle> sp. nov., isolated from human faeces. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">70:</emphasis>589–595.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0076" role="bibliographyEntry">
            <para>76.<emphasis role="strong">Sakon H, Nagai F, Morotomi M, Tanaka R.</emphasis> 2008. <citetitle><emphasis>Sutterella parvirubra</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Megamonas funiformis</emphasis></citetitle> sp. nov., isolated from human faeces. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">58:</emphasis>970–975.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0077" role="bibliographyEntry">
            <para>77.<emphasis role="strong">Moore LVH, Johnson JL, Moore WEC.</emphasis> 1987. <citetitle><emphasis>Selenomonas noxia</emphasis></citetitle> sp. nov., <citetitle><emphasis>Selenomonas flueggei</emphasis></citetitle> sp. nov., <citetitle><emphasis>Selenomonas infelix</emphasis></citetitle> sp. nov., <citetitle><emphasis>Selenomonas dianae</emphasis></citetitle> sp. nov., and <citetitle><emphasis>Selenomonas artemidis</emphasis></citetitle> sp. nov., from the human gingival crevice. <citetitle><emphasis>Int J Syst Bacteriol</emphasis></citetitle> <emphasis role="strong">37:</emphasis>271–280.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0078" role="bibliographyEntry">
            <para>78.<emphasis role="strong">Watanabe Y, Nagai F, Morotomi M.</emphasis> 2012. Characterization of <citetitle><emphasis>Phascolarctobacterium succinatutens</emphasis></citetitle> sp. nov., an asaccharolytic, succinate-utilizing bacterium isolated from human feces. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">78:</emphasis>511–518.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0079" role="bibliographyEntry">
            <para>79.<emphasis role="strong">Morotomi M, Nagai F, Watanabe Y.</emphasis> 2012. Description of <citetitle><emphasis>Christensenella minuta</emphasis></citetitle> gen. nov., sp. nov., isolated from human faeces, which forms a distinct branch in the order <citetitle><emphasis>Clostridiales</emphasis></citetitle>, and proposal of <citetitle><emphasis>Christensenellaceae</emphasis></citetitle> fam. nov. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">62:</emphasis>144–149.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0080" role="bibliographyEntry">
            <para>80.<emphasis role="strong">Alonso BL, Irigoyen von Sierakowski A, Sáez Nieto JA, Rosel AB.</emphasis> 2017. First report of human infection by <citetitle><emphasis>Christensenella minuta</emphasis></citetitle>, a gram-negative, strictly anaerobic rod that inhabits the human intestine. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">44:</emphasis>124–125.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0081" role="bibliographyEntry">
            <para>81.<emphasis role="strong">Zou Y, Xue W, Lin X, Hu T, Liu SW, Sun CH, Luo G, Lv M, Dai Y, Kristiansen K, Xiao L.</emphasis> 2021. Taxonomic description and genome sequence of <citetitle><emphasis>Christensenella intestinihominis</emphasis></citetitle> sp. nov., a novel cholesterol-lowering bacterium isolated from human gut. <citetitle><emphasis>Front Microbiol</emphasis></citetitle> <emphasis role="strong">12:</emphasis>632361.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0082" role="bibliographyEntry">
            <para>82.<emphasis role="strong">Morotomi M, Nagai F, Watanabe Y.</emphasis> 2011. <citetitle><emphasis>Parasutterella secunda</emphasis></citetitle> sp. nov., isolated from human faeces and proposal of <citetitle><emphasis>Sutterellaceae</emphasis></citetitle> fam. nov. in the order <citetitle><emphasis>Burkholderiales. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">61:</emphasis>637–643.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0083" role="bibliographyEntry">
            <para>83.<emphasis role="strong">Sakamoto M, Ikeyama N, Kunihiro T, Iino T, Yuki M, Ohkuma M.</emphasis> 2018. <citetitle><emphasis>Mesosutterella multiformis</emphasis></citetitle> gen. nov., sp. nov., a member of the family <citetitle><emphasis>Sutterellaceae</emphasis></citetitle> and <citetitle><emphasis>Sutterella megalosphaeroides</emphasis></citetitle> sp. nov., isolated from human faeces. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">68:</emphasis>3942–3950.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0084" role="bibliographyEntry">
            <para>84.<emphasis role="strong">Baron EJ.</emphasis> 1997. <citetitle><emphasis>Bilophila wadsworthia</emphasis></citetitle>: a unique Gram-negative anaerobic rod. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">3:</emphasis>83–86.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0085" role="bibliographyEntry">
            <para>85.<emphasis role="strong">Goldstein EJ, Citron DM, Peraino VA, Cross SA.</emphasis> 2003. <citetitle><emphasis>Desulfovibrio desulfuricans</emphasis></citetitle> bacteremia and review of human <citetitle><emphasis>Desulfovibrio</emphasis></citetitle> infections. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">41:</emphasis>2752–2754.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0086" role="bibliographyEntry">
            <para>86.<emphasis role="strong">Langendijk PS, Kulik EM, Sandmeier H, Meyer J, van der Hoeven JS.</emphasis> 2001. Isolation of <citetitle><emphasis>Desulfomicrobium orale</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Desulfovibrio</emphasis></citetitle> strain NY682, oral sulfate-reducing bacteria involved in human periodontal disease. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">51:</emphasis>1035–1044.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0087" role="bibliographyEntry">
            <para>87.<emphasis role="strong">Malnick H.</emphasis> 1997. <citetitle><emphasis>Anaerobiospirillum thomasii</emphasis></citetitle> sp. nov., an anaerobic spiral bacterium isolated from the feces of cats and dogs and from diarrheal feces of humans, and emendation of the genus <citetitle><emphasis>Anaerobiospirillum. Int J Syst Bacteriol</emphasis></citetitle> <emphasis role="strong">47:</emphasis>381–384.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0088" role="bibliographyEntry">
            <para>88.<emphasis role="strong">Schaumburg F, Dieckmann R, Schmidt-Bräkling T, Becker K, Idelevich EA.</emphasis> 2017. First description of an <citetitle><emphasis>Anaerobiospirillum succiniciproducens</emphasis></citetitle> prosthetic joint infection. <citetitle><emphasis>New Microbes New Infect</emphasis></citetitle> <emphasis role="strong">18:</emphasis>1–2.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0089" role="bibliographyEntry">
            <para>89.<emphasis role="strong">Morotomi M, Nagai F, Watanabe Y, Tanaka R.</emphasis> 2010. <citetitle><emphasis>Succinatimonas hippei</emphasis></citetitle> gen. nov., sp. nov., isolated from human faeces. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">60:</emphasis>1788–1793.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0090" role="bibliographyEntry">
            <para>90.<emphasis role="strong">Kapatral V, Anderson I, Ivanova N, Reznik G, Los T, Lykidis A, Bhattacharyya A, Bartman A, Gardner W, Grechkin G, Zhu L, Vasieva O, Chu L, Kogan Y, Chaga O, Goltsman E, Bernal A, Larsen N, D’Souza M, Walunas T, Pusch G, Haselkorn R, Fonstein M, Kyrpides N, Overbeek R.</emphasis> 2002. Genome sequence and analysis of the oral bacterium <citetitle><emphasis>Fusobacterium nucleatum</emphasis></citetitle> strain ATCC 25586. <citetitle><emphasis>J Bacteriol</emphasis></citetitle> <emphasis role="strong">184:</emphasis>2005–2018.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0091" role="bibliographyEntry">
            <para>91.<emphasis role="strong">Jousimies-Somer HSP, Citron DM, Baron EJ, Wexler HM, Finegold SM.</emphasis> 2002. <citetitle><emphasis>Wadsworth–KTL Anaerobic Bacteriology Manual</emphasis></citetitle>, 6th ed. Star Publishing, Belmont, CA.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0092" role="bibliographyEntry">
            <para>92.<emphasis role="strong">Lagier JC, Hugon P, Khelaifia S, Fournier PE, La Scola B, Raoult D.</emphasis> 2015. The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">28:</emphasis>237–264.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0093" role="bibliographyEntry">
            <para>93.<emphasis role="strong">Könönen E.</emphasis> 2000. Development of oral bacterial flora in young children. <citetitle><emphasis>Ann Med</emphasis></citetitle> <emphasis role="strong">32:</emphasis>107–112.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0094" role="bibliographyEntry">
            <para>94.<emphasis role="strong">Haraldsson G, Holbrook WP, Könönen E.</emphasis> 2004. Clonal persistence of oral <citetitle><emphasis>Fusobacterium nucleatum</emphasis></citetitle> in infancy. <citetitle><emphasis>J Dent Res</emphasis></citetitle> <emphasis role="strong">83:</emphasis>500–504.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0095" role="bibliographyEntry">
            <para>95.<emphasis role="strong">Bjerke GA, Wilson R, Storrø O, Øyen T, Johnsen R, Rudi K.</emphasis> 2011. Mother-to-child transmission of and multiple-strain colonization by <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle> in a cohort of mothers and their children. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">77:</emphasis>8318–8324.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0096" role="bibliographyEntry">
            <para>96.<emphasis role="strong">Zijnge V, van Leeuwen MB, Degener JE, Abbas F, Thurnheer T, Gmür R, Harmsen HJ.</emphasis> 2010. Oral biofilm architecture on natural teeth. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">5:</emphasis>e9321.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0097" role="bibliographyEntry">
            <para>97.<emphasis role="strong">Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA.</emphasis> 2006. Molecular analysis of the bacterial microbiota in the human stomach. <citetitle><emphasis>Proc Natl Acad Sci USA</emphasis></citetitle> <emphasis role="strong">103:</emphasis>732–737.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0098" role="bibliographyEntry">
            <para>98.<emphasis role="strong">Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, Martinez FJ, Huffnagle GB.</emphasis> 2011. Analysis of the lung microbiome in the “healthy” smoker and in COPD. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">6:</emphasis>e16384.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0099" role="bibliographyEntry">
            <para>99.<emphasis role="strong">Pei Z, Bini EJ, Yang L, Zhou M, Francois F, Blaser MJ.</emphasis> 2004. Bacterial biota in the human distal esophagus. <citetitle><emphasis>Proc Natl Acad Sci USA</emphasis></citetitle> <emphasis role="strong">101:</emphasis>4250–4255.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0100" role="bibliographyEntry">
            <para>100.<emphasis role="strong">Tett A, Pasolli E, Masetti G, Ercolini D, Segata N.</emphasis> 2021. <citetitle><emphasis>Prevotella</emphasis></citetitle> diversity, niches and interactions with the human host. <citetitle><emphasis>Nat Rev Microbiol</emphasis></citetitle> <emphasis role="strong">19:</emphasis>585–599.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0101" role="bibliographyEntry">
            <para>101.<emphasis role="strong">Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, Stobberingh EE.</emphasis> 2006. Factors influencing the composition of the intestinal microbiota in early infancy. <citetitle><emphasis>Pediatrics</emphasis></citetitle> <emphasis role="strong">118:</emphasis>511–521.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0102" role="bibliographyEntry">
            <para>102.<emphasis role="strong">Sánchez E, De Palma G, Capilla A, Nova E, Pozo T, Castillejo G, Varea V, Marcos A, Garrote JA, Polanco I, López A, Ribes-Koninckx C, García-Novo MD, Calvo C, Ortigosa L, Palau F, Sanz Y.</emphasis> 2011. Influence of environmental and genetic factors linked to celiac disease risk on infant gut colonization by <citetitle><emphasis>Bacteroides</emphasis></citetitle> species. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">77:</emphasis>5316–5323.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0103" role="bibliographyEntry">
            <para>103.<emphasis role="strong">Ley RE, Turnbaugh PJ, Klein S, Gordon JI.</emphasis> 2006. Microbial ecology: human gut microbes associated with obesity. <citetitle><emphasis>Nature</emphasis></citetitle> <emphasis role="strong">444:</emphasis>1022–1023.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0104" role="bibliographyEntry">
            <para>104.<emphasis role="strong">Onderdonk AB, Delaney ML, Fichorova RN.</emphasis> 2016. The human microbiome during bacterial vaginosis. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">29:</emphasis>223–238.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0105" role="bibliographyEntry">
            <para>105.<emphasis role="strong">Srinivasan S, Hoffman NG, Morgan MT, Matsen FA, Fiedler TL, Hall RW, Ross FJ, McCoy CO, Bumgarner R, Marrazzo JM, Fredricks DN.</emphasis> 2012. Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">7:</emphasis>e37818.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0106" role="bibliographyEntry">
            <anchor id="ch0074s0011s0003a0005"/>
            <para>106.<emphasis role="strong">Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, Lakshmanan A, Wade WG.</emphasis> 2010. The human oral microbiome. <citetitle><emphasis>J Bacteriol</emphasis></citetitle> <emphasis role="strong">192:</emphasis>5002–5017.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0107" role="bibliographyEntry">
            <para>107.<emphasis role="strong">Jensen A, Fagö-Olsen H, Sørensen CH, Kilian M.</emphasis> 2013. Molecular mapping to species level of the tonsillar crypt microbiota associated with health and recurrent tonsillitis. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">8:</emphasis>e56418.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0108" role="bibliographyEntry">
            <para>108.<emphasis role="strong">Siqueira JF Jr, Rôças IN.</emphasis> 2013. As-yet-uncultivated oral bacteria: breadth and association with oral and extra-oral diseases. <citetitle><emphasis>J Oral Microbiol</emphasis></citetitle> <emphasis role="strong">5:</emphasis>10.3402/jom.v5i0.21077.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0109" role="bibliographyEntry">
            <para>109.<emphasis role="strong">Könönen E, Müller HP.</emphasis> 2014. Microbiology of aggressive periodontitis. <citetitle><emphasis>Periodontol 2000</emphasis></citetitle> 65<emphasis role="strong">:</emphasis>46–78.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0110" role="bibliographyEntry">
            <para>110.<emphasis role="strong">Siqueira JF Jr, Rôças IN.</emphasis> 2013. Microbiology and treatment of acute apical abscesses. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">26:</emphasis>255–273.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0111" role="bibliographyEntry">
            <para>111.<emphasis role="strong">Dabdoub SM, Ganesan SM, Kumar PS.</emphasis> 2016. Comparative metagenomics reveals taxonomically idiosyncratic yet functionally congruent communities in periodontitis. <citetitle><emphasis>Sci Rep</emphasis></citetitle> <emphasis role="strong">6:</emphasis>38993.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0112" role="bibliographyEntry">
            <para>112.<emphasis role="strong">Fihman V, Raskine L, Petitpas F, Mateo J, Kania R, Gravisse J, Resche-Rigon M, Farhat I, Berçot B, Payen D, Sanson-Le Pors MJ, Herman P, Mebazaa A.</emphasis> 2008. Cervical necrotizing fasciitis: 8 years’ experience of microbiology. <citetitle><emphasis>Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">27:</emphasis>691–695.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0113" role="bibliographyEntry">
            <para>113.<emphasis role="strong">Blairon L, De Gheldre Y, Delaere B, Sonet A, Bosly A, Glupczynski Y.</emphasis> 2006. A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">12:</emphasis>527–532.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0114" role="bibliographyEntry">
            <para>114.<emphasis role="strong">Lassmann B, Gustafson DR, Wood CM, Rosenblatt JE.</emphasis> 2007. Reemergence of anaerobic bacteremia. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">44:</emphasis>895–900.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0115" role="bibliographyEntry">
            <para>115.<emphasis role="strong">Ngo JT, Parkins MD, Gregson DB, Pitout JD, Ross T, Church DL, Laupland KB.</emphasis> 2013. Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections. <citetitle><emphasis>Infection</emphasis></citetitle> <emphasis role="strong">41:</emphasis>41–48.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0116" role="bibliographyEntry">
            <para>116.<emphasis role="strong">Goren I, Brom A, Yanai H, Dagan A, Segal G, Israel A.</emphasis> 2020. Risk of bacteremia in hospitalised patients with inflammatory bowel disease: a 9-year cohort study. <citetitle><emphasis>United European Gastroenterol J</emphasis></citetitle> <emphasis role="strong">8:</emphasis>195–203.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0117" role="bibliographyEntry">
            <para>117.<emphasis role="strong">Bahrani-Mougeot FK, Paster BJ, Coleman S, Ashar J, Barbuto S, Lockhart PB.</emphasis> 2008. Diverse and novel oral bacterial species in blood following dental procedures. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">46:</emphasis>2129–2132.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0118" role="bibliographyEntry">
            <para>118.<emphasis role="strong">Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK.</emphasis> 2008. Bacteremia associated with toothbrushing and dental extraction. <citetitle><emphasis>Circulation</emphasis></citetitle> <emphasis role="strong">117:</emphasis>3118–3125.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0119" role="bibliographyEntry">
            <para>119.<emphasis role="strong">Emery DC, Cerajewska TL, Seong J, Davies M, Paterson A, Allen-Birt SJ, West NX.</emphasis> 2021. Comparison of blood bacterial communities in periodontal health and periodontal disease. <citetitle><emphasis>Front Cell Infect Microbiol</emphasis></citetitle> <emphasis role="strong">10:</emphasis>577485.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0120" role="bibliographyEntry">
            <para>120.<emphasis role="strong">Snydman DR, Jacobus NV, McDermott LA, Golan Y, Hecht DW, Goldstein EJ, Harrell L, Jenkins S, Newton D, Pierson C, Rihs JD, Yu VL, Venezia R, Finegold SM, Rosenblatt JE, Gorbach SL.</emphasis> 2010. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">50</emphasis>(Suppl 1)<emphasis role="strong">:</emphasis>S26–S33.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0121" role="bibliographyEntry">
            <para>121.<emphasis role="strong">De Keukeleire S, Wybo I, Naessens A, Echahidi F, Van der Beken M, Vandoorslaer K, Vermeulen S, Piérard D.</emphasis> 2016. Anaerobic bacteraemia: a 10-year retrospective epidemiological survey. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">39:</emphasis>54–59.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0122" role="bibliographyEntry">
            <para>122.<emphasis role="strong">Liu CY, Huang YT, Liao CH, Yen LC, Lin HY, Hsueh PR.</emphasis> 2008. Increasing trends in antimicrobial resistance among clinically important anaerobes and <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle> isolates causing nosocomial infections: emerging resistance to carbapenems. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">52:</emphasis>3161–3168.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0123" role="bibliographyEntry">
            <para>123.<emphasis role="strong">Rautio M, Saxén H, Siitonen A, Nikku R, Jousimies-Somer H.</emphasis> 2000. Bacteriology of histopathologically defined appendicitis in children. <citetitle><emphasis>Pediatr Infect Dis J</emphasis></citetitle> <emphasis role="strong">19:</emphasis>1078–1083.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0124" role="bibliographyEntry">
            <para>124.<emphasis role="strong">Sears CL.</emphasis> 2009. Enterotoxigenic <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle>: a rogue among symbiotes. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">22:</emphasis>349–369.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0125" role="bibliographyEntry">
            <para>125.<emphasis role="strong">Simmon KE, Mirrett S, Reller LB, Petti CA.</emphasis> 2008. Genotypic diversity of anaerobic isolates from bloodstream infections. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">46:</emphasis>1596–1601.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0126" role="bibliographyEntry">
            <para>126.<emphasis role="strong">Haghi F, Goli E, Mirzaei B, Zeighami H.</emphasis> 2019. The association between fecal enterotoxigenic <citetitle><emphasis>B. fragilis</emphasis></citetitle> with colorectal cancer. <citetitle><emphasis>BMC Cancer</emphasis></citetitle> <emphasis role="strong">19:</emphasis>879.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0127" role="bibliographyEntry">
            <para>127.<emphasis role="strong">Zamani S, Taslimi R, Sarabi A, Jasemi S, Sechi LA, Feizabadi MM.</emphasis> 2020. Enterotoxigenic <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle>: a possible etiological candidate for bacterially-induced colorectal precancerous and cancerous lesions. <citetitle><emphasis>Front Cell Infect Microb</emphasis></citetitle><citetitle><emphasis>iol</emphasis></citetitle> <emphasis role="strong">9:</emphasis>449.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0128" role="bibliographyEntry">
            <para>128.<emphasis role="strong">Butt J, Jenab M, Werner J, Fedirko V, Weiderpass E, Dahm CC, Tjønneland A, Olsen A, Boutron-Ruault MC, Rothwell JA, Severi G, Kaaks R, Turzanski-Fortner R, Aleksandrova K, Schulze M, Palli D, Pala V, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita B, Van Gils CH, Gram IT, Lukic M, Sala N, Sánchez Pérez MJ, Ardanaz E, Chirlaque MD, Palmquist R, Löwenmark T, Travis RC, Heath A, Cross AJ, Freisling H, Zouiouich S, Aglago E, Waterboer T, Hughes DJ.</emphasis> 2021. Association of pre-diagnostic antibody responses to <citetitle><emphasis>Escherichia coli</emphasis></citetitle> and <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle> toxin proteins with colorectal cancer in a European cohort. <citetitle><emphasis>Gut Microbes</emphasis></citetitle> <emphasis role="strong">13:</emphasis>1–14.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0129" role="bibliographyEntry">
            <para>129.<emphasis role="strong">Cheng Z, Huang Y, Wie W, Wang Y, Wang Z.</emphasis> 2019. Bloodstream infection caused by <citetitle><emphasis>Bacteroides caccae</emphasis></citetitle> in a diabetic patient: a case report and review of the literature. <citetitle><emphasis>Clin Lab</emphasis></citetitle> <emphasis role="strong">65:</emphasis>7755/ClinLab.2019.190534.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0130" role="bibliographyEntry">
            <para>130.<emphasis role="strong">Garcia M, Bouvet P, Petitpas F, Jayle C, Legeay C, Sautereau J, Michaud A, Burucoa C, Plouzeau C.</emphasis> 2016. First case report of a human sepsis involving a recently identified anaerobic agent: <citetitle><emphasis>Bacteroides faecis. Anaerobe</emphasis></citetitle> <emphasis role="strong">42:</emphasis>74–77.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0131" role="bibliographyEntry">
            <para>131.<emphasis role="strong">Tkadlec J, Krutova M, Matejkova J, Nyc O, Drevinek P.</emphasis> 2018. Bloodstream infection caused by <citetitle><emphasis>Bacteroides denticanum</emphasis></citetitle>, a close relative of <citetitle><emphasis>Bacteroides pyogenes</emphasis></citetitle>, misidentified by MALDI TOF- mass spectrometry. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">54:</emphasis>23–25.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0132" role="bibliographyEntry">
            <para>132.<emphasis role="strong">Brook I.</emphasis> 2008. Infective endocarditis caused by anaerobic bacteria. <citetitle><emphasis>Arch Cardiovasc Dis</emphasis></citetitle> <emphasis role="strong">101:</emphasis>665–676.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0133" role="bibliographyEntry">
            <para>133.<emphasis role="strong">Brook I.</emphasis> 2009. Pericarditis caused by anaerobic bacteria. <citetitle><emphasis>Int J Antimicrob Agents</emphasis></citetitle> <emphasis role="strong">33:</emphasis>297–300.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0134" role="bibliographyEntry">
            <para>134.<emphasis role="strong">Brook I.</emphasis> 2008. Microbiology and management of joint and bone infections due to anaerobic bacteria. <citetitle><emphasis>J Orthop Sci</emphasis></citetitle> <emphasis role="strong">13:</emphasis>160–169.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0135" role="bibliographyEntry">
            <para>135.<emphasis role="strong">Miksić NG, Kljaić Dujić M, Rejc Marko J, Vorši</emphasis>č <emphasis role="strong">M, But I.</emphasis> 2019. <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle> sacral spondylodiscitis and epidural abscess after sacrocolpopexy: a case report and literature review. <citetitle><emphasis>J Int Med Res</emphasis></citetitle> <emphasis role="strong">47:</emphasis>4568–4574.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0136" role="bibliographyEntry">
            <para>136.<emphasis role="strong">Weinberg SE, Tabet PP, McGregor CE, Arvidsson AM.</emphasis> 2020. Spontaneous <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle> spondylodiscitis in an elderly lady. <citetitle><emphasis>BMJ Case Rep</emphasis></citetitle> <emphasis role="strong">13:</emphasis>e233637.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0137" role="bibliographyEntry">
            <para>137.<emphasis role="strong">Chao CT, Lee SY, Yang WS, Chen HW, Fang CC, Yen CJ, Chiang CK, Hung KY, Huang JW.</emphasis> 2013. Peritoneal dialysis peritonitis by anaerobic pathogens: a retrospective case series. <citetitle><emphasis>BMC Nephrol</emphasis></citetitle> <emphasis role="strong">14:</emphasis>111.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0138" role="bibliographyEntry">
            <para>138.<emphasis role="strong">Le Moal G, Landron C, Grollier G, Bataille B, Roblot F, Nassans P, Becq-Giraudon B.</emphasis> 2003. Characteristics of brain abscess with isolation of anaerobic bacteria. <citetitle><emphasis>Scand J Infect Dis</emphasis></citetitle> <emphasis role="strong">35:</emphasis>318–321.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0139" role="bibliographyEntry">
            <para>139.<emphasis role="strong">Prasad KN, Mishra AM, Gupta D, Husain N, Husain M, Gupta RK.</emphasis> 2006. Analysis of microbial etiology and mortality in patients with brain abscess. <citetitle><emphasis>J Infect</emphasis></citetitle> <emphasis role="strong">53:</emphasis>221–227.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0140" role="bibliographyEntry">
            <para>140.<emphasis role="strong">Su TM, Lan CM, Tsai YD, Lee TC, Lu CH, Chang WN.</emphasis> 2008. Multiloculated pyogenic brain abscess: experience in 25 patients. <citetitle><emphasis>Neurosurgery</emphasis></citetitle> <emphasis role="strong">62</emphasis>(Suppl 2)<emphasis role="strong">:</emphasis>556–561.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0141" role="bibliographyEntry">
            <para>141.<emphasis role="strong">Mousa HA.</emphasis> 1997. Aerobic, anaerobic and fungal burn wound infections. <citetitle><emphasis>J Hosp Infect</emphasis></citetitle> <emphasis role="strong">37:</emphasis>317–323.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0142" role="bibliographyEntry">
            <para>142.<emphasis role="strong">Citron DM, Goldstein EJ, Merriam CV, Lipsky BA, Abramson MA.</emphasis> 2007. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">45:</emphasis>2819–2828.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0143" role="bibliographyEntry">
            <para>143.<emphasis role="strong">Ng LS, Kwang LL, Yeow SC, Tan TY.</emphasis> 2008. Anaerobic culture of diabetic foot infections: organisms and antimicrobial susceptibilities. <citetitle><emphasis>Ann Acad Med Singapore</emphasis></citetitle> <emphasis role="strong">37:</emphasis>936–939.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0144" role="bibliographyEntry">
            <para>144.<emphasis role="strong">Lau JSY, Korman TM, Yeung A, Streitberg R, Francis MJ, Graham M.</emphasis> 2016. <citetitle><emphasis>Bacteroides pyogenes</emphasis></citetitle> causing serious human wound infection from animal bites. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">42:</emphasis>172–175.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0145" role="bibliographyEntry">
            <anchor id="ch0074s0011s0003a0006"/>
            <para>145.<emphasis role="strong">Talan DA, Citron DM, Abrahamian FM, Moran GJ, Goldstein EJ, Emergency Medicine Animal Bite Infection Study Group.</emphasis> 1999. Bacteriologic analysis of infected dog and cat bites. <citetitle><emphasis>N Engl J Med</emphasis></citetitle> <emphasis role="strong">340:</emphasis>85–92.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0146" role="bibliographyEntry">
            <para>146.<emphasis role="strong">Park JE, Park SY, Song DJ, Huh HJ, Ki CS, Peck KR, Lee NY.</emphasis> 2016. A case of <citetitle><emphasis>Bacteroides pyogenes</emphasis></citetitle> bacteremia secondary to liver abscess. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">42:</emphasis>78–80.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0147" role="bibliographyEntry">
            <para>147.<emphasis role="strong">Tyrrell KL, Warren YA, Citron DM, Goldstein EJ.</emphasis> 2011. Re-assessment of phenotypic identifications of <citetitle><emphasis>Bacteroides putredinis</emphasis></citetitle> to <citetitle><emphasis>Alistipes</emphasis></citetitle> species using molecular methods. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">17:</emphasis>130–134.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0148" role="bibliographyEntry">
            <para>148.<emphasis role="strong">Fenner L, Roux V, Ananian P, Raoult D.</emphasis> 2007. <citetitle><emphasis>Alistipes finegoldii</emphasis></citetitle> in blood cultures from colon cancer patients. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">13:</emphasis>1260–1262.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0149" role="bibliographyEntry">
            <para>149.<emphasis role="strong">Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A.</emphasis> 2020. The genus <citetitle><emphasis>Alistipes</emphasis></citetitle>: gut bacteria with emerging implications to inflammation, cancer, and mental health. <citetitle><emphasis>Front Immunol</emphasis></citetitle> <emphasis role="strong">11:</emphasis>906.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0150" role="bibliographyEntry">
            <para>150.<emphasis role="strong">Holt SC, Ebersole JL.</emphasis> 2005. <citetitle><emphasis>Porphyromonas gingivalis, Treponema denticola</emphasis></citetitle>, and <citetitle><emphasis>Tannerella forsythia</emphasis></citetitle>: the “red complex”, a prototype polybacterial pathogenic consortium in periodontitis. <citetitle><emphasis>Periodontol 2000</emphasis></citetitle> 38<emphasis role="strong">:</emphasis>72–122.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0151" role="bibliographyEntry">
            <para>151.<emphasis role="strong">Könönen E, Paju S, Pussinen PJ, Hyvönen M, Di Tella P, Suominen-Taipale L, Knuuttila M.</emphasis> 2007. Population-based study of salivary carriage of periodontal pathogens in adults. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">45:</emphasis>2446–2451.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0152" role="bibliographyEntry">
            <para>152.<emphasis role="strong">Gomes BP, Jacinto RC, Pinheiro ET, Sousa EL, Zaia AA, Ferraz CC, Souza-Filho FJ.</emphasis> 2005. <citetitle><emphasis>Porphyromonas gingivalis, Porphyromonas endodontalis, Prevotella intermedia</emphasis></citetitle> and <citetitle><emphasis>Prevotella nigrescens</emphasis></citetitle> in endodontic lesions detected by culture and by PCR. <citetitle><emphasis>Oral Microbiol Immunol</emphasis></citetitle> <emphasis role="strong">20:</emphasis>211–215.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0153" role="bibliographyEntry">
            <para>153.<emphasis role="strong">Pye AD, Lockhart DE, Dawson MP, Murray CA, Smith AJ.</emphasis> 2009. A review of dental implants and infection. <citetitle><emphasis>J Hosp Infect</emphasis></citetitle> <emphasis role="strong">72:</emphasis>104–110.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0154" role="bibliographyEntry">
            <para>154.<emphasis role="strong">Mättö J, Asikainen S, Väisänen ML, Rautio M, Saarela M, Summanen P, Finegold S, Jousimies-Somer H.</emphasis> 1997. Role of <citetitle><emphasis>Porphyromonas gingivalis, Prevotella intermedia,</emphasis></citetitle> and <citetitle><emphasis>Prevotella nigrescens</emphasis></citetitle> in extraoral and some odontogenic infections. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">25</emphasis>(Suppl 2)<emphasis role="strong">:</emphasis>S194–S198.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0155" role="bibliographyEntry">
            <para>155.<emphasis role="strong">Persson R, Hitti J, Verhelst R, Vaneechoutte M, Persson R, Hirschi R, Weibel M, Rothen M, Temmerman M, Paul K, Eschenbach D.</emphasis> 2009. The vaginal microflora in relation to gingivitis. <citetitle><emphasis>BMC Infect Dis</emphasis></citetitle> <emphasis role="strong">9:</emphasis>6.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0156" role="bibliographyEntry">
            <para>156.<emphasis role="strong">León R, Silva N, Ovalle A, Chaparro A, Ahumada A, Gajardo M, Martinez M, Gamonal J.</emphasis> 2007. Detection of <citetitle><emphasis>Porphyromonas gingivalis</emphasis></citetitle> in the amniotic fluid in pregnant women with a diagnosis of threatened premature labor. <citetitle><emphasis>J Periodontol</emphasis></citetitle> <emphasis role="strong">78:</emphasis>1249–1255.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0157" role="bibliographyEntry">
            <para>157.<emphasis role="strong">Moen K, Brun JG, Valen M, Skartveit L, Eribe EK, Olsen I, Jonsson R.</emphasis> 2006. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. <citetitle><emphasis>Clin Exp Rheumatol</emphasis></citetitle> <emphasis role="strong">24:</emphasis>656–663.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0158" role="bibliographyEntry">
            <para>158.<emphasis role="strong">Iwai T, Inoue Y, Umeda M, Huang Y, Kurihara N, Koike M, Ishikawa I.</emphasis> 2005. Oral bacteria in the occluded arteries of patients with Buerger disease. <citetitle><emphasis>J Vasc Surg</emphasis></citetitle> <emphasis role="strong">42:</emphasis>107–115.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0159" role="bibliographyEntry">
            <para>159.<emphasis role="strong">Arjunan P, Swaminathan R, Yuan J, Al-Shabrawey M, Espinosa-Heidmann DG, Nussbaum J, Martin PM, Cutler CW.</emphasis> 2020. Invasion of human retinal pigment epithelial cells by <citetitle><emphasis>Porphyromonas gingivalis</emphasis></citetitle> leading to vacuolar/cytosolic localization and autophagy dysfunction in-vitro. <citetitle><emphasis>Sci Re</emphasis></citetitle><citetitle><emphasis>p</emphasis></citetitle> <emphasis role="strong">10:</emphasis>7468.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0160" role="bibliographyEntry">
            <para>160.<emphasis role="strong">Chopra A, Radhakrishnan R, Sharma M.</emphasis> 2020. <citetitle><emphasis>Porphyromonas gingivalis</emphasis></citetitle> and adverse pregnancy outcomes: a review on its intricate pathogenic mechanisms. <citetitle><emphasis>Crit Rev Microbiol</emphasis></citetitle> <emphasis role="strong">46:</emphasis>213–236.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0161" role="bibliographyEntry">
            <para>161.<emphasis role="strong">Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, Nguyen M, Haditsch U, Raha D, Griffin C, Holsinger LJ, Arastu-Kapur S, Kaba S, Lee A, Ryder MI, Potempa B, Mydel P, Hellvard A, Adamowicz K, Hasturk H, Walker GD, Reynolds EC, Faull RLM, Curtis MA, Dragunow M, Potempa J.</emphasis> 2019. <citetitle><emphasis>Porphyromonas gingivalis</emphasis></citetitle> in Alzheimer’s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. <citetitle><emphasis>Sci Adv</emphasis></citetitle> <emphasis role="strong">5</emphasis><emphasis role="strong">:</emphasis>eaau3333.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0162" role="bibliographyEntry">
            <para>162.<emphasis role="strong">Itzhaki RF, Golde TE, Heneka MT, Readhead B.</emphasis> 2020. Do infections have a role in the pathogenesis of Alzheimer disease? <citetitle><emphasis>Nat Rev Neurol</emphasis></citetitle> <emphasis role="strong">16:</emphasis>193–197.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0163" role="bibliographyEntry">
            <para>163.<emphasis role="strong">Schenkein HA, Papapanou PN, Genco R, Sanz M.</emphasis> 2020. Mechanisms underlying the association between periodontitis and atherosclerotic disease. <citetitle><emphasis>Periodontol 2000</emphasis></citetitle> 83<emphasis role="strong">:</emphasis>90–106.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0164" role="bibliographyEntry">
            <para>164.<emphasis role="strong">Yuan X, Liu Y, Kong J, Gu B, Qi Y, Wang X, Sun M, Chen P, Sun W, Wang H, Zhou F, Gao S.</emphasis> 2017. Different frequencies of <citetitle><emphasis>Porphyromonas gingivalis</emphasis></citetitle> infection in cancers of the upper digestive tract. <citetitle><emphasis>Cancer Lett</emphasis></citetitle> <emphasis role="strong">404:</emphasis>1–7.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0165" role="bibliographyEntry">
            <para>165.<emphasis role="strong">Rôças IN, Siqueira JF Jr.</emphasis> 2008. Root canal microbiota of teeth with chronic apical periodontitis. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">46:</emphasis>3599–3606.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0166" role="bibliographyEntry">
            <para>166.<emphasis role="strong">Kumar PS, Griffen AL, Barton JA, Paster BJ, Moeschberger ML, Leys EJ.</emphasis> 2003. New bacterial species associated with chronic periodontitis. <citetitle><emphasis>J Dent Res</emphasis></citetitle> <emphasis role="strong">82:</emphasis>338–344.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0167" role="bibliographyEntry">
            <para>167.<emphasis role="strong">Fredricks DN, Fiedler TL, Marrazzo JM.</emphasis> 2005. Molecular identification of bacteria associated with bacterial vaginosis. <citetitle><emphasis>N Engl J Med</emphasis></citetitle> <emphasis role="strong">353:</emphasis>1899–1911.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0168" role="bibliographyEntry">
            <para>168.<emphasis role="strong">Song Y, Liu C, Lee J, Bolanos M, Väisänen ML, Finegold SM.</emphasis> 2005. “<citetitle><emphasis>Bacteroides goldsteinii</emphasis></citetitle> sp. nov.” isolated from clinical specimens of human intestinal origin. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>4522–4527.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0169" role="bibliographyEntry">
            <para>169.<emphasis role="strong">Gunalan A, Biswas R, Sridharan B, Elamurugan TP.</emphasis> 2020. Pathogenic potential of <citetitle><emphasis>Parabacteroides distasonis</emphasis></citetitle> revealed in a splenic abscess case: a truth unfolded. <citetitle><emphasis>BMJ Case Rep</emphasis></citetitle> <emphasis role="strong">13:</emphasis>e236701.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0170" role="bibliographyEntry">
            <para>170.<emphasis role="strong">Sakamoto M, Suzuki N, Matsunaga N, Koshihara K, Seki M, Komiya H, Benno Y.</emphasis> 2009. <citetitle><emphasis>Parabacteroides gordonii</emphasis></citetitle> sp. nov., isolated from human blood cultures. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">59:</emphasis>2843–2847.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0171" role="bibliographyEntry">
            <para>171.<emphasis role="strong">Awadel-Kariem FM, Patel P, Kapoor J, Brazier JS, Goldstein EJ.</emphasis> 2010. First report of <citetitle><emphasis>Parabacteroides goldsteinii</emphasis></citetitle> bacteraemia in a patient with complicated intra-abdominal infection. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">16:</emphasis>223–225.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0172" role="bibliographyEntry">
            <para>172.<emphasis role="strong">Iwata K, Takahashi M.</emphasis> 2008. Is anaerobic blood culture necessary? If so, who needs it? <citetitle><emphasis>Am J Med Sci</emphasis></citetitle> <emphasis role="strong">336:</emphasis>58–63.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0173" role="bibliographyEntry">
            <para>173.<emphasis role="strong">Cobo F, Perez-Carrasco V, Gomez-Vicente E, Martin-Hita L, Garcia-Salcedo JA, Navarro-Mari JM.</emphasis> 2021. <citetitle><emphasis>Parabacteroides goldsteinii</emphasis></citetitle> abdominal infection in a patient with lymphoma. <citetitle><emphasis>Infect Dis Now</emphasis></citetitle> May 18:S2666-9919(21)00108–1.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0174" role="bibliographyEntry">
            <para>174.<emphasis role="strong">Tanner AC, Izard J.</emphasis> 2006. <citetitle><emphasis>Tannerella forsythia</emphasis></citetitle>, a periodontal pathogen entering the genomic era. <citetitle><emphasis>Periodontol 2000</emphasis></citetitle> 42<emphasis role="strong">:</emphasis>88–113.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0175" role="bibliographyEntry">
            <para>175.<emphasis role="strong">Bertl K, Zatorska B, Leonhard M, Matejka M, Schneider-Stickler B.</emphasis> 2012. Anaerobic and microaerophilic pathogens in the biofilm formation on voice prostheses: a pilot study. <citetitle><emphasis>Laryngoscope</emphasis></citetitle> <emphasis role="strong">122:</emphasis>1035–1039.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0176" role="bibliographyEntry">
            <para>176.<emphasis role="strong">Talan DA, Abrahamian FM, Moran GJ, Citron DM, Tan JO, Goldstein EJ, Emergency Medicine Human Bite Infection Study Group.</emphasis> 2003. Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">37:</emphasis>1481–1489.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0177" role="bibliographyEntry">
            <para>177.<emphasis role="strong">Chhour KL, Nadkarni MA, Byun R, Martin FE, Jacques NA, Hunter N.</emphasis> 2005. Molecular analysis of microbial diversity in advanced caries. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>843–849.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0178" role="bibliographyEntry">
            <para>178.<emphasis role="strong">Gürsoy M, Haraldsson G, Hyvönen M, Sorsa T, Pajukanta R, Könönen E.</emphasis> 2009. Does the frequency of <citetitle><emphasis>Prevotella intermedia</emphasis></citetitle> increase during pregnancy? <citetitle><emphasis>Oral Microbiol Immunol</emphasis></citetitle> <emphasis role="strong">24:</emphasis>299–303.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0179" role="bibliographyEntry">
            <para>179.<emphasis role="strong">Derouane F, Lambert M, De Greef J, Malghem J, Lecouvet FE.</emphasis> 2019. Primary infectious costochondritis due to <citetitle><emphasis>Prevotella nigrescens</emphasis></citetitle> in an immunocompetent patient: clinical and imaging findings. <citetitle><emphasis>Skeletal Radiol</emphasis></citetitle> <emphasis role="strong">48:</emphasis>1305–1309.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0180" role="bibliographyEntry">
            <para>180.<emphasis role="strong">Enwonwu CO, Falkler WA Jr, Idigbe EO.</emphasis> 2000. Oro-facial gangrene (noma/cancrum oris): pathogenetic mechanisms. <citetitle><emphasis>Crit Rev Oral Biol Med</emphasis></citetitle> <emphasis role="strong">11:</emphasis>159–171.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0181" role="bibliographyEntry">
            <para>181.<emphasis role="strong">Bolivar I, Whiteson K, Stadelmann B, Baratti-Mayer D, Gizard Y, Mombelli A, Pittet D, Schrenzel J, Geneva Study Group on Noma (GESNOMA).</emphasis> 2012. Bacterial diversity in oral samples of children in Niger with acute noma, acute necrotizing gingivitis, and healthy controls. <citetitle><emphasis>PLoS Negl Trop Di</emphasis></citetitle><citetitle><emphasis>s</emphasis></citetitle> <emphasis role="strong">6:</emphasis>e1556.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0182" role="bibliographyEntry">
            <para>182.<emphasis role="strong">Riggio MP, Aga H, Murray CA, Jackson MS, Lennon A, Hammersley N, Bagg J.</emphasis> 2007. Identification of bacteria associated with spreading odontogenic infections by 16S rRNA gene sequencing. <citetitle><emphasis>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</emphasis></citetitle> <emphasis role="strong">103:</emphasis>610–617.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0183" role="bibliographyEntry">
            <anchor id="ch0074s0011s0003a0007"/>
            <para>183.<emphasis role="strong">Duployez C, Loiez C, Hund R, Jegou B, Decoene C, Wallet F.</emphasis> 2020. A case of bacteriemic mediastinitis due to <citetitle><emphasis>Prevotella buccae</emphasis></citetitle> after cardiac surgery. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">61:</emphasis>102097.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0184" role="bibliographyEntry">
            <para>184.<emphasis role="strong">Cobo F, Rodríguez-Granger J, Sampedro A, Navarro-Marí JM.</emphasis> 2017. Infected breast cyst due to <citetitle><emphasis>Prevotella buccae</emphasis></citetitle> resistant to metronidazole. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">48:</emphasis>177–178.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0185" role="bibliographyEntry">
            <para>185.<emphasis role="strong">Asif AA, Roy M, Ahmad S.</emphasis> 2020. Rare case of <citetitle><emphasis>Prevotella pleuritidis</emphasis></citetitle> lung abscess. <citetitle><emphasis>BMJ Case Rep</emphasis></citetitle> <emphasis role="strong">13:</emphasis>e235960.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0186" role="bibliographyEntry">
            <para>186.<emphasis role="strong">Bittar F, Richet H, Dubus JC, Reynaud-Gaubert M, Stremler N, Sarles J, Raoult D, Rolain JM.</emphasis> 2008. Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">3:</emphasis>e2908.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0187" role="bibliographyEntry">
            <para>187.<emphasis role="strong">Bahrani-Mougeot FK, Paster BJ, Coleman S, Barbuto S, Brennan MT, Noll J, Kennedy T, Fox PC, Lockhart PB.</emphasis> 2007. Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">45:</emphasis>1588–1593.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0188" role="bibliographyEntry">
            <para>188.<emphasis role="strong">Domann E, Hong G, Imirzalioglu C, Turschner S, Kühle J, Watzel C, Hain T, Hossain H, Chakraborty T.</emphasis> 2003. Culture-independent identification of pathogenic bacteria and polymicrobial infections in the genitourinary tract of renal transplant recipients. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">41:</emphasis>5500–5510.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0189" role="bibliographyEntry">
            <para>189.<emphasis role="strong">Aberkane S, Pradel B, Dumont Y, Veloo ACM, Laurens C, Bonzon L, Godreuil S, Marchandin H, Jean-Pierre H.</emphasis> 2018. Clinical sources and antimicrobial susceptibility of <citetitle><emphasis>Prevotella timonensis</emphasis></citetitle> at the university hospital of Montpellier, France. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">50:</emphasis>19–21.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0190" role="bibliographyEntry">
            <para>190.<emphasis role="strong">Buhl M, Willmann M, Liese J, Autenrieth IB, Marschal M.</emphasis> 2016. <citetitle><emphasis>Prevotella colorans</emphasis></citetitle> sp. nov., isolated from a human wound. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">66:</emphasis>3005–3009.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0191" role="bibliographyEntry">
            <para>191.<emphasis role="strong">Lin CY, Lin CY, Yeh YM, Yang LY, Lee YS, Chao A, Chin CY, Chao AS, Yang CY.</emphasis> 2020. Severe preeclampsia is associated with a higher relative abundance of <citetitle><emphasis>Prevotella bivia</emphasis></citetitle> in the vaginal microbiota. <citetitle><emphasis>Sci Rep</emphasis></citetitle> <emphasis role="strong">10:</emphasis>18249.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0192" role="bibliographyEntry">
            <para>192.<emphasis role="strong">Posteraro P, De Maio F, Menchinelli G, Palucci I, Errico FM, Carbone M, Sanguinetti M, Gasbarrini A, Posteraro B.</emphasis> 2019. First bloodstream infection caused by <citetitle><emphasis>Prevotella copri</emphasis></citetitle> in a heart failure elderly patient with <citetitle><emphasis>Prevotella</emphasis></citetitle>-dominated gut microbiota: a case report. <citetitle><emphasis>Gut Pathog</emphasis></citetitle> <emphasis role="strong">11:</emphasis>44.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0193" role="bibliographyEntry">
            <para>193.<emphasis role="strong">Song YG, Shim SG, Kim KM, Lee DH, Kim DS, Choi SH, Song JY, Kang HL, Baik SC, Lee WK, Cho MJ, Rhee KH.</emphasis> 2014. Profiling of the bacteria responsible for pyogenic liver abscess by 16S rRNA gene pyrosequencing. <citetitle><emphasis>J Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>504–509.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0194" role="bibliographyEntry">
            <para>194.<emphasis role="strong">Kommedal Ø, Wilhelmsen MT, Skrede S, Meisal R, Jakovljev A, Gaustad P, Hermansen NO, Vik-Mo E, Solheim O, Ambur OH, Sæbø Ø, Høstmælingen CT, Helland C.</emphasis> 2014. Massive parallel sequencing provides new perspectives on bacterial brain abscesses. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>1990–1997.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0195" role="bibliographyEntry">
            <para>195.<emphasis role="strong">Roux V, Robert C, Raoult D.</emphasis> 2013. Non-contiguous finished genome sequence of <citetitle><emphasis>Phocaeicola abscessus</emphasis></citetitle> type strain 7401987(T.). <citetitle><emphasis>Stand Genomic Sci</emphasis></citetitle> <emphasis role="strong">9:</emphasis>351–358.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0196" role="bibliographyEntry">
            <para>196.<emphasis role="strong">Nóbrega LM, Montagner F, Ribeiro AC, Mayer MA, Gomes BP.</emphasis> 2016. Bacterial diversity of symptomatic primary endodontic infection by clonal analysis. <citetitle><emphasis>Braz Oral Res</emphasis></citetitle> <emphasis role="strong">30:</emphasis>e103.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0197" role="bibliographyEntry">
            <para>197.<emphasis role="strong">Brazier JS.</emphasis> 2006. Human infections with <citetitle><emphasis>Fusobacterium necrophorum. Anaerobe</emphasis></citetitle> <emphasis role="strong">12:</emphasis>165–172.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0198" role="bibliographyEntry">
            <para>198.<emphasis role="strong">Citron DM.</emphasis> 2002. Update on the taxonomy and clinical aspects of the genus <citetitle><emphasis>Fusobacterium. Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">35</emphasis>(Suppl 1)<emphasis role="strong">:</emphasis>S22–S27.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0199" role="bibliographyEntry">
            <para>199.<emphasis role="strong">Riordan T.</emphasis> 2007. Human infection with <citetitle><emphasis>Fusobacterium necrophorum</emphasis></citetitle> (Necrobacillosis), with a focus on Lemierre’s syndrome. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">20:</emphasis>622–659.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0200" role="bibliographyEntry">
            <para>200.<emphasis role="strong">Afra K, Laupland K, Leal J, Lloyd T, Gregson D.</emphasis> 2013. Incidence, risk factors, and outcomes of <citetitle><emphasis>Fusobacterium</emphasis></citetitle> species bacteremia. <citetitle><emphasis>BMC Infect Dis</emphasis></citetitle> <emphasis role="strong">13:</emphasis>264.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0201" role="bibliographyEntry">
            <para>201.<emphasis role="strong">Kuppalli K, Livorsi D, Talati NJ, Osborn M.</emphasis> 2012. Lemierre’s syndrome due to <citetitle><emphasis>Fusobacterium necrophorum. Lancet Infect Dis</emphasis></citetitle> <emphasis role="strong">12:</emphasis>808–815.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0202" role="bibliographyEntry">
            <para>202.<emphasis role="strong">Karkos PD, Asrani S, Karkos CD, Leong SC, Theochari EG, Alexopoulou TD, Assimakopoulos AD.</emphasis> 2009. Lemierre’s syndrome: a systematic review. <citetitle><emphasis>Laryngoscope</emphasis></citetitle> <emphasis role="strong">119:</emphasis>1552–1559.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0203" role="bibliographyEntry">
            <para>203.<emphasis role="strong">Nohrström E, Mattila T, Pettilä V, Kuusela P, Carlson P, Kentala E, Mattila PS.</emphasis> 2011. Clinical spectrum of bacteraemic <citetitle><emphasis>Fusobacterium</emphasis></citetitle> infections: from septic shock to nosocomial bacteraemia. <citetitle><emphasis>Scand J Infect Dis</emphasis></citetitle> <emphasis role="strong">43:</emphasis>463–470.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0204" role="bibliographyEntry">
            <para>204.<emphasis role="strong">Yang CC, Ye JJ, Hsu PC, Chang HJ, Cheng CW, Leu HS, Chiang PC, Lee MH.</emphasis> 2011. Characteristics and outcomes of <citetitle><emphasis>Fusobacterium nucleatum</emphasis></citetitle> bacteremia—a 6-year experience at a tertiary care hospital in northern Taiwan. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">70:</emphasis>167–174.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0205" role="bibliographyEntry">
            <para>205.<emphasis role="strong">Allen-Vercoe E, Strauss J, Chadee K.</emphasis> 2011. <citetitle><emphasis>Fusobacterium nucleatum</emphasis></citetitle>: an emerging gut pathogen? <citetitle><emphasis>Gut Microbes</emphasis></citetitle> <emphasis role="strong">2:</emphasis>294–298.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0206" role="bibliographyEntry">
            <para>206.<emphasis role="strong">Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA.</emphasis> 2012. <citetitle><emphasis>Fusobacterium nucleatum</emphasis></citetitle> infection is prevalent in human colorectal carcinoma. <citetitle><emphasis>Genome Res</emphasis></citetitle> <emphasis role="strong">22:</emphasis>299–306.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0207" role="bibliographyEntry">
            <para>207.<emphasis role="strong">Swidsinski A, Dörffel Y, Loening-Baucke V, Theissig F, Rückert JC, Ismail M, Rau WA, Gaschler D, Weizenegger M, Kühn S, Schilling J, Dörffel WV.</emphasis> 2011. Acute appendicitis is characterised by local invasion with <citetitle><emphasis>Fusobacterium nucleatum/necrophorum. Gut</emphasis></citetitle> <emphasis role="strong">60:</emphasis>34–40.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0208" role="bibliographyEntry">
            <para>208.<emphasis role="strong">Bailhache M, Mariani-Kurkdjian P, Lehours P, Sarlangue J, Pillet P, Bingen E, Faye A.</emphasis> 2013. <citetitle><emphasis>Fusobacterium</emphasis></citetitle> invasive infections in children: a retrospective study in two French tertiary care centres. <citetitle><emphasis>Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">32:</emphasis>1041–1047.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0209" role="bibliographyEntry">
            <para>209.<emphasis role="strong">Megged O, Assous MV, Miskin H, Peleg U, Schlesinger Y.</emphasis> 2013. Neurologic manifestations of <citetitle><emphasis>Fusobacterium</emphasis></citetitle> infections in children. <citetitle><emphasis>Eur J Pediatr</emphasis></citetitle> <emphasis role="strong">172:</emphasis>77–83.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0210" role="bibliographyEntry">
            <para>210.<emphasis role="strong">Al Masalma M, Lonjon M, Richet H, Dufour H, Roche PH, Drancourt M, Raoult D, Fournier PE.</emphasis> 2012. Metagenomic analysis of brain abscesses identifies specific bacterial associations. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">54:</emphasis>202–210.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0211" role="bibliographyEntry">
            <para>211.<emphasis role="strong">DiGiulio DB, Romero R, Amogan HP, Kusanovic JP, Bik EM, Gotsch F, Kim CJ, Erez O, Edwin S, Relman DA.</emphasis> 2008. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">3:</emphasis>e3056.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0212" role="bibliographyEntry">
            <para>212.<emphasis role="strong">Han YW, Shen T, Chung P, Buhimschi IA, Buhimschi CS.</emphasis> 2009. Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">47:</emphasis>38–47.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0213" role="bibliographyEntry">
            <para>213.<emphasis role="strong">Huggan PJ, Murdoch DR.</emphasis> 2008. Fusobacterial infections: clinical spectrum and incidence of invasive disease. <citetitle><emphasis>J Infect</emphasis></citetitle> <emphasis role="strong">57:</emphasis>283–289.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0214" role="bibliographyEntry">
            <para>214.<emphasis role="strong">Wang X, Buhimschi CS, Temoin S, Bhandari V, Han YW, Buhimschi IA.</emphasis> 2013. Comparative microbial analysis of paired amniotic fluid and cord blood from pregnancies complicated by preterm birth and early-onset neonatal sepsis. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">8:</emphasis>e56131.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0215" role="bibliographyEntry">
            <para>215.<emphasis role="strong">Corona PS, Lung M, Rodriguez-Pardo D, Pigrau C, Soldado F, Amat C, Carrera L.</emphasis> 2018. Acute periprosthetic joint infection due to <citetitle><emphasis>Fusobacterium nucleatum</emphasis></citetitle> in a non-immunocompromised patient. Failure using a debridement, antibiotics + implant retention approach. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">49:</emphasis>116–120.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0216" role="bibliographyEntry">
            <para>216.<emphasis role="strong">Rodríguez Duque JC, Galindo Rubín P, González Humara B, Quesada Sanz AA, Busta Vallina MB, Fernández-Sampedro M.</emphasis> 2018. <citetitle><emphasis>Fusobacterium nucleatum</emphasis></citetitle> prosthetic hip infection: case report and review of the literature of unusual anaerobic prosthetic joint infection. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">54:</emphasis>75–82.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0217" role="bibliographyEntry">
            <para>217.<emphasis role="strong">Vander Haar EL, So J, Gyamfi-Bannerman C, Han YW.</emphasis> 2018. <citetitle><emphasis>Fusobacterium nucleatum</emphasis></citetitle> and adverse pregnancy outcomes: epidemiological and mechanistic evidence. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">50:</emphasis>55–59.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0218" role="bibliographyEntry">
            <para>218.<emphasis role="strong">Han YW, Ikegami A, Rajanna C, Kawsar HI, Zhou Y, Li M, Sojar HT, Genco RJ, Kuramitsu HK, Deng CX.</emphasis> 2005. Identification and characterization of a novel adhesin unique to oral fusobacteria. <citetitle><emphasis>J Bacteriol</emphasis></citetitle> <emphasis role="strong">187:</emphasis>5330–5340.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0219" role="bibliographyEntry">
            <para>219.<emphasis role="strong">Fujiwara N, Kitamura N, Yoshida K, Yamamoto T, Ozaki K, Kudo Y.</emphasis> 2020. Involvement of <citetitle><emphasis>Fusobacterium</emphasis></citetitle> species in oral cancer progression: a literature review including other types of cancer. <citetitle><emphasis>Int J Mol Sci</emphasis></citetitle> <emphasis role="strong">21:</emphasis>6207.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0220" role="bibliographyEntry">
            <anchor id="ch0074s0011s0003a0008"/>
            <para>220.<emphasis role="strong">Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, Fainsod-Levi T, Yajuk O, Isaacson B, Abed J, Maalouf N, Nissan A, Sandbank J, Yehuda-Shnaidman E, Ponath F, Vogel J, Mandelboim O, Granot Z, Straussman R, Bachrach G.</emphasis> 2020. Breast cancer colonization by <citetitle><emphasis>Fusobacterium nucleatum</emphasis></citetitle> accelerates tumor growth and metastatic progression. <citetitle><emphasis>Nat Commun</emphasis></citetitle> <emphasis role="strong">11:</emphasis>3259.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0221" role="bibliographyEntry">
            <para>221.<emphasis role="strong">Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, Neuberg D, Huang K, Guevara F, Nelson T, Chipashvili O, Hagan T, Walker M, Ramachandran A, Diosdado B, Serna G, Mulet N, Landolfi S, Ramon Y Cajal S, Fasani R, Aguirre AJ, Ng K, Élez E, Ogino S, Tabernero J, Fuchs CS, Hahn WC, Nuciforo P, Meyerson M.</emphasis> 2017. Analysis of <citetitle><emphasis>Fusobacterium</emphasis></citetitle> persistence and antibiotic response in colorectal cancer. <citetitle><emphasis>Science</emphasis></citetitle> <emphasis role="strong">358:</emphasis>1443–1448.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0222" role="bibliographyEntry">
            <para>222.<emphasis role="strong">Ramos A, Hemann MT.</emphasis> 2017. Drugs, bugs, and cancer: <citetitle><emphasis>Fusobacterium nucleatum</emphasis></citetitle> promotes chemoresistance in colorectal cancer. <citetitle><emphasis>Cell</emphasis></citetitle> <emphasis role="strong">170:</emphasis>411–413.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0223" role="bibliographyEntry">
            <para>223.<emphasis role="strong">Rubinstein MR, Baik JE, Lagana SM, Han RP, Raab WJ, Sahoo D, Dalerba P, Wang TC, Han YW.</emphasis> 2019. <citetitle><emphasis>Fusobacterium nucleatum</emphasis></citetitle> promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1. <citetitle><emphasis>EMBO Rep</emphasis></citetitle> <emphasis role="strong">20:</emphasis>e47638.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0224" role="bibliographyEntry">
            <para>224.<emphasis role="strong">Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, Qian Y, Kryczek I, Sun D, Nagarsheth N, Chen Y, Chen H, Hong J, Zou W, Fang JY.</emphasis> 2017. <citetitle><emphasis>Fusobacterium nucleatum</emphasis></citetitle> promotes chemoresistance to colorectal cancer by modulating autophagy. <citetitle><emphasis>Cell</emphasis></citetitle> <emphasis role="strong">170:</emphasis>548–563.e16.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0225" role="bibliographyEntry">
            <para>225.<emphasis role="strong">Holm K, Rasmussen M.</emphasis> 2013. Binding and activation of plasminogen at the surface of <citetitle><emphasis>Fusobacterium necrophorum. Microb Pathog</emphasis></citetitle> <emphasis role="strong">59</emphasis><emphasis role="strong">-60:</emphasis>29–32.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0226" role="bibliographyEntry">
            <para>226.<emphasis role="strong">Hagelskjaer Kristensen L, Prag J.</emphasis> 2008. Lemierre’s syndrome and other disseminated <citetitle><emphasis>Fusobacterium necrophorum</emphasis></citetitle> infections in Denmark: a prospective epidemiological and clinical survey. <citetitle><emphasis>Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">27:</emphasis>779–789.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0227" role="bibliographyEntry">
            <para>227.<emphasis role="strong">Patel PN, Levi JR, Cohen MB.</emphasis> 2020. Lemierre’s syndrome in the pediatric population: trends in disease presentation and management in literature. <citetitle><emphasis>Int J Pediatr Otorhinolaryngol</emphasis></citetitle> <emphasis role="strong">136:</emphasis>110213.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0228" role="bibliographyEntry">
            <para>228.<emphasis role="strong">Amess JA, O’Neill W, Giollariabhaigh CN, Dytrych JK.</emphasis> 2007. A six-month audit of the isolation of <citetitle><emphasis>Fusobacterium necrophorum</emphasis></citetitle> from patients with sore throat in a district general hospital. <citetitle><emphasis>Br J Biomed Sci</emphasis></citetitle> <emphasis role="strong">64:</emphasis>63–65.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0229" role="bibliographyEntry">
            <para>229.<emphasis role="strong">Ehlers Klug T, Rusan M, Fuursted K, Ovesen T.</emphasis> 2009. <citetitle><emphasis>Fusobacterium necrophorum</emphasis></citetitle>: most prevalent pathogen in peritonsillar abscess in Denmark. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">49:</emphasis>1467–1472.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0230" role="bibliographyEntry">
            <para>230.<emphasis role="strong">Bank S, Christensen K, Kristensen LH, Prag J.</emphasis> 2013. A cost-effectiveness analysis of identifying <citetitle><emphasis>Fusobacterium necrophorum</emphasis></citetitle> in throat swabs followed by antibiotic treatment to reduce the incidence of Lemierre’s syndrome and peritonsillar abscesses. <citetitle><emphasis>Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">32:</emphasis>71–78.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0231" role="bibliographyEntry">
            <para>231.<emphasis role="strong">Samant JS, Peacock JE Jr.</emphasis> 2011. <citetitle><emphasis>Fusobacterium necrophorum</emphasis></citetitle> endocarditis case report and review of the literature. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">69:</emphasis>192–195.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0232" role="bibliographyEntry">
            <para>232.<emphasis role="strong">García Carretero R, Lopez-Lomba M, Vazquez-Gomez O, Rodriguez-Maya B.</emphasis> 2017. Bacteraemia and liver abscess due to <citetitle><emphasis>Fusobacterium necrophorum. BMJ Case Rep</emphasis></citetitle> <emphasis role="strong">2017:</emphasis>bcr-2017-220654.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0233" role="bibliographyEntry">
            <para>233.<emphasis role="strong">Meade CM, Cantos VD, Nasri H, Serbanescu M, Anderson EJ.</emphasis> 2017. Epidural abscess in Lemierre’s syndrome. <citetitle><emphasis>Am J Med Sci</emphasis></citetitle> <emphasis role="strong">354:</emphasis>325–326.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0234" role="bibliographyEntry">
            <para>234.<emphasis role="strong">Ishihara T, Yanagi H, Oki M, Ozawa H.</emphasis> 2021. <citetitle><emphasis>Fusobacterium necrophorum</emphasis></citetitle> pelvic peritonitis and bacteremia mimicking intestinal necrosis. <citetitle><emphasis>IDCases</emphasis></citetitle> <emphasis role="strong">24:</emphasis>e01134.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0235" role="bibliographyEntry">
            <para>235.<emphasis role="strong">Legaria MC, Lumelsky G, Rodriguez V, Rosetti S.</emphasis> 2005. Clindamycin-resistant <citetitle><emphasis>Fusobacterium varium</emphasis></citetitle> bacteremia and decubitus ulcer infection. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>4293–4295.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0236" role="bibliographyEntry">
            <para>236.<emphasis role="strong">K R, Biswas R, Bhat P, Sistla S, Kumari S, Kate V.</emphasis> 2019. Rare isolation of <citetitle><emphasis>Fusobacterium varium</emphasis></citetitle> from a case of Fournier’s gangrene. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">57:</emphasis>82–85.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0237" role="bibliographyEntry">
            <para>237.<emphasis role="strong">Vidaurrazaga MM, McKinley GF, Camins BC.</emphasis> 2020. Postpartum <citetitle><emphasis>Fusobacterium gonidiaformans</emphasis></citetitle> bacteremia. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">62:</emphasis>102168.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0238" role="bibliographyEntry">
            <para>238.<emphasis role="strong">Conrads G, Citron DM, Mutters R, Jang S, Goldstein EJ.</emphasis> 2004. <citetitle><emphasis>Fusobacterium canifelinum</emphasis></citetitle> sp. nov., from the oral cavity of cats and dogs. <citetitle><emphasis>Syst Appl Microbiol</emphasis></citetitle> <emphasis role="strong">27:</emphasis>407–413.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0239" role="bibliographyEntry">
            <para>239.<emphasis role="strong">Ullrich E, Grisold AJ, Feierl G, Lumenta DB, Leitner E.</emphasis> 2016. Severe forefoot infection complicated by <citetitle><emphasis>Fusobacterium russii. Anaerobe</emphasis></citetitle> <emphasis role="strong">42:</emphasis>162–165.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0240" role="bibliographyEntry">
            <para>240.<emphasis role="strong">Moon JH, Lee JH, Lee JY.</emphasis> 2015. Subgingival microbiome in smokers and non-smokers in Korean chronic periodontitis patients. <citetitle><emphasis>Mol Oral Microbiol</emphasis></citetitle> <emphasis role="strong">30:</emphasis>227–241.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0241" role="bibliographyEntry">
            <para>241.<emphasis role="strong">Eribe ER, Olsen I.</emphasis> 2008. <citetitle><emphasis>Leptotrichia</emphasis></citetitle> species in human infections. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">14:</emphasis>131–137.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0242" role="bibliographyEntry">
            <para>242.<emphasis role="strong">Caram LB, Linefsky JP, Read KM, Murdoch DR, Lalani T, Woods CW, Reller LB, Kanj SS, Premru MM, Ryan S, Al-Hegelan M, Donnio PY, Orezzi C, Paiva MG, Tribouilloy C, Watkin R, Harris O, Eisen DP, Corey GR, Cabell CH, Petti CA, International Collaboration on Endocarditis Investigator Group.</emphasis> 2008. <citetitle><emphasis>Leptotrichia</emphasis></citetitle> endocarditis: report of two cases from the International Collaboration on Endocarditis (ICE) database and review of previous cases. <citetitle><emphasis>Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">27:</emphasis>139–143.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0243" role="bibliographyEntry">
            <para>243.<emphasis role="strong">Couturier MR, Slechta ES, Goulston C, Fisher MA, Hanson KE.</emphasis> 2012. <citetitle><emphasis>Leptotrichia</emphasis></citetitle> bacteremia in patients receiving high-dose chemotherapy. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">50:</emphasis>1228–1232.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0244" role="bibliographyEntry">
            <para>244.<emphasis role="strong">Higurashi Y, Tatsuno K, Fujimoto F, Kobayashi I, Ida K, Seto Y, Ohkusu K, Ezaki T, Okugawa S, Moriya K.</emphasis> 2013. Two cases of bacteremia caused by <citetitle><emphasis>Leptotrichia trevisanii</emphasis></citetitle> in patients with febrile neutropenia. <citetitle><emphasis>J Infect Chemother</emphasis></citetitle> <emphasis role="strong">19:</emphasis>1181–1184.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0245" role="bibliographyEntry">
            <para>245.<emphasis role="strong">Cho EH, Park KS, Yang M, Song DJ, Huh HJ, Ki CS, Lee NY.</emphasis> 2017. Laboratory identification of <citetitle><emphasis>Leptotrichia</emphasis></citetitle> species isolated from bacteremia patients at a single institution. <citetitle><emphasis>Ann Lab Med</emphasis></citetitle> <emphasis role="strong">37:</emphasis>272–276.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0246" role="bibliographyEntry">
            <para>246.<emphasis role="strong">Eribe ERK, Olsen I.</emphasis> 2017. <citetitle><emphasis>Leptotrichia</emphasis></citetitle> species in human infections II. <citetitle><emphasis>J Oral Microbiol</emphasis></citetitle> <emphasis role="strong">9:</emphasis>1368848.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0247" role="bibliographyEntry">
            <para>247.<emphasis role="strong">Kawanami T, Fukuda K, Yatera K, Kido T, Yoshii C, Taniguchi H, Kido M.</emphasis> 2009. Severe pneumonia with <citetitle><emphasis>Leptotrichia</emphasis></citetitle> sp. detected predominantly in bronchoalveolar lavage fluid by use of 16S rRNA gene sequencing analysis. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">47:</emphasis>496–498.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0248" role="bibliographyEntry">
            <para>248.<emphasis role="strong">Mora-Palma JC, Rodríguez-Oliver AJ, Navarro-Marí JM, Gutiérrez-Fernández J.</emphasis> 2019. Emergent genital infection by <citetitle><emphasis>Leptotrichia trevisanii. Infection</emphasis></citetitle> <emphasis role="strong">47:</emphasis>111–114.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0249" role="bibliographyEntry">
            <para>249.<emphasis role="strong">Boennelycke M, Christensen JJ, Arpi M, Krause S.</emphasis> 2007. <citetitle><emphasis>Leptotrichia amnionii</emphasis></citetitle> found in septic abortion in Denmark. <citetitle><emphasis>Scand J Infect Dis</emphasis></citetitle> <emphasis role="strong">39:</emphasis>382–383.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0250" role="bibliographyEntry">
            <para>250.<emphasis role="strong">De Martino SJ, Mahoudeau I, Brettes JP, Piemont Y, Monteil H, Jaulhac B.</emphasis> 2004. Peripartum bacteremias due to <citetitle><emphasis>Leptotrichia amnionii</emphasis></citetitle> and <citetitle><emphasis>Sneathia sanguinegens</emphasis></citetitle>, rare causes of fever during and after delivery. <citetitle><emphasis>J Clin Mic</emphasis></citetitle><citetitle><emphasis>robiol</emphasis></citetitle> <emphasis role="strong">42:</emphasis>5940–5943.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0251" role="bibliographyEntry">
            <para>251.<emphasis role="strong">Decroix V, Goudjil S, Kongolo G, Mammeri H.</emphasis> 2013. ‘<citetitle><emphasis>Leptotrichia amnionii</emphasis></citetitle>’, a newly reported cause of early onset neonatal meningitis. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> <emphasis role="strong">62:</emphasis>785–788.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0252" role="bibliographyEntry">
            <para>252.<emphasis role="strong">Goto M, Hitomi S, Ishii T.</emphasis> 2007. Bacterial arthritis caused by <citetitle><emphasis>Leptotrichia amnionii. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">45:</emphasis>2082–2083.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0253" role="bibliographyEntry">
            <para>253.<emphasis role="strong">Bachy B, Bémer P, Tortellier L, Giraudeau C, Reynaud A, Corvec S.</emphasis> 2011. Septic arthritis due to a <citetitle><emphasis>Sneathia</emphasis></citetitle> species most closely related to <citetitle><emphasis>Sneathia sanguinegens. J Med Microbiol</emphasis></citetitle> <emphasis role="strong">60:</emphasis>1693–1696.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0254" role="bibliographyEntry">
            <para>254.<emphasis role="strong">Collins MD, Hoyles L, Tornqvist E, von Essen R, Falsen E.</emphasis> 2001. Characterization of some strains from human clinical sources which resemble “<citetitle><emphasis>Leptotrichia sanguinegens</emphasis></citetitle>”: description of <citetitle><emphasis>Sneathia sanguinegens</emphasis></citetitle> sp. nov., gen. nov. <citetitle><emphasis>Syst Appl Microbiol</emphasis></citetitle> <emphasis role="strong">24:</emphasis>358–361.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0255" role="bibliographyEntry">
            <para>255.<emphasis role="strong">Kotaskova I, Nemec P, Vanerkova M, Malisova B, Tejkalova R, Orban M, Zampachova V, Freiberger T.</emphasis> 2017. First report of <citetitle><emphasis>Sneathia sanguinegens</emphasis></citetitle> together with <citetitle><emphasis>Mycoplasma hominis</emphasis></citetitle> in postpartum prosthetic valve infective endocarditis: a case report. <citetitle><emphasis>BMC Infect D</emphasis></citetitle><citetitle><emphasis>is</emphasis></citetitle> <emphasis role="strong">17:</emphasis>563.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0256" role="bibliographyEntry">
            <para>256.<emphasis role="strong">Theis KR, Florova V, Romero R, Borisov AB, Winters AD, Galaz J, Gomez-Lopez N.</emphasis> 2021. <citetitle><emphasis>Sneathia</emphasis></citetitle>: an emerging pathogen in female reproductive disease and adverse perinatal outcomes. <citetitle><emphasis>Crit Rev Microbiol</emphasis></citetitle> <emphasis role="strong">47:</emphasis>517–542.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0257" role="bibliographyEntry">
            <anchor id="ch0074s0011s0003a0009"/>
            <para>257.<emphasis role="strong">Contreras A, Doan N, Chen C, Rusitanonta T, Flynn MJ, Slots J.</emphasis> 2000. Importance of <citetitle><emphasis>Dialister pneumosintes</emphasis></citetitle> in human periodontitis. <citetitle><emphasis>Oral Microbiol Immunol</emphasis></citetitle> <emphasis role="strong">15:</emphasis>269–272.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0258" role="bibliographyEntry">
            <para>258.<emphasis role="strong">Rôças IN, Siqueira JF Jr.</emphasis> 2006. Characterization of <citetitle><emphasis>Dialister</emphasis></citetitle> species in infected root canals. <citetitle><emphasis>J Endod</emphasis></citetitle> <emphasis role="strong">32:</emphasis>1057–1061.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0259" role="bibliographyEntry">
            <para>259.<emphasis role="strong">Drago L, Vassena C, Saibene AM, Del Fabbro M, Felisati G.</emphasis> 2013. A case of coinfection in a chronic maxillary sinusitis of odontogenic origin: identification of <citetitle><emphasis>Dialister pneumosintes. J Endod</emphasis></citetitle> <emphasis role="strong">39:</emphasis>1084–1087.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0260" role="bibliographyEntry">
            <para>260.<emphasis role="strong">Morio F, Jean-Pierre H, Dubreuil L, Jumas-Bilak E, Calvet L, Mercier G, Devine R, Marchandin H.</emphasis> 2007. Antimicrobial susceptibilities and clinical sources of <citetitle><emphasis>Dialister</emphasis></citetitle> species. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">51:</emphasis>4498–4501.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0261" role="bibliographyEntry">
            <para>261.<emphasis role="strong">Rousée JM, Bermond D, Piémont Y, Tournoud C, Heller R, Kehrli P, Harlay ML, Monteil H, Jaulhac B.</emphasis> 2002. <citetitle><emphasis>Dialister pneumosintes</emphasis></citetitle> associated with human brain abscesses. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">40:</emphasis>3871–3873.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0262" role="bibliographyEntry">
            <para>262.<emphasis role="strong">Cobo F, Rodríguez-Granger J, Sampedro A, Navarro-Marí JM.</emphasis> 2018. Bartholin’s abscess due to <citetitle><emphasis>Dialister micraerophilus</emphasis></citetitle> in a woman presenting with repetitive bartholinitis episodes. <citetitle><emphasis>Med Mal Infect</emphasis></citetitle> <emphasis role="strong">48:</emphasis>225–226.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0263" role="bibliographyEntry">
            <para>263.<emphasis role="strong">Mannan S, Ahmad T, Naeem A, Patel V.</emphasis> 2021. A case of <citetitle><emphasis>Dialister pneumosintes</emphasis></citetitle> bacteremia-associated neck and mediastinal abscess. <citetitle><emphasis>Am J Case Rep</emphasis></citetitle> <emphasis role="strong">22:</emphasis>e930559.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0264" role="bibliographyEntry">
            <para>264.<emphasis role="strong">Soeiro C, Quilici IR, Legoff A, Oussalah MB, Morin M, Alauzet C, Charmillon A.</emphasis> 2019. Hepatic abscess due to <citetitle><emphasis>Dialister pneumosintes</emphasis></citetitle>—a case report. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">59:</emphasis>35–37.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0265" role="bibliographyEntry">
            <para>265.<emphasis role="strong">Kolenbrander PE, Andersen RN, Moore LV.</emphasis> 1989. Coaggregation of <citetitle><emphasis>Fusobacterium nucleatum, Selenomonas flueggei, Selenomonas infelix, Selenomonas noxia,</emphasis></citetitle> and <citetitle><emphasis>Selenomonas sputigena</emphasis></citetitle> with strains from 11 genera of oral bacteria. <citetitle><emphasis>Infect Immun</emphasis></citetitle> <emphasis role="strong">57:</emphasis>3194–3203.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0266" role="bibliographyEntry">
            <para>266.<emphasis role="strong">Siqueira JF Jr, Rôças IN.</emphasis> 2004. Nested PCR detection of <citetitle><emphasis>Centipeda periodontii</emphasis></citetitle> in primary endodontic infections. <citetitle><emphasis>J Endod</emphasis></citetitle> <emphasis role="strong">30:</emphasis>135–137.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0267" role="bibliographyEntry">
            <para>267.<emphasis role="strong">Molitoris E, Wexler HM, Finegold SM.</emphasis> 1997. Sources and antimicrobial susceptibilities of <citetitle><emphasis>Campylobacter gracilis</emphasis></citetitle> and <citetitle><emphasis>Sutterella wadsworthensis. Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">25</emphasis>(Suppl 2)<emphasis role="strong">:</emphasis>S264–S265.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0268" role="bibliographyEntry">
            <para>268.<emphasis role="strong">Williams BL, Hornig M, Parekh T, Lipkin WI.</emphasis> 2012. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of <citetitle><emphasis>Sutterella</emphasis></citetitle> species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. <citetitle><emphasis>MBio</emphasis></citetitle> <emphasis role="strong">3:</emphasis>e00261–11.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0269" role="bibliographyEntry">
            <para>269.<emphasis role="strong">Urbán E, Hortobágyi A, Szentpáli K, Nagy E.</emphasis> 2004. Two intriguing <citetitle><emphasis>Bilophila wadsworthia</emphasis></citetitle> cases from Hungary. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> <emphasis role="strong">53:</emphasis>1167–1169.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0270" role="bibliographyEntry">
            <para>270.<emphasis role="strong">Kelesidis T.</emphasis> 2011. Bloodstream infection with <citetitle><emphasis>Anaerobiospirillum succiniciproducens</emphasis></citetitle>: a potentially lethal infection. <citetitle><emphasis>South Med J</emphasis></citetitle> <emphasis role="strong">104:</emphasis>205–214.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0271" role="bibliographyEntry">
            <para>271.<emphasis role="strong">Malnick H, Williams K, Phil-Ebosie J, Levy AS.</emphasis> 1990. Description of a medium for isolating <citetitle><emphasis>Anaerobiospirillum</emphasis></citetitle> spp., a possible cause of zoonotic disease, from diarrheal feces and blood of humans and use of the medium in a survey of human, canine, and feline feces. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">28:</emphasis>1380–1384.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0272" role="bibliographyEntry">
            <para>272.<emphasis role="strong">Pienaar C, Kruger AJ, Venter EC, Pitout JD.</emphasis> 2003. <citetitle><emphasis>Anaerobiospirillum succiniciproducens</emphasis></citetitle> bacteraemia. <citetitle><emphasis>J Clin Pathol</emphasis></citetitle> <emphasis role="strong">56:</emphasis>316–318.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0273" role="bibliographyEntry">
            <para>273.<emphasis role="strong">Epstein DJ, Ernst K, Rogers R, Carmody E, Aguero-Rosenfeld M.</emphasis> 2017. The brief case: <citetitle><emphasis>Anaerobiospirillum succiniciproducens</emphasis></citetitle> bacteremia and pyomyositis. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">55:</emphasis>665–669.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0274" role="bibliographyEntry">
            <para>274.<emphasis role="strong">Inokuchi R, Ishida T, Maeda J, Nakajima S, Yahagi N, Matsumoto A.</emphasis> 2014. <citetitle><emphasis>Anaerobiospirillum succiniciproducens</emphasis></citetitle>-induced bacteremia in a healthy man. <citetitle><emphasis>Am J Emerg Med</emphasis></citetitle> <emphasis role="strong">32</emphasis><emphasis role="strong">:</emphasis>812.e1–3.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0275" role="bibliographyEntry">
            <para>275.<emphasis role="strong">Alguacil-Guillen M, Ramos-Ruperto L, Ramos Ramos JC, Robles-Marhuenda A, García-Rodriguez J, Mingorance J, Romero-Gómez MP.</emphasis> 2019. MALDI-TOF MS for rapid diagnosis of <citetitle><emphasis>Anaerobiospirillum succiniciproducens</emphasis></citetitle>, an unusual causative agent of bacteraemia in humans. Two case reports and literature review. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">55:</emphasis>130–135.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0276" role="bibliographyEntry">
            <para>276.<emphasis role="strong">Markusse IM, van Mens SP, de Vries PJ.</emphasis> 2018. An unusual causative pathogen of sepsis after a cat bite: <citetitle><emphasis>Anaerobiospirillum succiniciproducens. Neth J Med</emphasis></citetitle> <emphasis role="strong">76:</emphasis>87–89.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0277" role="bibliographyEntry">
            <para>277.<emphasis role="strong">Loubinoux J, Jaulhac B, Piemont Y, Monteil H, Le Faou AE.</emphasis> 2003. Isolation of sulfate-reducing bacteria from human thoracoabdominal pus. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">41:</emphasis>1304–1306.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0278" role="bibliographyEntry">
            <para>278.<emphasis role="strong">Pimentel JD, Chan RC.</emphasis> 2007. <citetitle><emphasis>Desulfovibrio fairfieldensis</emphasis></citetitle> bacteremia associated with choledocholithiasis and endoscopic retrograde cholangiopancreatography. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">45:</emphasis>2747–2750.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0279" role="bibliographyEntry">
            <para>279.<emphasis role="strong">Warren YA, Citron DM, Merriam CV, Goldstein EJ.</emphasis> 2005. Biochemical differentiation and comparison of <citetitle><emphasis>Desulfovibrio</emphasis></citetitle> species and other phenotypically similar genera. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>4041–4045.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0280" role="bibliographyEntry">
            <para>280.<emphasis role="strong">Ichiishi S, Tanaka K, Nakao K, Izumi K, Mikamo H, Watanabe K.</emphasis> 2010. First isolation of <citetitle><emphasis>Desulfovibrio</emphasis></citetitle> from the human vaginal flora. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">16:</emphasis>229–233.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0281" role="bibliographyEntry">
            <para>281.<emphasis role="strong">Liderot K, Larsson M, Boräng S, Ozenci V.</emphasis> 2010. Polymicrobial bloodstream infection with <citetitle><emphasis>Eggerthella lenta</emphasis></citetitle> and <citetitle><emphasis>Desulfovibrio desulfuricans. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">48:</emphasis>3810–3812.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0282" role="bibliographyEntry">
            <para>282.<emphasis role="strong">Verstreken I, Laleman W, Wauters G, Verhaegen J.</emphasis> 2012. <citetitle><emphasis>Desulfovibrio desulfuricans</emphasis></citetitle> bacteremia in an immunocompromised host with a liver graft and ulcerative colitis. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">50:</emphasis>199–201.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0283" role="bibliographyEntry">
            <para>283.<emphasis role="strong">Hagiwara S, Yoshida A, Omata Y, Tsukada Y, Takahashi H, Kamewada H, Koike S, Okuzumi K, Hishinuma A, Kobayashi K, Nakano M.</emphasis> 2014. <citetitle><emphasis>Desulfovibrio desulfuricans</emphasis></citetitle> bacteremia in a patient hospitalized with acute cerebral infarction: case report and review. <citetitle><emphasis>J Infect Chemother</emphasis></citetitle> <emphasis role="strong">20:</emphasis>274–277.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0284" role="bibliographyEntry">
            <para>284.<emphasis role="strong">Yamazaki T, Joshita S, Kasuga E, Horiuchi K, Sugiura A, Fujimori N, Komatsu M, Umemura T, Matsumoto A, Tanaka E.</emphasis> 2018. A case of liver abscess co-infected with <citetitle><emphasis>Desulfovibrio desulfuricans</emphasis></citetitle> and <citetitle><emphasis>Escherichia coli</emphasis></citetitle> and review of the literature. <citetitle><emphasis>J Infect Chemother</emphasis></citetitle> <emphasis role="strong">24:</emphasis>393–397.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0285" role="bibliographyEntry">
            <para>285.<emphasis role="strong">Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, Youn E, Summanen PH, Granpeesheh D, Dixon D, Liu M, Molitoris DR, Green JA III.</emphasis> 2010. Pyrosequencing study of fecal microflora of autistic and control children. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">16:</emphasis>444–453.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0286" role="bibliographyEntry">
            <para>286.<emphasis role="strong">Vianna ME, Holtgraewe S, Seyfarth I, Conrads G, Horz HP.</emphasis> 2008. Quantitative analysis of three hydrogenotrophic microbial groups, methanogenic archaea, sulfate-reducing bacteria, and acetogenic bacteria, within plaque biofilms associated with human periodontal disease. <citetitle><emphasis>J Bacteriol</emphasis></citetitle> <emphasis role="strong">190:</emphasis>3779–3785.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0287" role="bibliographyEntry">
            <para>287.<emphasis role="strong">Citron DM, Warren YA, Hudspeth MK, Goldstein EJ.</emphasis> 2000. Survival of aerobic and anaerobic bacteria in purulent clinical specimens maintained in the Copan Venturi Transystem and Becton Dickinson Port-a-Cul transport systems. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">38:</emphasis>892–894.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0288" role="bibliographyEntry">
            <para>288.<emphasis role="strong">Lynch T, Peirano G, Lloyd T, Read R, Carter J, Chu A, Shaman JA, Jarvis JP, Diamond E, Ijaz UZ, Church D.</emphasis> 2019. Molecular diagnosis of vaginitis: comparing quantitative PCR and microbiome profiling approaches to current microscopy scoring. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">57:</emphasis>e00300–19.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0289" role="bibliographyEntry">
            <para>289.<emphasis role="strong">Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, Elborn JS.</emphasis> 2008. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. <citetitle><emphasis>Am J Respir Crit Care Med</emphasis></citetitle> <emphasis role="strong">177</emphasis><emphasis role="strong">:</emphasis>995–1001.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0290" role="bibliographyEntry">
            <para>290.<emphasis role="strong">Gaydos CA, Beqaj S, Schwebke JR, Lebed J, Smith B, Davis TE, Fife KH, Nyirjesy P, Spurrell T, Furgerson D, Coleman J, Paradis S, Cooper CK.</emphasis> 2017. Clinical validation of a test for the diagnosis of vaginitis. <citetitle><emphasis>Obstet Gynecol</emphasis></citetitle> <emphasis role="strong">130:</emphasis>181–189.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0291" role="bibliographyEntry">
            <para>291.<emphasis role="strong">Dunne WM Jr, Westblade LF, Ford B.</emphasis> 2012. Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory. <citetitle><emphasis>Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">31:</emphasis>1719–1726.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0292" role="bibliographyEntry">
            <para>292.<emphasis role="strong">Gloor GB, Hummelen R, Macklaim JM, Dickson RJ, Fernandes AD, MacPhee R, Reid G.</emphasis> 2010. Microbiome profiling by illumina sequencing of combinatorial sequence-tagged PCR products. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">5:</emphasis>e15406.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0293" role="bibliographyEntry">
            <para>293.<emphasis role="strong">Sherry NL, Porter JL, Seemann T, Watkins A, Stinear TP, Howden BP.</emphasis> 2013. Outbreak investigation using high-throughput genome sequencing within a diagnostic microbiology laboratory. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">51:</emphasis>1396–1401.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0294" role="bibliographyEntry">
            <anchor id="ch0074s0011s0003a0010"/>
            <para>294.<emphasis role="strong">Horz HP, Scheer S, Vianna ME, Conrads G.</emphasis> 2010. New methods for selective isolation of bacterial DNA from human clinical specimens. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">16:</emphasis>47–53.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0295" role="bibliographyEntry">
            <para>295.<emphasis role="strong">Vianna ME, Horz HP, Gomes BP, Conrads G.</emphasis> 2005. Microarrays complement culture methods for identification of bacteria in endodontic infections. <citetitle><emphasis>Oral Microbiol Immunol</emphasis></citetitle> <emphasis role="strong">20:</emphasis>253–258.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0296" role="bibliographyEntry">
            <para>296.<emphasis role="strong">Conrads G, Abdelbary MMH.</emphasis> 2019. Challenges of next-generation sequencing targeting anaerobes. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">58:</emphasis>47–52.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0297" role="bibliographyEntry">
            <para>297.<emphasis role="strong">Justesen T, Justesen US.</emphasis> 2013. A simple and sensitive quality control method of the anaerobic atmosphere for identification and antimicrobial susceptibility testing of anaerobic bacteria. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">76:</emphasis>138–140.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0298" role="bibliographyEntry">
            <para>298.<emphasis role="strong">Fiori B, D’Inzeo T, Di Florio V, De Maio F, De Angelis G, Giaquinto A, Campana L, Tanzarella E, Tumbarello M, Antonelli M, Sanguinetti M, Spanu T.</emphasis> 2014. Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>3558–3567.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0299" role="bibliographyEntry">
            <para>299.<emphasis role="strong">Thé T, Curfman A, Burnham CD, Hayes E, Schnadower D, with the Pediatric Emergency Medicine Collaborative Research Committee (PEM-CRC).</emphasis> 2019. Pediatric anaerobic blood culture practices in industrialized countries. <citetitle><emphasis>J Appl Lab Med</emphasis></citetitle> <emphasis role="strong">3:</emphasis>553–558.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0300" role="bibliographyEntry">
            <para>300.<emphasis role="strong">Jensen A, Hagelskjaer Kristensen L, Nielsen H, Prag J.</emphasis> 2008. Minimum requirements for a rapid and reliable routine identification and antibiogram of <citetitle><emphasis>Fusobacterium necrophorum. Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">27:</emphasis>557–563.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0301" role="bibliographyEntry">
            <para>301.<emphasis role="strong">Eribe ERK, Paster BJ, Caugant DA, Dewhirst FE, Stromberg VK, Lacy GH, Olsen I.</emphasis> 2004. Genetic diversity of <citetitle><emphasis>Leptotrichia</emphasis></citetitle> and description of <citetitle><emphasis>Leptotrichia goodfellowii</emphasis></citetitle> sp. nov., <citetitle><emphasis>Leptotrichia hofstadii</emphasis></citetitle> sp. nov., <citetitle><emphasis>Leptotrichia shahii</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Leptotrichia wadei</emphasis></citetitle> sp. nov. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">54:</emphasis>583–592.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0302" role="bibliographyEntry">
            <para>302.<emphasis role="strong">Tee W, Midolo P, Janssen PH, Kerr T, Dyall-Smith ML.</emphasis> 2001. Bacteremia due to <citetitle><emphasis>Leptotrichia trevisanii</emphasis></citetitle> sp. nov. <citetitle><emphasis>Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">20:</emphasis>765–769.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0303" role="bibliographyEntry">
            <para>303.<emphasis role="strong">Loubinoux J, Valente FM, Pereira IA, Costa A, Grimont PA, Le Faou AE.</emphasis> 2002. Reclassification of the only species of the genus <citetitle><emphasis>Desulfomonas, Desulfomonas pigra</emphasis></citetitle>, as <citetitle><emphasis>Desulfovibrio piger</emphasis></citetitle> comb. nov. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>1305–1308.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0304" role="bibliographyEntry">
            <para>304.<emphasis role="strong">Lagier JC, Armougom F, Mishra AK, Nguyen TT, Raoult D, Fournier PE.</emphasis> 2012. Non-contiguous finished genome sequence and description of <citetitle><emphasis>Alistipes timonensis</emphasis></citetitle> sp. nov. <citetitle><emphasis>Stand Genomic Sci</emphasis></citetitle> <emphasis role="strong">6:</emphasis>315–324.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0305" role="bibliographyEntry">
            <para>305.<emphasis role="strong">Goldstein EJ, Citron DM, Goldman PJ, Goldman RJ.</emphasis> 2008. National hospital survey of anaerobic culture and susceptibility methods. <citetitle><emphasis>III. Anaerobe</emphasis></citetitle> <emphasis role="strong">14:</emphasis>68–72.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0306" role="bibliographyEntry">
            <para>306.<emphasis role="strong">Mory F, Alauzet C, Matuszeswski C, Riegel P, Lozniewski A.</emphasis> 2009. Evaluation of the new Vitek 2 ANC card for identification of medically relevant anaerobic bacteria. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">47:</emphasis>1923–1926.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0307" role="bibliographyEntry">
            <para>307.<emphasis role="strong">Rennie RP, Brosnikoff C, Turnbull L, Reller LB, Mirrett S, Janda W, Ristow K, Krilcich A.</emphasis> 2008. Multicenter evaluation of the Vitek 2 anaerobe and <citetitle><emphasis>Corynebacterium</emphasis></citetitle> identification card. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">46:</emphasis>2646–2651.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0308" role="bibliographyEntry">
            <para>308.<emphasis role="strong">Lee EH, Degener JE, Welling GW, Veloo AC.</emphasis> 2011. Evaluation of the Vitek 2 ANC card for identification of clinical isolates of anaerobic bacteria. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">49:</emphasis>1745–1749.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0309" role="bibliographyEntry">
            <para>309.<emphasis role="strong">Pedersen RM, Marmolin ES, Justesen US.</emphasis> 2013. Species differentiation of <citetitle><emphasis>Bacteroides dorei</emphasis></citetitle> from <citetitle><emphasis>Bacteroides vulgatus</emphasis></citetitle> and <citetitle><emphasis>Bacteroides ovatus</emphasis></citetitle> from <citetitle><emphasis>Bacteroides xylanisolvens</emphasis></citetitle>—back to basics. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">24:</emphasis>1–3.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0310" role="bibliographyEntry">
            <para>310.<emphasis role="strong">Sakamoto M, Benno Y.</emphasis> 2006. Reclassification of <citetitle><emphasis>Bacteroides distasonis, Bacteroides goldsteinii</emphasis></citetitle> and <citetitle><emphasis>Bacteroides merdae</emphasis></citetitle> as <citetitle><emphasis>Parabacteroides distasonis</emphasis></citetitle> gen. nov., comb. nov., <citetitle><emphasis>Parabacteroides goldsteinii</emphasis></citetitle> comb. nov. and <citetitle><emphasis>Parabacteroides merdae</emphasis></citetitle> comb. nov. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">56:</emphasis>1599–1605.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0311" role="bibliographyEntry">
            <para>311.<emphasis role="strong">Song YL, Liu CX, McTeague M, Finegold SM.</emphasis> 2004. <citetitle><emphasis>“Bacteroides nordii</emphasis></citetitle>” sp. nov. and “<citetitle><emphasis>Bacteroides salyersae</emphasis></citetitle>” sp. nov. isolated from clinical specimens of human intestinal origin. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">42:</emphasis>5565–5570.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0312" role="bibliographyEntry">
            <para>312.<emphasis role="strong">Hudspeth MK, Hunt Gerardo S, Maiden MF, Citron DM, Goldstein EJ.</emphasis> 1999. Characterization of <citetitle><emphasis>Bacteroides forsythus</emphasis></citetitle> strains from cat and dog bite wounds in humans and comparison with monkey and human oral strains. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">37:</emphasis>2003–2006.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0313" role="bibliographyEntry">
            <para>313.<emphasis role="strong">Gürsoy M, Harju I, Matomäki J, Bryk A, Könönen E.</emphasis> 2017. Performance of MALDI-TOF MS for identification of oral <citetitle><emphasis>Prevotella</emphasis></citetitle> species. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">47:</emphasis>89–93.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0314" role="bibliographyEntry">
            <para>314.<emphasis role="strong">Downes J, Sutcliffe I, Tanner ACR, Wade WG.</emphasis> 2005. <citetitle><emphasis>Prevotella marshii</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Prevotella baroniae</emphasis></citetitle> sp. nov., isolated from the human oral cavity. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">55:</emphasis>1551–1555.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0315" role="bibliographyEntry">
            <para>315.<emphasis role="strong">Bank S, Nielsen HM, Mathiasen BH, Leth DC, Kristensen LH, Prag J.</emphasis> 2010. <citetitle><emphasis>Fusobacterium necrophorum</emphasis></citetitle>—detection and identification on a selective agar. <citetitle><emphasis>APMIS</emphasis></citetitle> <emphasis role="strong">118:</emphasis>994–999.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0316" role="bibliographyEntry">
            <para>316.<emphasis role="strong">Nagai F, Morotomi M, Sakon H, Tanaka R.</emphasis> 2009. <citetitle><emphasis>Parasutterella excrementihominis</emphasis></citetitle> gen. nov., sp. nov., a member of the family <citetitle><emphasis>Alcaligenaceae</emphasis></citetitle> isolated from human faeces. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">59:</emphasis>1793–1797.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0317" role="bibliographyEntry">
            <para>317.<emphasis role="strong">Justesen US, Holm A, Knudsen E, Andersen LB, Jensen TG, Kemp M, Skov MN, Gahrn-Hansen B, Møller JK.</emphasis> 2011. Species identification of clinical isolates of anaerobic bacteria: a comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry systems. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">49:</emphasis>4314–4318.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0318" role="bibliographyEntry">
            <para>318.<emphasis role="strong">Nagy E, Maier T, Urban E, Terhes G, Kostrzewa M, ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria.</emphasis> 2009. Species identification of clinical isolates of <citetitle><emphasis>Bacteroides</emphasis></citetitle> by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">15:</emphasis>796–802.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0319" role="bibliographyEntry">
            <para>319.<emphasis role="strong">Stîngu CS, Rodloff AC, Jentsch H, Schaumann R, Eschrich K.</emphasis> 2008. Rapid identification of oral anaerobic bacteria cultivated from subgingival biofilm by MALDI-TOF-MS. <citetitle><emphasis>Oral Microbiol Immunol</emphasis></citetitle> <emphasis role="strong">23:</emphasis>372–376.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0320" role="bibliographyEntry">
            <para>320.<emphasis role="strong">Wybo I, Soetens O, De Bel A, Echahidi F, Vancutsem E, Vandoorslaer K, Piérard D.</emphasis> 2012. Species identification of clinical <citetitle><emphasis>Prevotella</emphasis></citetitle> isolates by matrix-assisted laser desorption ionization-time of flight mass spectrometry. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">50:</emphasis>1415–1418.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0321" role="bibliographyEntry">
            <para>321.<emphasis role="strong">Veloo AC, Knoester M, Degener JE, Kuijper EJ.</emphasis> 2011. Comparison of two matrix-assisted laser desorption ionisation-time of flight mass spectrometry methods for the identification of clinically relevant anaerobic bacteria. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">17:</emphasis>1501–1506.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0322" role="bibliographyEntry">
            <para>322.<emphasis role="strong">Fournier R, Wallet F, Grandbastien B, Dubreuil L, Courcol R, Neut C, Dessein R.</emphasis> 2012. Chemical extraction versus direct smear for MALDI-TOF mass spectrometry identification of anaerobic bacteria. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">18:</emphasis>294–297.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0323" role="bibliographyEntry">
            <para>323.<emphasis role="strong">Alcalá L, Marín M, Ruiz A, Quiroga L, Zamora-Cintas M, Fernández-Chico MA, Muñoz P, Rodríguez-Sánchez B.</emphasis> 2021. Identifying anaerobic bacteria using MALDI-TOF mass spectrometry: a four-year experience. <citetitle><emphasis>Front Cell Infect Microbiol</emphasis></citetitle> <emphasis role="strong">11:</emphasis>521014.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0324" role="bibliographyEntry">
            <para>324.<emphasis role="strong">Nagy E, Becker S, Sóki J, Urbán E, Kostrzewa M.</emphasis> 2011. Differentiation of division I (<citetitle><emphasis>cfiA</emphasis></citetitle>-negative) and division II (<citetitle><emphasis>cfiA</emphasis></citetitle>-positive) <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle> strains by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> <emphasis role="strong">60:</emphasis>1584–1590.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0325" role="bibliographyEntry">
            <para>325.<emphasis role="strong">Wybo I, De Bel A, Soetens O, Echahidi F, Vandoorslaer K, Van Cauwenbergh M, Piérard D.</emphasis> 2011. Differentiation of <citetitle><emphasis>cfiA</emphasis></citetitle>-negative and <citetitle><emphasis>cfiA</emphasis></citetitle>-positive <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle> isolates by matrix-assisted laser desorption ionization-time of flight mass spectrometry. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">49:</emphasis>1961–1964.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0326" role="bibliographyEntry">
            <para>326.<emphasis role="strong">Ho PL, Yau CY, Ho LY, Chen JHK, Lai ELY, Lo SWU, Tse CWS, Chow KH.</emphasis> 2017. Rapid detection of <citetitle><emphasis>cfiA</emphasis></citetitle> metallo-β-lactamase-producing <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle> by the combination of MALDI-TOF MS and CarbaNP. <citetitle><emphasis>J Clin Pathol</emphasis></citetitle> <emphasis role="strong">70:</emphasis>868–873.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0327" role="bibliographyEntry">
            <para>327.<emphasis role="strong">Cordovana M, Kostrzewa M, Sóki J, Witt E, Ambretti S, Pranada AB.</emphasis> 2018. <citetitle><emphasis>Bacteroides fragilis:</emphasis></citetitle> a whole MALDI-based workflow from identification to confirmation of carbapenemase production for routine laboratories. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">54:</emphasis>246–253.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0328" role="bibliographyEntry">
            <anchor id="ch0074s0011s0003a0011"/>
            <para>328.<emphasis role="strong">Li Y, Shan M, Zhu Z, Mao X, Yan M, Chen Y, Zhu Q, Li H, Gu B.</emphasis> 2019. Application of MALDI-TOF MS to rapid identification of anaerobic bacteria. <citetitle><emphasis>BMC Infect Dis</emphasis></citetitle> <emphasis role="strong">19:</emphasis>941.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0329" role="bibliographyEntry">
            <para>329.<emphasis role="strong">Shannon S, Kronemann D, Patel R, Schuetz AN.</emphasis> 2018. Routine use of MALDI-TOF MS for anaerobic bacterial identification in clinical microbiology. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">54:</emphasis>191–196.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0330" role="bibliographyEntry">
            <para>330.<emphasis role="strong">Toprak NU, Veloo ACM, Urban E, Wybo I, Jean-Pierre H, Morris T, Justesen US, Tripkovic V, Jeverica S, Soyletir G, Nagy E, ESCMID Study Group for Anaerobic Infections (ESGAI).</emphasis> 2019. Comparing identification of clinically relevant <citetitle><emphasis>Prevotella</emphasis></citetitle> species by VITEK MS and MALDI biotyper. <citetitle><emphasis>Acta Microbiol Immunol Hung</emphasis></citetitle> <emphasis role="strong">67:</emphasis>6–13.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0331" role="bibliographyEntry">
            <para>331.<emphasis role="strong">Zamora-Cintas M, Marín M, Quiroga L, Martínez A, Fernández-Chico MA, Bouza E, Rodríguez-Sánchez B, Alcalá L.</emphasis> 2018. Identification of <citetitle><emphasis>Porphyromonas</emphasis></citetitle> isolates from clinical origin using MALDI-TOF mass spectrometry. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">54:</emphasis>197–200.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0332" role="bibliographyEntry">
            <para>332.<emphasis role="strong">Clarridge JE III.</emphasis> 2004. Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">17:</emphasis>840–862.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0333" role="bibliographyEntry">
            <para>333.<emphasis role="strong">Song Y, Liu C, Bolanos M, Lee J, McTeague M, Finegold SM.</emphasis> 2005. Evaluation of 16S rRNA sequencing and reevaluation of a short biochemical scheme for identification of clinically significant <citetitle><emphasis>Bacteroides</emphasis></citetitle> species. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>1531–1537.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0334" role="bibliographyEntry">
            <para>334.<emphasis role="strong">Adékambi T, Drancourt M, Raoult D.</emphasis> 2009. The <citetitle><emphasis>rpoB</emphasis></citetitle> gene as a tool for clinical microbiologists. <citetitle><emphasis>Trends Microbiol</emphasis></citetitle> <emphasis role="strong">17:</emphasis>37–45.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0335" role="bibliographyEntry">
            <para>335.<emphasis role="strong">Strauss J, White A, Ambrose C, McDonald J, Allen-Vercoe E.</emphasis> 2008. Phenotypic and genotypic analyses of clinical <citetitle><emphasis>Fusobacterium nucleatum</emphasis></citetitle> and <citetitle><emphasis>Fusobacterium periodonticum</emphasis></citetitle> isolates from the human gut. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">14:</emphasis>301–309.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0336" role="bibliographyEntry">
            <para>336.<emphasis role="strong">Chen YR, Zhou LZ, Fang ST, Long HY, Chen JY, Zhang GX.</emphasis> 2019. Isolation of <citetitle><emphasis>Desulfovibrio</emphasis></citetitle> spp. from human gut microbiota using a next-generation sequencing directed culture method. <citetitle><emphasis>Lett Appl Microbiol</emphasis></citetitle> <emphasis role="strong">68:</emphasis>553–561.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0337" role="bibliographyEntry">
            <para>337.<emphasis role="strong">Boers SA, Jansen R, Hays JP.</emphasis> 2019. Understanding and overcoming the pitfalls and biases of next-generation sequencing (NGS) methods for use in the routine clinical microbiological diagnostic laboratory. <citetitle><emphasis>Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">38:</emphasis>1059–1070.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0338" role="bibliographyEntry">
            <para>338.<emphasis role="strong">Church DL, Cerutti L, Gürtler A, Griener T, Zelazny A, Emler S.</emphasis> 2020. Performance and application of 16S rRNA gene cycle sequencing for routine identification of bacteria in the clinical microbiology laboratory. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">33:</emphasis>e00053–19.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0339" role="bibliographyEntry">
            <para>339.<emphasis role="strong">Yoo IY, Kang OK, Lee MK, Kim YJ, Cho SY, Huh K, Kang CI, Chung DR, Peck KR, Huh HJ, Lee NY.</emphasis> 2020. Comparison of 16S ribosomal RNA targeted sequencing and culture for bacterial identification in normally sterile body fluid samples: report of a 10-year clinical laboratory review. <citetitle><emphasis>Ann Lab Med</emphasis></citetitle> <emphasis role="strong">40:</emphasis>63–67.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0340" role="bibliographyEntry">
            <para>340.<emphasis role="strong">Jamal W, Khodakhast FB, AlAzmi A, Sόki J, AlHashem G, Rotimi VO.</emphasis> 2020. Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle> among 13-year collection of isolates in Kuwait. <citetitle><emphasis>BMC Microb</emphasis></citetitle><citetitle><emphasis>iol</emphasis></citetitle> <emphasis role="strong">20:</emphasis>14.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0341" role="bibliographyEntry">
            <para>341.<emphasis role="strong">Kierzkowska M, Majewska A, Mlynarczyk G.</emphasis> 2020. Trends and impact in antimicrobial resistance among <citetitle><emphasis>Bacteroides</emphasis></citetitle> and <citetitle><emphasis>Parabacteroides</emphasis></citetitle> species in 2007-2012 compared to 2013-2017. <citetitle><emphasis>Microb Drug Resist</emphasis></citetitle> <emphasis role="strong">26:</emphasis>1452–1457.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0342" role="bibliographyEntry">
            <para>342.<emphasis role="strong">Maraki S, Mavromanolaki VE, Stafylaki D, Kasimati A.</emphasis> 2020. Surveillance of antimicrobial resistance in recent clinical isolates of Gram-negative anaerobic bacteria in a Greek university hospital. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">62:</emphasis>102173.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0343" role="bibliographyEntry">
            <para>343.<emphasis role="strong">Forbes JD, Kus JV, Patel SN.</emphasis> 2021. Antimicrobial susceptibility profiles of invasive isolates of anaerobic bacteria from a large Canadian reference laboratory: 2012-2019. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">70:</emphasis>102386.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0344" role="bibliographyEntry">
            <para>344.<emphasis role="strong">König E, Ziegler HP, Tribus J, Grisold AJ, Feierl G, Leitner E.</emphasis> 2021. Surveillance of antimicrobial usceptibility of anaerobe clinical isolates in Southeast Austria: <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle> group is on the fast track to resistance. <citetitle><emphasis>Antibiotics (Base</emphasis></citetitle><citetitle><emphasis>l)</emphasis></citetitle> <emphasis role="strong">10:</emphasis>479.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0345" role="bibliographyEntry">
            <para>345.<emphasis role="strong">Goldstein EJC, Citron DM, Tyrrell KL.</emphasis> 2018. In vitro activity of eravacycline and comparator antimicrobials against 143 recent strains of <citetitle><emphasis>Bacteroides</emphasis></citetitle> and <citetitle><emphasis>Parabacteroides</emphasis></citetitle> species. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">52:</emphasis>122–124.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0346" role="bibliographyEntry">
            <para>346.<emphasis role="strong">Snydman DR, McDermott LA, Jacobus NV, Kerstein K, Grossman TH, Sutcliffe JA.</emphasis> 2018. Evaluation of the in vitro activity of eravacycline against a broad spectrum of recent clinical anaerobic isolates. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">62:</emphasis>e02206–19.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0347" role="bibliographyEntry">
            <para>347.<emphasis role="strong">Conrads G, Nagy E, Könönen E.</emphasis> 2019. <citetitle><emphasis>Bacteroides, Porphyromonas, Prevotella, Fusobacterium</emphasis></citetitle>, and other anaerobic Gram-negative rods, p 995–1023. <citetitle><emphasis>In</emphasis></citetitle> Carroll KC, Pfaller MA, Landry ML, McAdam AJ, Patel R, Richter SS, Warnock DW (ed), <citetitle><emphasis>Manual of Clinical Microbiology</emphasis></citetitle>, 12th ed. ASM Press, Washington, DC.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0348" role="bibliographyEntry">
            <para>348.<emphasis role="strong">Byun JH, Kim M, Lee Y, Lee K, Chong Y.</emphasis> 2019. Antimicrobial susceptibility patterns of anaerobic bacterial clinical isolates from 2014 to 2016, including recently named or renamed species. <citetitle><emphasis>Ann Lab Med</emphasis></citetitle> <emphasis role="strong">39:</emphasis>190–199.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0349" role="bibliographyEntry">
            <para>349.<emphasis role="strong">Gao Q, Wu S, Xu T, Zhao X, Huang H, Hu F.</emphasis> 2019. Emergence of carbapenem resistance in <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle> in China. <citetitle><emphasis>Int J Antimicrob Agents</emphasis></citetitle> <emphasis role="strong">53:</emphasis>859–863.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0350" role="bibliographyEntry">
            <para>350.<emphasis role="strong">Sóki J, Wybo I, Hajdú E, Toprak NU, Jeverica S, Stingu CS, Tierney D, Perry JD, Matuz M, Urbán E, Nagy E, ESCMID Study Group on Anaerobic Infections.</emphasis> 2020. A Europe-wide assessment of antibiotic resistance rates in <citetitle><emphasis>Bacteroides</emphasis></citetitle> and <citetitle><emphasis>Parabacteroides</emphasis></citetitle> isolates from intestinal microbiota of healthy subjects. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">62:</emphasis>102182.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0351" role="bibliographyEntry">
            <para>351.<emphasis role="strong">Ulger Toprak N, Veloo ACM, Urban E, Wybo I, Justesen US, Jean-Pierre H, Morris T, Akgul O, Kulekci G, Soyletir G, Nagy E, ESCMID Study Group for Anaerobic Infections (ESGAI).</emphasis> 2018. A multicenter survey of antimicrobial susceptibility of <citetitle><emphasis>Prevotella</emphasis></citetitle> species as determined by Etest methodology. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">52:</emphasis>9–15.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0352" role="bibliographyEntry">
            <para>352.<emphasis role="strong">Ogane K, Tarumoto N, Kodana M, Onodera A, Imai K, Sakai J, Kawamura T, Takeuchi S, Murakami T, Mitsutake K, Ikebuchi K, Maesaki S, Maeda T.</emphasis> 2020. Antimicrobial susceptibility and prevalence of resistance genes in <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle> isolated from blood culture bottles in two tertiary care hospitals in Japan. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">64:</emphasis>102215.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0353" role="bibliographyEntry">
            <para>353.<emphasis role="strong">Hansen KCM, Schwensen SAF, Henriksen DP, Justesen US, Sydenham TV.</emphasis> 2017. Antimicrobial resistance in the <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle> group in faecal samples from patients receiving broad-spectrum antibiotics. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">47:</emphasis>79–85.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0354" role="bibliographyEntry">
            <para>354.<emphasis role="strong">Rong SMM, Rodloff AC, Stingu CS.</emphasis> 2021. Diversity of antimicrobial resistance genes in <citetitle><emphasis>Bacteroides</emphasis></citetitle> and <citetitle><emphasis>Parabacteroides</emphasis></citetitle> strains isolated in Germany. <citetitle><emphasis>J Glob Antimicrob Resist</emphasis></citetitle> <emphasis role="strong">24:</emphasis>328–334.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0355" role="bibliographyEntry">
            <para>355.<emphasis role="strong">Boyanova L, Markovska R, Mitov I.</emphasis> 2019. Multidrug resistance in anaerobes. <citetitle><emphasis>Future Microbiol</emphasis></citetitle> <emphasis role="strong">14:</emphasis>1055–1064.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0356" role="bibliographyEntry">
            <para>356.<emphasis role="strong">Sethi S, Shukla R, Bala K, Gautam V, Angrup A, Ray P.</emphasis> 2019. Emerging metronidazole resistance in <citetitle><emphasis>Bacteroides</emphasis></citetitle> spp. and its association with the <citetitle><emphasis>nim</emphasis></citetitle> gene: a study from North India. <citetitle><emphasis>J Glob Antimicrob Resist</emphasis></citetitle> <emphasis role="strong">16:</emphasis>210–214.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0357" role="bibliographyEntry">
            <para>357.<emphasis role="strong">Yekani M, Baghi HB, Naghili B, Vahed SZ, Sóki J, Memar MY.</emphasis> 2020. To resist and persist: important factors in the pathogenesis of <citetitle><emphasis>Bacteroides fragilis. Microb Pathog</emphasis></citetitle> <emphasis role="strong">149:</emphasis>104506.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0358" role="bibliographyEntry">
            <para>358.<emphasis role="strong">Ghotaslou R, Yekani M, Memar MY.</emphasis> 2018. The role of efflux pumps in <citetitle><emphasis>Bacteroides fragilis</emphasis></citetitle> resistance to antibiotics. <citetitle><emphasis>Microbiol Res</emphasis></citetitle> <emphasis role="strong">210:</emphasis>1–5.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0359" role="bibliographyEntry">
            <para>359.<emphasis role="strong">Band VI, Weiss DS.</emphasis> 2019. Heteroresistance: a cause of unexplained antibiotic treatment failure? <citetitle><emphasis>PLoS Pathog</emphasis></citetitle> <emphasis role="strong">15</emphasis><emphasis role="strong">:</emphasis>e1007726.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0360" role="bibliographyEntry">
            <para>360.<emphasis role="strong">Sóki J, Eitel Z, Urbán E, Nagy E, ESCMID Study Group on Anaerobic Infections.</emphasis> 2013. Molecular analysis of the carbapenem and metronidazole resistance mechanisms of <citetitle><emphasis>Bacteroides</emphasis></citetitle> strains reported in a Europe-wide antibiotic resistance survey. <citetitle><emphasis>Int J Antimicrob Agents</emphasis></citetitle> <emphasis role="strong">41:</emphasis>122–125.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0361" role="bibliographyEntry">
            <para>361.<emphasis role="strong">Dubreuil L, Veloo AC, Sóki J, ESCMID Study Group for Anaerobic Infections (ESGAI).</emphasis> 2021. Correlation between antibiotic resistance and clinical outcome of anaerobic infections: mini-review. <citetitle><emphasis>Anaerobe</emphasis></citetitle> <emphasis role="strong">72:</emphasis>102463.</para>
          </listitem>
          <listitem id="ch0074s0011s0003li0362" role="bibliographyEntry">
            <para>362.<emphasis role="strong">Shafquat Y, Jabeen K, Farooqi J, Mehmood K, Irfan S, Hasan R, Zafar A.</emphasis> 2019. Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan. <citetitle><emphasis>Antimicrob Resist Infect Control</emphasis></citetitle> <emphasis role="strong">8:</emphasis>99.</para>
          </listitem>
        </itemizedlist>
      </sect2>
    </sect1>
  </chapter>
